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FOSTERING COMPASSIONATE CARE FOR PERSONS WITH ALZHEIMER’S 
DISEASE LIVING IN NURSING FACILITIES 
Sam Gilbert Cotton  
November 12, 2018  
The aim of this dissertation study was to examine the impact of the 
implementation of a new Compassionate Care (CC) curriculum on the quality of care 
provided by Certified Nursing Assistants (CNAs) to residents with Alzheimer’s disease 
(AD). More specifically, this dissertation used Kirkpatrick’s model of evaluation to 
assess the reactions, learning, and behavior change of the CNAs exposed to the 
curriculum, and ultimately the impact of the curriculum on the stress levels of residents 
with AD. To accomplish this, we had two studies that aligned with the Kirkpatrick model 
of evaluation.   
For Study #1, the evaluation of the compassionate care curriculum (Kirkpatrick 
Levels One, Two, and Three), the following hypotheses guided the study: Hypothesis 1: 
After completion of the compassionate care curriculum by the CNA experimental group, 
CNAs will show a significantly higher increase in knowledge, caregiving self-efficacy, 
caregiving satisfaction and a significantly higher reduction in feelings of affiliate stigma 
than the CNAs who completed the current standard curriculum (control group).  
 vii 
For Study #2, Evaluation of the Compassionate Care Curriculum (Kirkpatrick 
Level Four), the following hypotheses were used to guide the study:  Hypothesis 1a: 
Residents with AD from the experimental nursing facility will have a different 12-week 
agitation change trajectory from the residents with AD from the control nursing facility. 
Hypothesis 1b: Residents with AD from the experimental nursing facility will have a 
different 12-week salivary cortisol change trajectory from the residents with AD from the 
control nursing facility. Hypothesis 2a: Differences in change in CNAs knowledge, 
confidence, satisfaction and affiliate stigma will have a differential effect on the 12-week 
agitation trajectories of residents with AD in the experimental and control nursing 
facilities. Hypothesis 2b: Differences in change in CNAs knowledge, confidence, 
satisfaction and stigma and differences in residents with AD agitation will have a 
differential effect on the 12-week salivary cortisol trajectories of residents with AD in the 
experimental and control nursing facilities. 
Methods: The study included an experimental and control nursing facility. The 
sample of residents with AD from the two facilities, including a convenient sample of 25 
residents from the experimental group and 27 from the control group. All the CNAs who 
took care of the residents with AD that took part in the study were also included in the 
study for a total of 99 CNAs, 48 in the experimental group and 51 in the control group.   
At baseline, prior to the implementation of the curriculum, data were collected on 
the demographics of the CNAs along with their pre-test on AD knowledge, self-efficacy, 
caregiving satisfaction, and affiliate stigma for both the experimental and control groups. 
At the 12-week period, after the curriculum and care groups were implemented, data on 
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AD knowledge, self-efficacy, caregiving satisfaction, and affiliate stigma were collected 
again for both groups. 
After equivalency between the two groups was tested, a two-way mixed method 
MANOVA was utilized to examine how scores changed for all of the dependent 
variables. For this study, the focus of the analysis was to examine whether there was a 
significant difference over time (within-subjects), whether there were differences 
between the control and experimental groups (between-subjects), and whether there was 
an interaction effect between time and group, indicating if the groups change differently 
over time.  
The second study examined the final element of the Kirkpatrick model, namely 
stress levels of residents with AD. This study was conducted by testing a hybrid 
multilevel growth model.  
Results: CNAs changes in terms of their knowledge of AD, self-efficacy, 
caregiving satisfaction and affiliate stigma were analyzed to understand the impact the 
compassionate care curriculum had on the CNAs, using levels 1, 2 and 3 of the 
Kirkpatrick Evaluation Model. For AD knowledge, we saw a significant increase in 
scores from baseline to 12 weeks for the experimental group while the control group 
remained the same over the 12-week period. Self-efficacy for the experimental group 
improved between baseline and 12-weeks but deteriorated slightly for the control group. 
Caregiver satisfaction showed a slight improvement at 12-weeks for both groups, yet the 
experimental group showed a trend of greater improvement than the control group. For 
the experimental group, feelings of affiliate stigma declined between baseline and 12- 
weeks, while the control group remained similar at the 12-week period.   
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From the Kirkpatrick model, level 4 examined outcomes. This study focused on 
the stress outcomes of the residents with AD, specifically agitation and salivary cortisol 
levels.  All models built showed that the experimental group performed better in reducing 
agitation and reducing salivary cortisol levels. The final models were able to show how 
the changes in the CNAs specifically affected these positive outcomes. CNA knowledge 
and self-efficacy had the most impact on changing agitation levels, and CNA knowledge 
and agitation levels had the most impact on salivary cortisol levels.  
Conclusions: The results of this study showed that integrating a compassionate 
care curriculum into the work that CNAs perform with persons with AD can lead to 
positive outcomes on CNAs knowledge, self-efficacy, caregiving satisfaction, affiliate 
stigma and a reduction of agitation and cortisol levels in persons with AD. This has 
implications for the way we conceptualize the type of care that is provided by CNAs to 
persons with AD in nursing facilities. Currently, CNAs are trained to only provide 
traditional basic nursing care focuses primarily on the basic needs of the person such as 
attending to activities of daily living. While traditional basic nursing care is important, it 
should be supplemented with compassionate care for persons with AD. Compassionate 
care (CC) emphasizes the bond between the caregiver (the CNA) and the care receiver 
(the person with AD) and their journey together. CC can also provide CNAs with skills to 
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CHAPTER I: PROBLEM STATEMENT 
Alzheimer’s Disease (AD) is a progressive neurodegenerative disorder that affects 
cognition and daily functioning (Liang et al., 2016). It is characterized by what it strips 
from persons suffering in its grasp. It progressively destroys the ability to eat, walk, bathe 
and dress. It slowly erodes memories and perceptions of time, along the way, taking 
pieces of one’s identity. The changes experienced by persons with AD contributes to an 
inability to recall the context of what is occurring, which in turn, invites delusions, 
anxiety, and at times agitation. As the brain undergoes changes, persons with AD slowly 
retreat from the realities of this world and into a world of their own. In some instances 
persons with AD  are labeled the “living dead” and their last years are referred to as “the 
funeral that never ends” (Behuniak, 2011).   
 As the sixth leading cause of death in the United States (Centers for Disease 
Control and Prevention, 2017 ), AD kills more persons each year than prostate and breast 
cancer combined (Alzheimer’s Association, 2018). It is the only disease in the top 
contributors of death for which we have no prevention or cure and no means of slowing 
its progression (Alzheimer’s Association, 2018). The average time lapse between an 
individual exhibiting any symptoms of the disease and receiving the diagnosis is 2.8 
years (Brookmeyer, Corrada, Curriero, & Kawas, 2002). Currently, one in 10 persons 
aged 65 and older have a diagnosis of AD-type dementia (Alzheimer’s Association, 
2018). Between 2000 and 2014, there was an 89% increase in deaths attributed to the 
 2 
disease. During this time frame, deaths from AD nearly doubled while reported deaths of 
the number one killer, cardiovascular disease, declined (Alzheimer’s Association, 2018). 
The disease affects 5.5 million persons in the United States and every 66 seconds a 
person is diagnosed with AD (Centers for Disease Control and Prevention, 2017 ). In 
Kentucky, home to just over 4 million people, the story is similarly dire. Kentucky is 
ranked 18th in the nation for AD mortality (United States Department of Health and 
Human Services Centers for Disease Control, 2018). There are 71,000 persons or 1.6 % 
of the population diagnosed with AD in Kentucky, and this number is projected to 
increase by 21.1% to 86,000 persons by 2025 or 1.9% of the population (Alzheimer’s 
Association, 2018).  
As Alzheimer’s disease progresses cognition, including language, thought, memory, 
executive function, judgment, attention, perception, and the ability to live a purposeful 
life changes and it becomes difficult for persons with AD to live a normal life (National 
Research Council, 2000). Behavior changes and daily living concerns caused by the 
disease creates problems for caregivers to provide care and engagement in a meaningful 
way (Beck, Ortigara, Mercer, & Shue, 1999). Estimates suggest that aggression occurs in 
roughly 40% to 60% of persons living in facilities such as nursing homes  (Corbett, 
Smith, Creese, & Ballard, 2012). These behaviors are related to greater overall 
impairment in functioning and short survival time (Weiner, Hynan, Bret, & White, 2005). 
The focus of care shifts to keeping persons with AD safe and managing activities of daily 
living.  
As a result, more persons with AD and other forms of dementia are receiving care 
from formal care providers in nursing home facilities (Gaugler, Fang, Davila, & Shippee, 
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2014). According to a study by the Centers for Disease Control and Prevention, in 2014 
there were 1,369,700 current residents in nursing homes with more than half having AD 
or related dementia (Harris-Kojetin et al., 2016). Having an AD diagnosis increases the 
chance that an individual will be admitted to a nursing home. It is predicted that an 
estimated 4% of the general population will be admitted into a nursing home by age 80 
compared to 75% of persons with AD at the same age (Alzheimer’s Association, 2018). 
Within nursing homes in the United States, Certified Nursing Assistants (CNAs) 
are predominately charged with providing care to persons with AD. It is estimated that 
more than 600,000 CNAs provide direct care that includes personal and activities of daily 
living (ADL) support for the 1.4 million persons with AD that live in nursing facilities in 
the United States (U.S. Census Bureau, 2015). The work performed by CNAs is arduous 
and challenging due to the complexities of providing care to persons with AD. The 
profession experiences high levels of turnover and issues with recruitment from burnout 
and job dissatisfaction (Sengupta, Ejaz, & Harris-Kojetin, 2012).  
The bulk of the care provided by CNAs in nursing facilities is described as basic 
nursing care (Pennington, Scott, & Magilvy, 2003; Reinhard, Young, Kane, & Quinn, 
2003; Stombaugh & Judd, 2014; U.S. Department of Health and Human Services, 2002; 
Wiener, Squillace, Anderson, & Khatutsky, 2009). Basic nursing care is task-oriented and 
designed to meet the essential needs of the person (U.S. Department of Health and 
Human Services, 2002). It is defined as basic infection control, bathing, bed-making, safe 
patient handling, elimination assistance, nutrition and fluids, personal hygiene and 
grooming, and vital signs (Stombaugh & Judd, 2014; U.S. Department of Health and 
Human Services, 2002; Wiener et al., 2009). Certification for CNAs is federally 
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mandated and includes 75-hours of basic nursing care that will be explained in more 
detail later in this chapter. (Reinhard et al., 2003; Wiener et al., 2009). 
Compassionate Care 
CNAs receive limited dementia training, and therefore, are often ill-prepared to 
provide care to persons with AD (Chu, Wodchis, & McGilton, 2014; Pennington et al., 
2003). In Kentucky, CNAs who are employed at nursing homes only receive 10 hours of 
specific dementia training, as part of their license certification (Kentucky Adminstrative 
Regulations, 2006; Patient Protection and Affordable Care Act, 2010). The content of this 
training is primarily focused on the process of providing basic nursing care specifically to 
persons with AD  (Kentucky Adminstrative Regulations, 2006; Patient Protection and 
Affordable Care Act, 2010). Additionally, a portion of the training focuses on how to 
understand and communicate with persons with AD (Kentucky Adminstrative 
Regulations, 2006; Patient Protection and Affordable Care Act, 2010). The training 
CNAs receive in dementia care is insufficient to provide the care persons with AD 
require as the disease progresses (Sengupta, Harris-Kojetin, & Ejaz, 2010).  
Due to the complexities of the disease, persons with AD needs more than just 
basic nursing care. They need care that will allow them to flourish. Flourishing refers to 
the experience of a life going well and represents a combination of feeling good and 
functioning effectively (Huppert & So, 2013), with high levels of emotional, 
psychological, and social well-being (Keyes, 2005). For persons with AD this may not 
look like it would in a highly functioning individual, but it represents living within an 
optimal range of human functioning (Fredrickson & Losada, 2005). It is a state of 
existence where disease or impairment co-exists with dignity and quality of life. The 
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conceptualization of flourishing differs in part from many definitions of health in that the 
expectation of freedom from disease, disability, high cognitive and physical functioning 
and active engagement with life (Rowe & Kahn, 1998) are not required in order to 
flourish.  
In order to train CNAs to provide care that allows persons with AD to flourish 
and improve patient outcomes it is recommended that CNA training hours be increased 
(Trinkoff, Storr, Lerner, Yang, & Han, 2017). This curriculum should supplement the 
existing mandated training CNAs receive and provide a deeper understanding of the 
journey that persons with AD experience as they progress through the disease. CNAs 
have expressed that they felt inadequately prepared for real-life resident care and 
requested additional training (Sengupta et al., 2010).  
Compassionate Care (CC) refers to care that promotes and allows persons with 
AD to flourish by improving the dyadic relationship between the CNA and persons with 
AD. It is achieved by focusing on the physical and mental health of persons with AD 
including neurological, cognitive, general health and psychosocial factors, and also 
factors that are more dynamic, such as the physical and social environment and the 
changing needs and states within persons with AD (Norton, Allen, Snow, Hardin, & 
Burgio, 2010). Improving the dyadic relationship between  persons with AD and their 
caregiver contributes greatly to improved physical and mental health outcomes 
(Pickering, Nurenberg, & Schiamberg, 2017). CC is a response to suffering, distress or 
discomfort that is associated with disease or decline in mental and physical functioning 
(Tierney, Seers, Tutton, & Reeve, 2017).  CC respects the dignity of persons with AD by 
providing the task-oriented care needed to ensure safety and physical functioning as well 
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as the care needed to support mental health, as the disease progresses. CC is deliberate 
and intentional in its focus to alleviate pain and suffering while also promoting that 
persons with AD can flourish throughout their lifespan. This is achieved through the 
implementation of enhanced responses to behaviors and situations that persons with AD 
exhibit. It includes deeper caregiver and care-receiver relationships where the caregiver 
has the ability to communicate in a manner that promotes positive energy within and 
between persons with AD and their families (D. Cohen, 2000). 
 While definitions for CC vary (Dewar, Adamson, Smith, Surfleet, & King, 2014; 
Schantz, 2007; von Dietze & Orbb, 2000) most include the relief of suffering as a key 
concept. The concept of relieving suffering is distinguishable from related concepts such 
as kindness, empathy, sympathy, and pity. In order to provide CC, caregivers must have 
the ability to be open, alert, and sensitive to suffering, and also take action to alleviate or 
prevent suffering from continuing (Gilbert & Choden, 2013). While CNAs are trained to 
alleviate suffering following task-oriented procedures, the standard protocol focused on 
basic nursing care fails to highlight compassionate caregiving that promotes human 
flourishing.  This model requires that the CNA not only changes personal attitudes, 
beliefs and actions in working with persons with AD but also have a desire to infuse CC 
in the larger organization or health care system. Current CNA training programs do not 
spend enough time to allow CNAs to understand the complexities of providing CC.  
The goal of this study is to develop a CC curriculum for CNAs in nursing 
facilities and evaluate how the delivery of such a curriculum will improve care to 
persons with AD in nursing facilities. In order to understand the complexity of the 
disease, including its origin, treatment, and care, this chapter outlines the history of AD, 
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the development of pharmaceuticals, and the history of care provisions to older adults 
from home care to the growth of institutional care.  
 The History of Alzheimer’s Disease 
 To fully understand the lack of compassionate care for persons with AD, one must 
first examine the characterizations of the disease throughout history. Since the origins of 
the disease, persons with AD have often been stigmatized and portrayed as less than 
human for the way that the disease contributes to their decline both mentally and 
physically. To begin unraveling the story of dementia and understand how the disease 
came to be misunderstood and stigmatized, one must start with the development of the 
ancient medical structure.  
Dementia in Antiquity (approximately 476 BC- 1453 AD)  
During antiquity, everyday life was met with natural disasters, fatal disease and a 
never-ending series of warfare. Medical practice, during this time, was heavily predicated 
on the use of magic and sacred ritual. According to the Greeks, the healing god 
Aesculapius was considered the highest authority of medicine (Stanton, 1999; Zilboorg & 
Henry, 1941). Mythological writings dating back to around 1500 BC suggest that 
Aesculapius was the son of Apollo and his mortal mistress Coronis. According to the 
narrative, in a fit of rage Apollo killed Coronis upon learning she was pregnant. He took 
the baby after her death and gave him to a centaur to learn the ancient art of healing 
(Stanton, 1999). Subsequently, temples were erected in Aesculapius’s name, and a high 
order of priests carried out a series of rituals to heal the ill. Until Hippocrates’ time, 
laymen were not permitted to administer any treatment. Only specialized clergy was 
allowed to administer medical treatment (Roman, 2003; Zilboorg & Henry, 1941).  
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 Treatment at the temple included a combination of acts on the part of both the 
patient and the priests. In most cases, the patient would be required to sleep near the 
temple and dream of the God appearing to them. Based on the interpretation of this 
dream, there were various remedies of fermented mixtures that were used to cure the 
ailment and rites that included ceremonies involving both music and dance (Roman, 
2003). As early as the Neolithic period, humans understood the utility of plants and other 
substances found in the wild that could be mixed to alleviate pain, nausea, and other 
maladies (Hillman, 2014).  
Within the confines of the medical temples and Greek society, physical ailments 
were the only diseases that were treated. Little consideration was given to mental 
disorders, and no treatment was provided if an individual suffered from mental illnesses 
or the symptoms associated with cognitive decline that we know today (Cilliers & Retief, 
2009).  Interestingly, some persons with various forms of mental illness were granted a 
higher status within society and viewed as having special powers. They were often used 
to interpret dreams and assist clergy in providing treatment to those with physical 
ailments within the temples of Aesculapius (Zilboorg & Henry, 1941). Around the same 
period that the Greeks were receiving treatment delivered in the name of Aesculapius, the 
ancient Egyptians developed a precise art to the care and preparation of the dead, known 
as mummification, which was believed to assist the person in their journey to the after-
life. Little thought was given to the brain during this process of mummification. In fact, 
this vital organ was deemed so insignificant that it was extracted through the nose using a 
hook and discarded immediately after death (Wickens, 2015). Other writings from the 
time also suggest that the brain was viewed simply as a vessel for moving mucus from 
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the body to the nose (Wickens, 2015).This was in contrast to views on the heart, which 
was viewed as the center of all things good (Wickens, 2015). As different historical 
scholars began to articulate theories about cognitive decline and aging, the location of 
mental capacities would change dependent on the popular theory of the time (Boller & 
Forbes, 1998). While ancient Egyptians were not concerned with the brain, hieroglyphics 
from around 2000 BC suggest that they were aware of cognitive decline and associated 
this decline with one’s age. However, this theory was predicated on the notion that the 
heart and diaphragm were the seats of mental capacities (Boller & Forbes, 1998). 
The first formal descriptions of dementia are commonly attributed to Pythagoras (ca. 
570-490 BC). He was an often-controversial figure within Greek history and primarily 
known as a philosopher and mathematician. Pythagoras is primarily known as the 
inventor of a theorem bearing his name that states that the square of a hypotenuse is equal 
to the sum of the squares of the other two sides (Ingram, 2014).  While Pythagoras 
produced no formal writings, reports from his contemporaries provide insight into his 
work (Huffman, 2014). The long history of formalizing clinical descriptions of dementia 
begins with Pythagoras’ construction of a delineation of the human lifespan into five 
distinct phases corresponding with ages 7, 21, 49, 63, and 81 (Halpert, 1983). Each phase 
is marked by defining characteristics. The last two phases Pythagoras termed senium, 
referred to the increasing mental decline that occurred in this phase for most humans. 
This was also a time when the body began to enter into a state of decline and decay 
(Halpert, 1983). Pythagoras equated senium as similar to the period of infancy and 
childhood (Berchtold & Cotman, 1998; Halpert, 1983). Pythagoras, furthermore, 
commented on the fact that it was rare during this time to live to old age with the average 
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life expectancy during this time frame being only 30 years (Roman, 2003). In other 
writings detailing Pythagoras’ work, the word imbecility is attributed to the process of 
cognitive decline (Halpert, 1983). By the 19th century, this term would evolve to become 
used as a derogatory term for persons with intellectual disabilities (Trent, 1995).  
During the Greco-Roman era (ca. 332-395 BC), mental health was studied from both 
the medical perspective and detailed in the literature. Scholars have noted that there is a 
difference in these conceptualizations of mental health with medical writings focusing 
primarily on the biological mechanisms involved while contemporary literature from this 
time period focused primarily on the supernatural or divine origins of the disease (Cilliers 
& Retief, 2009). Homer’s epic poem The Odyssey, written near the end of the 8th 
century, describes the theory regarding the connection between age and cognitive ability. 
In The Odyssey, readers are introduced to King Laertes of Ithaca, the father of the titular 
character Odysseus. Homer writes of Laertes prestigious role as a physically vigorous 
war hero (Homer, 1996). When Odysseus returns to his home in Ithaca twenty years after 
first leaving to fight in the Trojan war, he finds his father in a much different state 
(Homer, 1996). To distinguish Laertes condition from other psychological diseases, 
Homer places emphases on his memory, particularly his long-term memories (Homer, 
1996). For example, Laertes is described as an individual that despite his wealth and 
prestige, decides to spend his days in the gardens of the city and sleeping in barns since 
this is where his fondest childhood experiences occurred. Laertes seems unaware of any 
short-term memory that he has gained in the twenty years since Odysseus first left, and 
this is reiterated in a passage where Odysseus identifies himself to his father by pointing 
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to a scar that he obtained during childhood as well as reciting the number of trees that the 
duo planted together in the gardens decades ago (Homer, 1996).  
Descriptions of dementia are equally present in Greek mythology suggesting that the 
disease was considered an aspect of life. Mythology was commonly used to explain any 
phenomenon that was not understood at the time. In one myth, Tithonus is described as 
handsome but mortal, and he is married to the goddess of dawn Eos. As a gift to her 
husband, Eos pleads with Zeus to make her husband immortal. Her wish is granted. 
However, she failed to ask that he keep his youth. Thus, Tithonus continued to age, 
despite his immortality and began showing features of dementia including incessant talk 
that was unintelligible to his wife. When Eos could no longer stand watching her 
husband’s decline, she turned him into a grasshopper (Bulfinch, 2014). While the 
mythology does not offer a formal name for dementia, only a description, it can  be 
ascertained from the moral of the story, that as Tithonus aged, despite his newfound 
immortality, his behaviors and mannerisms were similar to an “aging mind” that we now 
refer to as cognitive decline (J. Jones & Jones, 2010). 
Legal writings further reveal social commentary on the perceived nature of cognitive 
decline during antiquity. While only fragments of his writings still exist today, Solon 
(630-530 BC) is known for generating reforms in Athens by developing revisions to 
codified laws. Solon is credited with foraging a reform to end political and moral decline. 
In regards to dementia, Solon determined that old age was one factor that could 
contribute to impaired judgment and thus, persons might not have a sound mind to make 
decisions (Boller & Forbes, 1998).    
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While a trend towards describing the symptoms of dementia was apparent in 
literature, scholars, and philosophers after Pythagoras continued to posit theories about 
the nature of the brain and cognitive decline. Nearly two centuries after Pythagoras 
detailed the life stages previously described, Hippocrates (ca. 460-370 BC) demarcated 
his own medical classification. Hippocrates is known as one of the most influential 
medical doctors of all times. Hippocrates work is still utilized within the medical field 
(Breitenfeld, Jurasic, & Breitenfeld, 2014). There are 60 known works that are credited to 
Hippocrates. However, it is commonly believed that much of his writing was written by 
his students (Porter, 2004).  Hippocrates does not provide an exact characterization of 
dementia; however, many scholars often equate the use of the term paranoia to the same 
definition that Pythagoras provides for imbecility (Berchtold & Cotman, 1998; Halpert, 
1983). It has been suggested that the absence of the terms cognitive decline or dementia 
is due to the common perception that it was intertwined with old age (Roman, 2003). 
Since Hippocrates did not provide direct commentary for mental decline, it is difficult to 
determine whether paranoia was an accurate description of dementia. However, it should 
be noted that the Hippocratic cannon postulated that all illnesses could be attributed to an 
imbalance in the four cardinal body fluids. During this time, ancient Greeks held that 
there were four cardinal body fluids, often referred to as humours, and four primary and 
opposite fundamental qualities known as hot, cold, wet and dry. This theory posited that 
each humour was connected to a mental state and thus, an imbalance would contribute to 
certain declines or behaviors (Boller & Forbes, 1998; Jouanna, Eijk, & Allies, 2012; 
Porter, 2004).  
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Hippocrates’ work was central to the development of medicine. Until his work, the 
field of medicine was not organized, and treatment of conditions was largely performed 
by religious leaders or clergy. Furthermore, given the emphasis on religion, there was not 
an emphasis on scientific inquiry (Porter, 2004). Thus, Hippocrates work with identifying 
humours is important since this led to the prevention and treatment of physical 
conditions. For example, if the imbalance occurred within the individual’s blood system, 
such as a buildup of toxins, then bloodletting was recommended as a suitable treatment 
for this ailment (Porter, 2004).  
Despite Hippocrates work in medicine, the debate about the nature of the mind 
persisted within philosophy. Plato (ca. 429-347 BC) and his student, Aristotle (ca. 384-
322 BC) wrote about the correlation between age and cognitive decline. Aristotle’s most 
notable work in the field of psychology is De Anima, which provides a broad overview of 
his theories on the nature of living things (Shields, 2016). In particular, it is clear from 
Aristotle’s writings that there is a perception that cognitive decline as one ages is an 
inevitable condition. Furthermore, Aristotle disagreed with Hippocrates theory that the 
brain (or head) was the center of mental functioning. Instead, Aristotle arrived at the 
conclusion that the heart was the source of mental faculties and life.    
Contribution to the debate about the nature of mental capacity and old age was also 
provided by Cicero (ca. 106-43 BC). Cicero was a Roman philosopher, known as a great 
orator who primarily studied the law. By the time that Cicero was writing, the connection 
between old age and cognitive decline was generally accepted. However, Cicero 
disagreed with the prevailing notion that cognitive decline, which he referred to as senile 
debility, was an inherent nature of old age. Instead, Cicero argued that only those that 
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were of weak constitution suffered from senility, thus adding an element directly 
correlated to one’s morality (Boller & Forbes, 1998). Furthermore, Cicero believed that 
cognitive decline could be prevented, primarily by one staying active and keeping an 
active mind (Boller, Bick, & Duyckaerts, 2007). This, Cicero believed, was the key to 
avoiding the disease.  
Roman physician Celsus (ca. AD 14-37), who translated significant medical works 
from Greek to Latin, is thought to have been the first to employ the terms dementia and 
insanity as medical terms in De Medicina (Berrios, 1990; Roman, 2003). Celsus, 
influenced by the work of Hippocrates, divided insanity into three different categories 
that included melancholia, phrenitis, and dementia. Each was determined by a different 
cause (Roman, 2003). Prior to the work of Celsus, many mental disorders were 
characterized under the same phenomenon given the overarching symptomology. From 
the work of Celsus, we know that he was continuously on a search for the most effective 
drugs for his patients (Hillman, 2014).  
Galen (ca. AD 129 -200), the Greek physician is known as a prolific writer, having 
completed 21 volumes of work of an estimated 1,000 pages each. His writings are heavily 
influenced by the work of Hippocrates (P. N. Singer, 2016; Wickens, 2015). More of 
Galen’s writings have survived by comparison to those physicians and philosophers 
writing prior to this time (Hillman, 2014). In one of his voluminous encyclopedias, the 
physician listed morosis, his word for dementia, as a mental disease linked to the brain 
(Berchtold & Cotman, 1998; Schäfer, 2005). In his description of morosis, he 
characterized that disease by stating, “some who in the knowledge of letters and other 
arts are totally obliterated; indeed they can’t even remember their own names” (Berchtold 
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& Cotman, 1998). Given that he was heavily influenced by the work of Hippocrates, 
Galen’s writings posit that old age itself was considered a disease given the process that 
persons experience (Berchtold & Cotman, 1998; Halpert, 1983; Schäfer, 2005). 
Furthermore, Galen conjectured that disorders, such as cognitive impairment, could be 
related to diseases or processes in other organs in the body, a theory that was first posited 
by Hippocrates (Boller & Forbes, 1998). While most of Galen’s work was a continuation 
of previous scholars, Galen distinguished himself from others in that he went a step 
further to prove the theories that he wrote about. Despite the fact that these were rare 
practices during this time, writings show that Galen performed scientific experiments and 
dissection which provided more concrete knowledge about the human body (Wickens, 
2015).  
Galen’s work comes at the end of the Greco-Roman period. By the time he was 
writing and producing scientific evidence, the decline of the empire had already started. 
From the works of this period, it can be ascertained that dementia was established as a 
normal process of aging. Epidemics, disease, and death due to lack of resources were a 
part of life.However, it was viewed that if one survived to old age cognitive decline 
would inevitably occur.  
By the 5th century (AD), due to a shifting political landscape and a decline in 
power, the Western Roman Empire was largely considered a failed state (Philippides, 
1980). Despite these major losses, the Eastern Roman Empire, known primarily today as 
the Byzantine Empire, continued on and lasted from approximately 330 AD  to 1453 AD  
(Philippides, 1980). Much of the research and scholarly work during this time was an 
extension on the work that had been developed during the Greco-Roman period.  
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The roots of gerontology begin to take shape during the Byzantine Empire 
(Lascaratos & Poulakou-Rebelakou, 2000). We know through the work of Aetius of 
Amida, that by the 6th century (AD) , there were physicians that treated the aging 
population, simply referred to as the “aged” (Poulakou-Rebelakou, Kalantzis, Tsiamis, & 
Ploumpidis, 2012). The emphasis on providing specialty care to older adults is 
particularly interesting given that during the Byzantine Empire there is the first known 
movement towards a desire to appear more youthful. In particular, Empress Zoe is 
credited with starting this trend, as she continued to search for elixirs and remedies to 
appear much younger during her 60s (Panas, Poulakou-Rebelakou, Kalfakis, & 
Vassilopoulos, 2012). The detailed accounts of Zoe’s quest for youth are noteworthy in 
that it provides insight into Byzantine pharmacology. Medicinal practices during this time 
grew to be heavily predicated on the use of plants. Unlike their predecessors, the 
Byzantine’s began to cultivate plants that were known more for their medicinal properties 
(Scarborough, 2002).  
Aging was not the only concern during this period as the significant medical 
discourse during this time period was focused on the Justinian Plague (around 542 AD ), 
the cause of which we now know to be yersinia pestis, the same bacteria responsible for 
the Bubonic plague (Drancourt et al., 2004). This pandemic was devastating to the 
population, and an estimated 13% of the world population succumbed to death from the 
outbreak (W. Rosen, 2007). Detailed descriptions and theories about the plague were 
postulated by Paul of Aegina and provided the foundation for understanding more about 
dementia and memory loss. Paul recorded a number of persons that were struck by the 
plague also exhibited memory loss as the disease progressed. Building upon the work of 
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Hippocrates, Paul suggested that this memory loss, or as modern descriptions term it, 
dementia, was due to the buildup of certain fluids in the humours (Poulakou-Rebelakou et 
al., 2012).   
 While dementia was viewed as only a symptom of the plague, other historians 
began to take notice of cognitive decline through their observations of the Emperors. 
Surviving historical texts from the Byzantine Empire suggests that dementia was not 
uncommon among Emperors that lived into older age.  There was a number of persons 
that lived to be 70 years or older (Poulakou-Rebelakou et al., 2012). Records from this 
period are extremely detailed, and it was not unusual for historians to document an 
Emperor across their lifespan. These detailed, longitudinal texts provide accounts that 
suggest symptoms that are hallmarks of the different forms of dementia. From Justine I 
(518-527 AD) all the way to Andronicus II Palaeologus (1282-1328 AD), there are 
accounts of dementia, or at the very least some mention of cognitive decline. For 
example, analysis of documents pertaining to Justin I (518-527) notes the leader’s 
remarkable decision-making skill in governing and military matters while later texts 
suggests that his cognitive abilities deteriorated to the point where his nephew Justinian 
carried out many of his obligations (Poulakou-Rebelakou et al., 2012). Sadly, Justinian 
would later suffer a similar fate, as historians described the onset of mental decline that 
forced his wife, Theodora to carry out his duties (Poulakou-Rebelakou et al., 2012). Even 
famed Empress Zoe, known for her incessant need to appear young and exuberant, was 
described in later years as suffering from many of the symptoms that we now know are 
characteristics of dementia (Poulakou-Rebelakou et al., 2012).  
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 This period provides us with commentary about specific historical persons that 
suffered from the disease. We know their names, their work, and what their lives were 
like before and after the disease. This is important because it is the first surviving 
chronicle of cognitive disease.  This period is also particularly important due to the 
development of more standardized pharmacological interventions that were developed to 
treat physical ailments, but there is no mention of treating cognitive decline.  
In tracing the origins of characterizations of dementia in the writings of scholars of 
antiquity in this section provides an understanding of how misunderstanding and stigma 
became attached to the disease. The earliest surviving documents illustrate that the brain 
was secondary to the heart, which was considered the soul and primary hub for all 
thought. Little was known about the functions of the brain. Although medicines for 
physical ailments such as pain and nausea were being developed in antiquity, the lack of 
understanding of dementia and cognitive decline delayed a search for treating or curative 
medicine for cognitive decline. Examination of this period also provides an 
understanding of how the field of medicine developed. From the origins of the temples 
devoted to Aesculapius, whereby persons presented with ailments and were provided 
with treatment the focus was on physical ailments, not mental ailments, firmly 
establishing medicine as a separate field. 
Medieval era (approximately 5th century to the 16th century)      
Commentary on what is now known as AD and other forms of dementia 
continued intermittently until the Middle Ages. However, any progress that was made 
stalled during the Medieval period. The lack of writings and depictions of the disease 
during this period can be attributed to two primary causes: the rise of the Church and the 
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rapid spread of the Black Plague. The Catholic church became a formidable force during 
the Middle Ages, and its stances on scientific research contributed to a decline in research 
(Carruthers, 2008).  
During this time, the Church rose as a powerful force and ultimately contributed 
to the decline in the status of medicine, science and the work of scholars from these fields 
(Logan, 2002). The clergy was the ultimate authority over knowledge and reasons leaving 
little room for those that disagreed, such as physicians and scientists. The Black Plague 
spread quickly throughout much of Europe and was the foremost cause for any public 
health concerns (J. Kelly, 2005). Given this, the only known existing essay on the disease 
during this time was written by Franciscan Friar Roger Bacon. During his life, Bacon was 
known for his use of empirical methods and his push towards scientific reason. He was 
subsequently imprisoned for his views (Brophy, 1963). While in solitary confinement just 
before his death, he wrote ‘Methods of Preventing The Appearance of Senility,’ in which 
he describes old age and links the loss of memory and cognition to the posterior part of 
the brain (Brophy, 1963). Furthermore, Bacon described persons as being without reason, 
and essentially without the capacity for thought. While Bacon does not provide 
justification for his argument, this is the first publication that linked memory and 
cognition to a specific portion of the brain.        
Despite the lack of literature on dementia from the Medieval period, what is 
noteworthy is the prominence that was placed on memory, particularly by the church. For 
the medieval period, great emphasis was placed on collective memory (Brenner, Cohen, 
& Franklin-Brown, 2013). Works of art and writings, particularly those rooted in 
Christian ideology are filled with allegories and metaphors (Carruthers, 2008). Take for 
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example, ‘Hypnerotomachia Poliphili,’ which in English translates to Poliphilo’s Strife 
of Love in a Dream, which comes at the end of the Medieval period. The book has been 
attributed to many authors and is written in a rather bizarre mix of Latinate Italian. It 
remains an important work because of its overuse of imagery and is an example of 
Medieval allegory of the moral perils of love (Trippe, 2002). The original versions of the 
books were adorned with large wood etchings that depicted scenes from the story. The 
same feelings are conjured through the work of Medieval artist Giotto. His scene of the 
Nativity or the Crucifixion of Rimini utilizes similar themes and approaches ("Giotto Di 
Bondone," 2017). 
These works are important because the use of imagery allows people to form 
memories of the images depicted. By and large, during the Medieval period, persons were 
illiterate, so it would stand to reason that building memory based on these images was 
important. Scholars argued that building a collective memory during this period was not 
merely a byproduct of the lack of education for most persons. Instead, it could be viewed 
under the auspices of the goals of the Church (S. Katz, 2013). Use of collective memory 
assisted in developing a moral and just population. Ethics were built through the 
development of these memories.  Even the clergy was taught the importance of memory 
and trained to eat and drink while reading scripture in hopes of retaining the properties of 
the text they were studying (S. Katz, 2013).  
The maintenance of memory was so desired that it was often lauded through the 
descriptions of influential persons by noting their ability to remember. For example, 
Thomas Aquinas, the priest, who was respected and renowned during the Medieval 
period, is still often described as both excellent at recalling information and morally 
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superb (Carruthers, 1990). The implications in these statements are that one’s moral 
identity is inherently connected to their ability to remember.  
For our discussion of dementia, this emphasis on building memory created a 
lasting impact. First, it was predicated on this concept that everyone should have the 
capacity to build memory. Regardless of one’s educational status, there was an 
expectation that if you heard a sermon or any number of stories that were contained with 
religious text, you would be able to recount it orally to others. Memory was not directed 
through intellect or physiology. The inability to complete such tasks was viewed as a 
moral deficit. While the Medieval period is often known as the dark era for the lack of 
philosophical and scientific inquiry, for characterizations of dementia it would prove to 
have damning effects in that the stigmatization of not being able to remember was a 
moral defect. 
Dementia During the Enlightenment Period (17th -18th Century)  
 As the Enlightenment period began paving the way for modern developments, 
public health began receiving more attention. In the Medieval era, record keeping became 
an accepted way of providing information about the population at large. Major cities such 
as London kept records on vital statistics, such as prevalent diseases that physicians 
reported treating and the causes of death of its citizens. In smaller towns, records were 
often less detailed with brief descriptions of ailments.  As the Medieval period ended, and 
the world shifted towards increasing discovery and innovation, more emphasis was 
placed on naming diseases and providing an overview of the symptoms commonly 
associated with specific diseases. With increasing longevity, scholars were taking note of 
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concerns about public health in part through an analysis of the existing records (Pagden, 
2013) .  
 This renewed interest in science paved the way for many important discoveries 
within the medical field. Surgical procedures, while still rudimentary by modern 
standards, were implemented as medical interventions by the mid-1600’s (Gay, 1966). 
During this time frame, the practice of bloodletting and similar procedures was still used. 
By 1661, the development of the microscope allowed physicians and scholars to view 
microscopic structures that were previously not accessible. The discovery of blood 
circulation led to the use of blood transfusion for many diseases. By the mid-1700’s, 
inoculation for diseases such as smallpox were in use. It was indeed a time of rapid 
development for many diseases and interventions.  
 Classification of medical terminology also developed through the course of the 
17th to 18th centuries.  Dementia was now characterized by a grouping of diverse terms 
such as imbecility, amentia, phrenesis, and most commonly, senility. This would change 
with the publication of a classification of mental disorders entitled ‘Nosographie 
philosophique ou méthode de l'analyse appliquée à la medicine’ by physician Phillippe 
Pinel (Wallace & Gach, 2010). Originally written in 1798 and widely embraced, Pinel 
coined the term dementia to define the broad characteristics of cognitive decline. Pinel 
differentiated between delusion and manic behaviors, which were previously associated 
solely with cognitive decline. Pinel argued that persons with dementia were without the 
capacity for logic and decision-making. While much of the depictions are dated and used 
antiquated terminology, Pinel was the first to provide a lengthy analysis of the loss of 
memory, cognitive function, and the notion that dementia was a progressive disease 
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(Wallace & Gach, 2010). Hence, prior to Alzheimer’s presentation, Pinel was 
predominately credited with providing an overview of cognitive decline.  
By the 17th and 18th centuries, characterizations of the disease would permeate 
cultural works as well. Whether in comedy or tragedy the disease was portrayed as a 
representation of the curse of getting old. This period marked a shift towards the 
Enlightenment period. Thus, literature during this time reflected the movements towards 
social commentary and often included satirical works. The depictions of dementia varied 
from serious soliloquies to the use of ironic humor to portray the failures of the mind that 
are associated with the disease (Boller & Forbes, 1998).  
Renowned playwright William Shakespeare provided several allusions to the 
devastation caused by dementia in his plays. Shakespeare’s works ‘As You Like It,’ 
‘Hamlet,’ and ‘King Lear’ all contain soliloquies that explore a character’s thoughts 
relating to the aging process. In ‘As You Like It,’ Shakespeare introduces the concept of 
dementia in direct correlation to becoming old in the following passage from Scene 2, 
Act 7 (W.  Shakespeare, 1623), as follows:  
“With spectacles on nose and pouch on side 
His youthful hose, well saved, a world too wide 
For his shrunk shank; and his big manly voice, 
Turning again towards childish treble, pipes 
And whistles in his sound. Last scene of all 
That ends this strange eventful history 
Is second childishness and mere oblivion 
Sans teeth, sans eyes, sans teeth, sans everything.” 
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Unlike medical scholars of the time, Shakespeare also made clear distinctions 
between senility as portrayed in ‘King Lear,’ and the differing accounts of delirium 
associated with madness as exhibited by Lady Macbeth in ‘Macbeth.’ This was unusual 
for this time period because most physicians believed that these forms of cognitive 
decline were the same. In ‘King Lear’ Act IV, Scene 7, the featured character explores 
his memory loss (W. Shakespeare, 1606), as follows:  
“I am a very foolish fond old man, 
Fourscore and upward, not an hour more nor less; 
And, to deal plainly, 
I fear that I am no in my perfect mind. 
Methinks I should know you, and know this man; 
Yet I am doubtful for I am mainly ignorant 
What place this is; and all the skill I have 
Remembers not these garments; not I know not 
Where I did lodge last night… (…) Am I in France?” 
Dementia is also mentioned within the fictional world of ‘Gulliver’s Travels.’ 
First published in 1726, Jonathan Swift’s book is a satirical work that targeted nearly 
everyone of prominence from the Church to the Monarchy and quickly became a 
bestselling novel (Ingram, 2014). At the time, Swift’s hard-hitting satire was widely 
controversial prompting the author to publish the book under the moniker given to the 
titular character, Gulliver.  
On his third journey, toward the end of the book, Gulliver travels to the colony of 
Luggnagg. Upon arriving, Gulliver observes, “The Luggnaggians are polite and generous 
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people,” yet it is the Struldbrugs, a group of persons living in the colony that really 
capture his attention, for the Struldbrugs are said to be immortal (Swift, 1726). Initially, 
Gulliver is enamored by this concept stating “I freely own myself to have been struck 
with inexpressible delight, upon hearing this account”; the idea that anyone would have 
the opportunity to live forever without fear of death was an extraordinary idea (Swift, 
1726). His initial thrill regarding the ability to live forever is quickly deflated after 
meeting several Struldbrugs, for it seems that immortality, in this case, was marred by the 
problems with which it is associated (Swift, 1726).  
As the story progresses, Gulliver soon learns that the Struldbrugs are profoundly 
disabled by their lack of memory as they age through observations of these immortal 
persons. It is remarked that those that lose their memories entirely fair the best since this 
loss comes without feelings of sorrow. These encounters left Gulliver shaken, and he 
concluded that the Struldbrugs were a mortifying sight, one that no longer evokes envy 
regarding their immortality (Swift, 1726).  
In a horrific twist of fate, nearly a decade after Swift penned these descriptions of 
dementia; he wrote a letter to a friend stating “I have entirely lost my memory… I can 
hardly understand one word I write” (Ingram, 2014). Correspondence such as this letter 
along with writings of his friends and colleagues have left many scholars to suggest that 
Swift suffered from AD or another form of dementia (Bewley, 1998; Ingram, 2014). 
However, this has been largely debated in recent decades, as some scholars argue that 
Swift’s symptoms as described were more in alignment with Pick’s disease, a rare form 
of progressive dementia, that affects the frontal lobes of the brain (Bewley, 1998; 
Crichton, 1993; Lorch, 2006).  By 1742, Swift was declared incompetent, and 
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subsequently, all of his affairs were handled by caregivers. He passed away from the 
disease two years later (Bewley, 1998; Ingram, 2014).  
The incorporation of dementia into the themes of these cultural works illustrated 
key concepts in the discourse about the historical conceptions of dementia even though 
these were fictional accounts. The way in which dementia was depicted as being 
intrinsically related to old age demonstrated that by this time, the correlation between the 
two was solidified. These depictions presented a dark side of dementia that further 
contributed to the stigmatization of the disease.  
Modern Descriptions of Alzheimer’s disease (the 1900’s- Present) 
On November 4th, 1906, Dr. Alois Alzheimer stood before attendees of the 37th 
meeting of the South West Germany Society of Psychiatry in Tubingen, Germany and 
delivered an extraordinary address regarding the disease that would eventually bear his 
name (Cipriani, Dolciotti, Picchi, & Bonuccelli, 2011; Goedert & Ghetti, 2007; Maurer & 
Maurer, 2003). As he took the stage, Alzheimer began his address, entitled ‘On a 
Peculiar, Severe Disease Process of the Cerebral Cortex’, by thanking his former 
employer, Professor Emil Sioli, for allowing him to present the accumulation of clinical 
notes and tissue collections from the autopsy on his former patient, known only as 
Auguste D (Alzheimer, 1907; Maurer & Maurer, 2003; Maurer, Volk, & Gerbaldo, 
1997).  
The room was quiet as Alzheimer began his speech with the following, “From a 
clinical perspective my Auguste D. case already offered such a distinctive clinical picture 
that it would not be classified among any of the known illnesses. I will describe it to you 
in what follows” (Maurer & Maurer, 2003).  
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Alzheimer first encountered Auguste nearly five years earlier as a patient who had 
presented at the Asylum for the Insane and Epileptic, a psychiatric facility in Frankfurt 
(Cipriani et al., 2011; Maurer & Maurer, 2003; Maurer et al., 1997). Alzheimer served as 
an assistant physician and had worked under the mentorship of Sioli to improve the 
conditions at the facility. On his first day, Alzheimer was appalled by the horrid 
conditions and wrote, “Some patients appeared with pockets filled with all sorts of waste, 
others had masses of paper and writing materials hidden all over the place and in big 
packets under their arms.” By the time Auguste D. was admitted to the facility, 
Alzheimer, Sioli, and their colleague Dr. Franz Nissel had initiated policies to ensure all 
patients were fed, bathed, rooms were cleaned and not used as isolation rooms when 
possible, and duration baths were established to calm and reduce the agitation of patients 
(Maurer & Maurer, 2003). In 1901, these approaches were considered progressive in the 
treatment of persons with mental illness. Traditionally, psychiatric institutions had been 
separated from medical hospitals. Classical treatment included bloodletting and 
cathartics. However, these methods were slowly being replaced with non-restraints and 
moral therapy which had first been introduced by Philippe Pinel in the mid-1800’s. Pinel 
was well respected in the psychiatric community, known for his nosological classification 
of all diseases including senile dementia (Bynum, 2008).  
For Auguste, the facility would become home for the final five years of her life. At 
51 years of age, Auguste exhibited a rapid decline in functioning that was 
uncharacteristic given her family history and with no known cause. Eight months prior to 
admission, Auguste exhibited no symptoms (Cipriani et al., 2011). Her husband, a 
railway clerk, could no longer provide for her care forcing him to admit her. A review of 
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her medical records indicated that at the time of admittance she suffered from paranoia, 
delusions and hallucinations, along with progressively declining cognitive impairment 
(Cipriani et al., 2011; Goedert & Spillantini, 2006; Hippius & Neundorfer, 2003). During 
one of his first assessments, Alzheimer sat with her while she ate her midday meal and 
recorded the following interaction:  
“At midday Auguste D. had cauliflower and pork for lunch.  
Alzheimer- What are you eating?  
Auguste D.- Spinach! 
She chewed the meat.  
Alzheimer- What are you eating now? 
Auguste D.- First I eat the potatoes and then the horseradish.” (Maurer & Maurer, 
2003) 
On this first encounter, he continued his observations by showing her several objects. 
After a short span of time, Auguste no longer knew what the objects were that she had 
been shown (Maurer & Maurer, 2003). Her short-term memory seemed completely 
erased. When Alzheimer offered her a pencil to write her name on a sheet of paper, she 
could barely scribble out the A in Auguste before stopping and entering into a confused 
state (Maurer & Maurer, 2003). While Auguste was initially not at ease with Alzheimer’s 
presence, this changed overtime, and they were able to form a bond that was based on 
their mutual experiences growing up in the  same town in Germany (Maurer et al., 1997).  
The disease that had no name would continue to haunt Auguste as her condition 
worsened. Clinical notes by Alzheimer and other physicians provided a first-hand 
account of the horrors that Auguste was suffering. Whatever this disease was, its onset 
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had been quick, and its symptoms were intense. Often, Auguste would shout in agony 
succumbing to her fear that someone was attempting to kill her while other times she 
would sit quietly, alone and stare blankly into space (Maurer & Maurer, 2003; Maurer et 
al., 1997). She would pace and speak unintelligibly often directed to her husband and her 
child, despite their absence. Her memories seemed distorted as if someone was slowly 
chipping away at their contents. Sleep was disrupted as she would often pace or sit up in 
her bed in lieu of resting. On occasion, she was known to go into the main room of the 
facility, where other patients congregated, grab their faces and strike them violently with 
her hands (Cipriani et al., 2011; Maurer & Maurer, 2003).  
In his experience as a physician, Alzheimer had encountered similar cases in other 
patients, yet, he was intrigued due to the manifestation of these symptoms in someone 
much younger. At the time, such behaviors were exhibited by persons much older than 
Auguste’s 51 years (Maurer et al., 1997). Given the age of his previous patients, 
Alzheimer had hypothesized that this form of mental decline was associated with the 
thickening of the blood vessels of the brain, known as atherosclerosis (Maurer & Maurer, 
2003).  
As was customary for the time, Alzheimer’s primary course of treatment included an 
approach to reduce the patient’s agitation. Assessments were completed through talking 
with patients and records indicated that Alzheimer did this frequently. Alzheimer did 
extensive research on the therapeutic effects of warm and mild baths that extended over 
several hours, and in some cases, days, to soothe and calm extremely agitated patients 
(Maurer & Maurer, 2003). Alcohol was to be administered in mild doses for its calming 
properties. Not unlike modern facilities, for Auguste, and other patients at the asylum, 
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pharmaceuticals were used and considered to be useful in working with agitated patients. 
It was common practice to use 2 to 3 grams of Chloral Hydrate, a sedative, to manage 
behavior. With this treatment, no injection was needed, and therefore, patients in 
Auguste’s condition would not need to be confined to receive treatment (López-Muñoz, 
Ucha-Udabe, & Alamo, 2005).  
On at least one occasion, Alzheimer had to fight to keep Auguste at the asylum. Her 
husband could no longer pay the fees to keep her at the facility, and a plan was put in 
place to transfer her to another asylum. Knowing her importance to his work, Alzheimer 
was able to negotiate for her to stay (Maurer & Maurer, 2003). By 1903, Alzheimer had 
accepted a new position working as head of the anatomy lab at the Royal Psychiatric 
Clinic. However, he had not forgotten his patient and continued to track her progress 
(Hippius & Neundorfer, 2003). On April 9th, 1906, Alzheimer received a call that 
Auguste had passed away, he immediately requested her brain be sent him for further 
research so that he could complete a histological analysis (Hippius & Neundorfer, 2003; 
Maurer & Hoyer, 2006). Using silver staining, developed by his colleague, Max 
Bielschowsky, Alzheimer was able to clearly describe the senile plaques and 
neurofibrillary tangles in the patient’s brain (J. Jones & Jones, 2010). His analysis 
revealed what is now considered pathological hallmarks of the disease (D. H. Small & 
Cappai, 2006). It should be noted that by the time that Alzheimer made his discovery, 
dementia, as a general term to describe the loss of memory as one ages, was utilized 
within the medical lexicon, and both Phillipe Pinel and Jean-Etienne Esquirol had 
provided characterizations of the disease (Cipriani et al., 2011). Furthermore, the 
presence of plaques and tangles were also noted in the literature, however, neither had 
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been connected as a marker of cognitive decline (Cipriani et al., 2011). Thus, when 
Alzheimer made the connection between these two elements and posited that Auguste’s 
decline was due to the plaques and tangles that formed in her brain, his theory changed 
the dominant view regarding senile dementia.  
On that day in November 1906, as Alzheimer finished presenting his slides that 
included the histological analysis, he posited not only the connection between the plaques 
and tangles and the memory loss and bizarre behaviors of his patient but also shattered 
the notion that dementia was only related to old age. When he was finished with his 
presentation, he anticipated a lively discussion. Yet was met with unexpected silence. He 
had, after all, just explained, in his professional opinion, the details of a potentially rare 
disease for the very first time. It was customary for the chair of the meeting to bring forth 
any questions from the audience, however, on this occasion, the audience seemed 
preoccupied (Cipriani et al., 2011; Dahm, 2006; Hippius & Neundorfer, 2003). The 
facilitator inquired about questions and comments, and the audience remained silent. 
Alzheimer left the podium feeling perplexed by the lack of response (Maurer & Maurer, 
2003).  
Today the story of a seemingly rare disease, to use Alzheimer’s words, would make 
the front pages of all the major news outlets. However, coverage of Alzheimer’s 
presentation was limited, with the Tubinger Chronicle only noting the following, “Dr. 
Alzheimer from Munich gave an account of a peculiarly severe disease process, which 
caused significant shrinkage of the nerve cells within four and a half years” (Maurer & 
Maurer, 2003). Alzheimer’s presentation had been overshadowed by a formidable foe 
namely, the psychoanalytic movement. By 1906, names like Freud, Adler, and Jung were 
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making waves, and the psychiatric community was, in effect, seduced with the idea of 
psychosexual development and talk therapy. Sitting in the audience at the conference was 
C.G. Jung, a collaborator of Sigmund Freud, and a proponent of psychoanalytic theory. 
His presence contributed to the shift in focus to the psychological aspect in the often 
tense debates that ignited during the conference (Maurer & Maurer, 2003). The debate 
erupted into the equivalent of an academic shouting match centered around a lecture 
presented the previous May by Professor Gustav Aschaffenburg from Cologne. This 
lecture was a provocative criticism of Freudian theory that centered on compulsive 
masturbation. This was followed by a presentation on a proposed modification that the 
author termed psychosynthesis. The presenting opinions of these scholars ignited a lively 
debate among the crowd including a heated exchange between members of the audience 
and Jung regarding the principles of psychoanalytics (Maurer & Maurer, 2003).  
While the audience contributed to the increasing debate surrounding Freudian theory, 
the disease that Alzheimer described seemed to be lost, much like the memory of his 
patient. Despite the initial setback incurred at the conference, Alzheimer was undeterred 
and published an article based on his findings in 1907 entitled, “A Characteristic Serious 
Disease of the Cerebral Cortex” (Alzheimer, 1907; Strassing & Ganguli, 2005). In the 
years that followed, a number of other publications noted the histological symptoms of 
patients discovered post-mortem with descriptions of behaviors similar to Auguste D. 
when they were alive. A year after Alzheimer’s publication, his Italian co-worker 
Francesco Bonfiglio described a second patient with similar symptoms and presenting 
behaviors (Cipriani et al., 2011). In In 1909, the case of Auguste D. was once again 
presented along with three other cases of similar origin, at the Psychiatric Clinic of the 
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German University of Prague, focusing on a detailed description of histopathological 
changes in dementia (Cipriani et al., 2011).  
In the end, it was German psychiatrist Emil Kraepelin that introduced the eponym 
‘Alzheimer’s disease’ in the eighth edition of the Handbook of Psychiatry published in 
1910 (Hippius & Müller, 2008). Kraepelin was an esteemed, well-respected psychiatrist, 
that spent most of his career developing a classification of psychiatric disorders (Bynum, 
2008). In his text, Kraepelin separated AD from presenile dementia, citing it as a separate 
disease, a theory that contemporary research has since overturned (Cipriani et al., 2011). 
Despite Kraepelin’s contention that this was a separate, potentially new disease, it 
should be noted that it is unclear what, if any, discussions that Alzheimer and Kraepelin 
had about the nature of the disease and its classification. Since Kraepelin’s publication in 
1910, scholars have speculated his motivation for naming the disease after Alois 
Alzheimer (Hippius & Neundorfer, 2003). Kraepelin would have been aware of the other 
scholars working in the field to define the disease. It could be that Kraepelin did in 
earnest believe that Alzheimer had discovered a new disease, one that needed to be, for 
clinical purposes, separated from presenile dementia (Beach, 1987; Goedert & Ghetti, 
2007). It is also worth noting that Alzheimer worked in Kraepelin’s lab in Munich and 
closely collaborated with him during his time in Munich (Maurer et al., 1997). 
Furthermore, it was Kraepelin who encouraged Alzheimer to present his findings at a 
scientific meeting in Tubingen (Hippius & Neundorfer, 2003). Thus, his motivation may 
have been the rivalry between his lab and that of Pick in Prague, where Fischer worked 
(Goedert & Ghetti, 2007). This has led many scholars to suggest that the eponym 
Alzheimer’s disease is not accurate (Boller & Forbes, 1998).  
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Regardless of Kraepelin’s motivations, giving this disease a name did little to bring it 
to the collective consciousness in terms of a matter pertinent to public health. Even with 
Kraepelin’s stature in the psychiatric community, senile dementia continued to be 
considered a byproduct of aging, and little attention was given to cases of early-onset 
dementia (Lock, 2014). Furthermore, after his death in 1915, Alzheimer was remembered 
more for his histological acumen and his intensive work ethic than for the disease that 
carried his name (Ballenger, 2006). Thus, in the intervening years, after Kraepelin 
introduced the term Alzheimer’s disease, there was little research occurring regarding the 
disease (Hippius & Neundorfer, 2003). Alzheimer’s research culminated in other 
researchers replicating Alzheimer’s observations and initial histological analysis of the 
patient’s brain specimen’s post-mortem.  
Paradoxically, Alzheimer’s discovery is situated during a time of increasing medical 
innovation and insight. Prior to the advances in medicine made during the late 19th and 
early 20th centuries, the lifespan of persons with many chronic conditions was short and 
debilitating.  By 1897 Felix Hoffman, a German chemist, synthesized Aspirin, a drug that 
now has implications in the daily lives of persons worldwide (Van Dulken, 2001). In 
1907, Alfred Bertheim and Paul Ehrlich began the era of antibiotic chemotherapy, by 
developing arsphenamine to be used to treat the infection associated with syphilis 
(Parascandola, 2009). This paved the way for the development of penicillin in 1928 by 
Alexander Fleming (Ligon, 2004). These innovations produced significant improvements 
for the quality of life and the human condition. Furthermore, these discoveries and others 
contributed to the extension of the human lifespan. However, a tension between the 
progressive medical techniques being developed and the mental health system at the time 
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created notable tension due to the historical mistreatment of persons with mental illness 
and cognitive impairment. By the early 19th century, older adults with AD were often 
grouped together with adults of all ages that had cognitive impairments such as 
intellectual disabilities and Down syndrome (Trent, 1995). Persons with any form of 
cognitive impairment were known as imbeciles, idiots, or feeble-minded and their 
condition was often thought to be connected to moral decay or impurity (Trent, 1995). 
This led to many individuals, including those with AD to be institutionalized in, often, 
deplorable conditions much like the one that Alzheimer encountered when he first arrived 
to work at the Asylum for the Insane and Epileptic.  
AD remained in the dark, both metaphorically and quite literally, due to the 
cascading effect of several, significant factors. First, senile dementia has primarily been 
viewed as a byproduct of aging. If one survived the array of maladies and diseases that 
killed most persons before the prevalence of modern medicine, they would surely 
succumb to the afflictions associated with old age (Bishop, 1904). Second, as previously 
stated, although AD was noted in the literature it was not until the mid-20th century that 
scholars refocused their attention to the disease as falling under the umbrella of dementia 
rather than senile dementia. Dementia was viewed as a product of aging, one that was 
largely associated with old age given that a distinction between the decline in acuity that 
accompanies normal aging and the decline seen in persons with dementia was not clearly 
formulated. Hence, early scholars and researchers arrived at the conclusion that this was 
an inevitable condition. The fact that this was a circumstance of living to old age meant 
that this disease could not possibly be cured and thus, preventative medical interventions 
were not explored.  
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This characterization of cognitive decline permeated scientific inquiry through time, 
even today, nearly 116 years later. AD and other forms of dementia are inherently tied to 
the process of aging which has an impact on the disease in terms of funding, research, 
and stigma. AD research is far behind that of other diseases of public health concern, 
particularly if one examines the funding that is allocated each year through the National 
Institute of Health.  
Current Characterizations of Alzheimer’s Type Dementia. Alzheimer’s Disease 
is now classified as a neurocognitive disorder (NCD) with major or mild subtypes. The 
term “dementia,” is still used in settings due to custom, familiarity with the term, and 
continuity of medical data (American Psychological Association, 2013). The term 
dementia is used as an umbrella term to describe a decline in cognitive ability that is 
severe enough to impede activities of daily living. Currently, there exist several known 
neurobiological causes of dementia. Furthermore, each type of dementia has different 
patterns of symptoms and brain abnormalities, with some similarities between specific 
forms of dementia. AD is by far the most commonly diagnosed form of dementia, which 
accounts for an estimated 60% to 80% of all cases (Alzheimer’s Association, 2018; 
Centers for Disease Control and Prevention, 2017 ). This is followed by vascular 
dementia, dementia with Lewy bodies (DLB), Parkinson’s disease dementia and mixed 
dementia, which is the presence of abnormalities of more than one cause of dementia 
(Alzheimer’s Association, 2018). Rarer cases of dementia include frontotemporal lobar 
degeneration (FTLD), Creutzfeldt-Jakob disease, and normal pressure hydrocephalus 
(Alzheimer’s Association, 2018). 
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AD is defined by a distinct pathology that includes the presence of senile plaques 
(SPs) composed of beta amyloid (Aβ) and neurofibrillary tangles (NFTs) consisting of 
tau (Esiri, 2007; Harrington, 2012). The human brain contains tens of billions of neurons.  
These are cells that control and transmit information through a series of electrical and 
chemical signals (Whalley, 2001). Neurons are critical in providing information to 
different parts of the human body to maintain and function properly. Amyloid plaques 
within the brain are found within spaces between neurons. The plaque consists primary of 
abnormal deposits of a brain protein fragment known as beta-amyloid (Aβ) (DeKosky, 
2003). It is not currently known whether these plaque buildups are the cause of AD or a 
result of the disease’s progression. Inside neurons, neurofibrillary tangles (NFTs) are also 
a hallmark sign of the presence of AD (Serrano-Pozo, Frosch, Masliah, & Hyman, 2011). 
NFTs are clumps of the protein tau, and when an individual suffers from Alzheimer’s 
disease, tau undergoes an abnormal transformation that causes it to detach from 
microtubules and stick to tau molecules (DeKosky, 2003; Serrano-Pozo et al., 2011). This 
results in the formation of clumps of tangles. Finally, there is a loss of neural connections 
when the synaptic connections between certain groups of neurons stop working and thus, 
begin to degenerate, causing cell death (Whalley, 2001). Unlike cells in other parts of the 
human body, neurons do not divide, and when they die, they are not replaced by new 
ones. While the loss of neural connections is present within the disease, it is simply 
unknown if the loss of neural connections is related to the buildup of amyloid plaques 
and tau. Furthermore, researchers are currently examining if there are other abnormalities 
in the brain that could provide new insights into the disease (DeKosky, 2003). 
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Under a microscope, the presence of beta amyloid plaques is detected as 
extracellular deposits while the accumulation of the tau protein occurs at the intracellular 
level (Harrington, 2012). The current prevailing theory, of which most medical research 
and development is predicated, is that Aβ deposition is the primary lesion that contributes 
to Alzheimer’s disease and that neurofibrillary tangles are secondary, perhaps caused by 
the presence of Aβ. (Penke, Bogar, & Fulop, 2017; Sajjad, Arif, Shah, Manzoor, & 
Mustafa, 2018).  
The presence of the two compounds are not the only changes that appear within 
the brain. Typically, the weight of the brain decreases anywhere from 100-200 grams as 
the disease takes over, with atrophy showing in the temporal, parietal, and frontal lobes 
along with the hippocampus (Poirier & Gauthier, 2014). As these sections of the brain 
begin to atrophy, the ventricular system becomes enlarged (Budson & Solomon, 2016). 
Furthermore, the neurochemistry of the brain is altered and a deficit of acetylcholine, a 
neurotransmitter, is consistently found in persons with AD (Budson & Solomon, 2016).  
Despite the understanding of these changes occurring within the brain, there are 
conflicting accounts of what produces the pathology of the disease. There are many 
questions that are the focal point of active research, such as: Does the presence of plaques 
and tangles represent the essence of the disease? Or: Are plaques and tangles merely 
byproducts of the disease process? Furthermore, even if the answer to either one of these 
questions is affirmative, this does not establish what causes this pathology in the brain to 
occur (Poirier & Gauthier, 2014).  
Current research within the AD field is focused on pinpointing the trajectory of 
the disease as this could lead to potential pharmaceutical interventions. As to what causes 
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these changes in the brain to occur, there have been a plethora of studies that have 
pointed to everything from excessive air pollution (Moulton & Wei, 2012) to sleep 
disorders (Cipriani, Danti, Vedovello, Nuti, & Lucetti, 2014), and even, aluminum 
(Kawahara, 2005) as being the culprits in causing AD while social engagement (Krueger 
et al., 2009), diet (Gu, Luchsinger, Stern, & Scarmeas, 2010; Luchsinger, Noble, & 
Scarmeas, 2007), and exercise (Coelho et al., 2013; Yaffe, 2010), have all been touted as 
preventative measures for decreasing cognitive decline. The results of these studies and 
others similar in content are often sensationalized in the popular media, which often leads 
to stereotypes (Kirkman, 2006) all the while, there is still so much that is unknown 
regarding the disease.  
Symptoms and Behaviors Associated with AD. As previously noted, AD has 
profound effects on the brain and its’ ability to function and communicate with the rest of 
the body. This results in decline in activities of daily living to behaviors that are both 
disruptive and, often, harmful. Persons with mild AD experience profound memory loss 
that affects many of the activities of daily living. Person with AD may wander and 
become lost in environments that should be familiar. Social interactions may become 
difficult as persons with mild AD can become lost in conversation and ask the same 
questions repeatedly. Routine activities may take longer than usual to complete. 
Furthermore, persons may have difficulty with familiar tasks related to money 
management such as paying bills or receiving change back from a cashier. Family 
members and friends may notice increased changes in the individual’s demeanor and 
behaviors. As the disease progresses, the presence of behavioral symptoms, such as 
agitation and aggression, are commonly associated with moderate AD. These behaviors 
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are related to greater overall impairment in functioning and short survival time (Weiner et 
al., 2005).  
As time progresses, persons with moderate AD may experience more profound 
effects. The memory loss experienced in the mild impairment stage may worsen, and 
persons may lose the functional capacity to communicate, to reason, and participate in 
abstract thought. As memory loss worsens, persons with moderate AD may not be able to 
recognize family members, friends or care providers. They may have issues with 
completing multi-step tasks such as putting on clothes or preparing meals. Moreover, as 
confusion sets in the individual may develop paranoia, delusional thoughts, and in some 
instances, act in an agitated or aggressive manner. Estimates suggest that aggression 
occurs in roughly 40% to 60% of persons living in facilities such as nursing homes  
(Corbett et al., 2012).  
In the final stages of the disease, persons with severe AD are increasingly 
dependent on others for care and require increased sleep. Furthermore, as their body 
begins to shut down from the effects of the disease, they may experience weight loss 
from the lack of appetite or difficulty swallowing. The person with AD may suffer 
seizures; this can be attributed to gliosis and neuronal injury in the brain as a result of the 
dementia process. If they are confined to bed, they may experience skin infections from 
decreased mobility.  
While each individual’s journey with AD is different, the aforementioned stages 
provide a brief overview of the progression of the disease and how it affects the 
individual’s ability to function. For some individuals, the process is swift, while others 
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must endure a long and painful journey.  In some cases, persons with AD pass within 3 
years of diagnosis, while others suffer for as long as 20 years (Brookmeyer et al., 2002).    
The Development of Pharmaceuticals  
 For as long as humans have been aware of illness and disease, they have tried to 
develop treatments and cures. Today, after decades of scientific discovery, most 
medications are chemically synthesized compounds that are created and tested in labs, 
and then approved for mass production by federal regulating bodies (Liebenau, 1987). 
However, the origins of medicines are rooted in the use of simple solutions that were 
historically readily available such as plants and, in some cases, animal compounds. Many 
cultures maintained records of medications that were most effective for treating common 
ailments. China was by far the most sophisticated in their approach. By 1100 BCE, China 
developed and documented at least one dozen treatments for common ailments (Leung, 
2006). By the 16th century, this significantly increased to more than 1,900 different 
remedies (Leung, 2006).The first pharmacopeia, known as the De Material Medica, is 
estimated to have been written in the first century CE and is attributed to Dioscorides.  
Little is known about the scholar except that he was thought to be from Greece, and a 
botanist (Eadie, 2004). In India, Ayurveda is a medical system that was developed around 
5000 years ago. Within its structure remedies included herbs and other substances found 
in nature. The first medicinal documentation in English that is known is The English 
Physician, published in 1652 by Nicholas Culpeper (Culpeper, 2016). It is noteworthy for 
its comprehensive categorization of medicinal herbs and their usages.  
The late 1800’s and early 1900’s was a time of increased medical innovation and 
discovery. In the case of tetanus, a series of discoveries led to the understanding of 
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tetanus bacillus, the development of antitoxin, and the use of a vaccine to ward off this 
infectious disease (Porter, 1999).  The case of tetanus is only one case study that 
represents the overarching development of pharmaceuticals.   
The movement toward increased research marks a shift in thought about medical 
practices. The field of medicine, and physicians were less equated with the mysticism 
than in previous centuries. This shift can also be attributed to the development in the 
understanding of modern organic chemistry. Before the 1800’s, chemists posited that 
compounds that were obtained from humans and other living organisms were gifted with 
what they termed a vital force; this was in part to distinguish from inorganic compounds. 
The underlying theory was that these compounds could only be produced within living 
organisms, thus making them unique. This changed in 1828 when Fredrich Wöhler made 
a profound discovery in which he could produce the organic chemical urea, a constituent 
of urine, from the entirely inorganic compound, ammonium cyanate (Porter, 1999).  
From Small Apothecaries to Big Pharma  
The current pharmaceutical industry can be traced from two primary sources, all 
of which emerged during the late 1800’s through the early 1900’s.  Today, 
pharmaceutical companies such as Pfizer, Johnson & Johnson, GlaxcoSmith Kline, and 
Merck are international, Fortune 500 companies (Malerba & Orsenigo, 2015). Yet, 
during the 1800’s, their origins were far humbler, as each of these companies started as a 
family-owned apothecary (Liebenau, 1987).  As medications during this time 
predominately consisted of herbs and other plant compounds, an apothecary was 
managed by persons skilled in the trade of mixing combinations of herbs, minerals, and 
other commonly found items to produce solutions or pastes in the treatment of a variety 
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of ailments (Malerba & Orsenigo, 2015). Other remedies that were used included 
morphine and quinine. Eventually, these smaller apothecaries were replaced as it became 
easier to manufacture drugs in mass. Thus, many of these apothecaries transitioned from 
natural products to developing and manufacturing medications on a larger scale (Malerba 
& Orsenigo, 2015).  
While there are many companies today that started as apothecaries and eventually 
developed into medication manufacturing, many companies such as Bayer and Pfizer 
started as dyestuff and chemical companies. With the pharmaceutical market showing 
steady growth these companies established research labs and applied for patents for drugs 
(DiMasi, Hansen, & Grabowski, 2003). By the 1930’s, these companies were established 
drug developers, yet they developed slowly. In 1930, most medications were still 
procured without a prescription. People suffering from a malady could go into a 
pharmacy, explain their symptoms, and receive a compounded drug. During this period 
physicians were also dispensing medications directly to their patients (Freeman & Louçã, 
2002).  
 In the 1920s and 1930s both penicillin and insulin were discovered and 
manufactured, albeit at a modest scale. The Second World War provided a major 
stimulus to the developing pharmaceutical industry, with requirements for the large-scale 
manufacture of analgesics and antibiotics and increasing demands from governments to 
undertake research to identify treatments for a wide range of conditions. The post-war 
period from the 1950s to the 1990s saw major advances in drug development with the 
introduction of new antibiotics, new analgesics, such as acetaminophen and ibuprofen, 
and completely new classes of pharmaceuticals such as oral contraceptives, beta-
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blockers, benzodiazepines and a wide range of novel anti-cancer medicines (Chandler Jr., 
2005; Liebenau, 1987). 
Commercializing Medication  
As the decades passed, pharmaceutical companies such as Pfizer and Eli Lilly 
became more prominent. It was during this time that pharmaceutical sales began to be 
heavily promoted. Drugs were marketed to doctors with the intent to spur more 
prescriptions and sales. Doctors were financially rewarded by the pharmaceutical 
companies for promoting their products (Chandler Jr., 2005).  
 The rise of big pharmaceutical companies was also bolstered through marketing 
directly focused on potential consumers. Until the mid-1980’s print and digital marketing 
to consumers were not common. When print marketing, in magazines and newspapers 
began, there were federal regulations that stated that drugs could not be touted as a 
miracle cure for ailments, and all of the side effects of the medication had to be listed at 
the bottom of the advertisement to safeguard the public. Furthermore, the Food and Drug 
Administration enacted a provision in 1969 requiring that all advertising had to be both 
fair and balanced (Chandler Jr., 2005). In 1986, the first commercial advertisement for 
medication was filmed that directly targeted consumers.  This opened the door for more 
medications to be marketed directly to consumers without the need to market to 
physicians (J. Li, 2014) 
The following is an example of consumer pharmaceutical advertising that 
highlights the problem with direct marketing to consumers. Seldane (generic: 
terfenadine) was first approved for use in 1985. The drug was an antihistamine used to 
treat allergies, hives, and other allergic inflammatory conditions without causing 
 45 
drowsiness. In the first commercial that aired in 1986 for Seldane, the name of the drug 
could not be used, but the marketing campaign urged consumers to ask their doctor about 
a new drug that could help them if they were suffering from allergies.  This was a way of 
getting around the FDA regulation. By all accounts, the campaign was successful. It was 
estimated the drug sales for Seldane were roughly $34 million, and several years after the 
advertisement first aired, sales were estimated at $800 million.  However, by 1998, 
Seldane was completely removed from the market (Geier, 1998). Throughout the 12 
years that it was on the market, the FDA received numerous complaints and inquires 
because, as it would later be revealed, the drug interacted with several antifungal drugs 
(generics: ketoconazole and itraconazole), several antibiotics (generics: E.E.S, E-Mycin, 
Ery-Tab; clarithromycin; azithromycin) and a popular ulcer medication (cimetidine) 
(Geier, 1998). This interaction included serious heart abnormalities and contributed to 8 
known deaths. Citing this, the FDA finally pulled the drug from the market (Geier, 1998). 
The 1980’s and 1990’s saw more leniency in pharmaceutical advertising regulations that 
allowed the name and proposed benefits of drugs to appear in advertisements (J. Li, 
2014).  
Medications and Alzheimer’s Disease  
Living with AD in a nursing facility often proves difficult for the person with AD, 
their family, and for those providing care to them. Feeling disconnected from family and 
in a foreign setting can lead to unrest. Confused by the unfamiliar faces of the ever-
changing stream of staff providing direct care, agitation may ensue. Agitation has been 
defined as “inappropriate verbal, vocal, or motor activity that is not judged by an outside 
observer to be an obvious outcome of the needs or confusion of the individual” (Cohen-
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Mansfield, 2001). Given the nature and severity of the behaviors of persons with AD, 
psychotropic medications are often the first line intervention for those living in nursing 
facilities, even though it has been recommended that they should be avoided in patients 
with dementia (Borda, 2006; Gentile, 2010). 
Often known by their generic names, drugs such as Seroquel, Abilify, and 
Risperidone are commonly used to treat aggression, agitation, and delusions. 
Furthermore, these medications can be prescribed to persons with AD in nursing facilities 
to combat the behaviors often associated with the disease (Borda, 2006). While 
administering dosages of one or more of these medications can prove helpful in calming 
down an agitated or aggressive resident in a nursing facility, these medications are not 
without side effects. Antipsychotic medication use in older adults with AD can contribute 
to an increase in cognitive decline, increase in falls, metabolic changes such as 
hyperglycemia and diabetes, and dysphasia (Garrard, Chen, & Dowd, 1995). The most 
alarming side effect from the use of antipsychotic medications is the increase in mortality 
of those who take them. This evidence is based on 17 placebo-controlled trials over a 6 to 
12-week time frames. While significant changes were shown in participant’s levels of 
agitation and aggression, there was a 1.6-1.7 increased risk for mortality in the groups 
that received antipsychotic medications (C. G. Ballard, Gauthier, Cummings, & Lyketsos, 
2009). Causes of death in these studies varied, however, most were attributed to 
cardiovascular or infectious events. This evidence has led the Food and Drug 
Administration (FDA) to issue black box warnings to several anti-psychotic medications, 
including Risperidone, indicating that these medications have severe or life-threatening 
adverse effects (Lenzer, 2005). Currently, there are no FDA approved antipsychotic 
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medications for use with persons with dementia, including AD (C. G.  Ballard, Waite, & 
Birks, 2006).  
The big problem is that many of the published articles promoting drugs are written 
by researchers working on behalf of pharmaceutical companies. One example of this is 
Janssen Pharmaceutica’s research and marketing of Risperidone (Lenzer, 2005) which 
was shown effective and safe by their researchers. Janssen Pharmaceuticals is a 
subsidiary of the Johnson & Johnson company, considered an American institution. 
Although primarily known as the manufacture of staple household products, such as baby 
oil, baby powder, and shampoos Johnson & Johnson actually makes 91% of it’s profit 
from medical devices and drugs, not from consumer products. Production of Risperidone 
began in 1994 and was intended to replace Haldol, which came off-patent in 1986 
(Colpaert, 2003). Part of the marketing strategy for Risperidone was to make it the “top 
choice” of medications for Medicaid run programs for older adults in state nursing 
facilities. By 2005, the FDA issued black box warnings on several anti-psychotic 
medications, including Risperidone. The company continued to promote Risperidone for 
unapproved usages, including for older adults with dementia, to physicians prescribing 
medications in nursing home settings as a safe and efficient drug but unfortunately, that 
was not the case. In 2012, Johnson & Johnson reached a $181 million consumer fraud 
settlement that included 36 states along with the District of Columbia (Thomas, 2012). 
The company was also accused of minimizing and concealing the risks associated with 
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the medication’s use. These events were purported to occur after the FDA issued their 
black box warning on the medication (El Haj et al., 2016).  
In addition to the black box warnings, and the fines imposed on companies, there are 
other provisions established to prevent the misuse of antipsychotic medications in nursing 
homes. Primarily known as OBRA-87, the Omnibus Budget Reconciliation Act of 1987 
requires that new long-term care residents be assessed for mental illness and 
nonpharmacological treatments be used to manage behaviors (M. Kelly, 1989). This law 
was added after repeated concerns were expressed in the media and among leaders in the 
geriatric field that medication management was dangerous in most long-term care 
facilities. OBRA-87 took effect in October 1990 and provided guidelines for state 
surveyors to determine nursing home compliance with federal regulations (Anderson & 
Bjorklund, 2009). Persons transitioning into nursing facilities for long-term care must 
undergo the Pre-admission Screening and Resident Review (PASRR) to ensure that they 
are not inappropriately placed in long-term care (Madhusoodanan, Nwedo, Brenner, & 
Mirza, 2014). PASRR as a federal mandate brings states in accordance with the Supreme 
Court decision, Olmsted vs. L.C., which held that all persons have the right to live in the 
least restrictive setting possible (United States Reports, 1999) . PASRR requires that 1) 
all applicants to a Medicaid-certified nursing facility be evaluated for mental illness 
and/or intellectual disability; 2) be offered the most appropriate setting for their needs (in 
the community, a nursing facility, or acute care settings); and 3) receive the services they 
need in those settings. While the PASSR provisions exist at the federal level, many states 
including Kentucky, include exemptions to these rules. Residents being admitted directly 
from hospitals are exempt from screening and furthermore, persons that have a diagnosis 
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of dementia or intellectual disability are exempt from PASSR (Madhusoodanan et al., 
2014).  
In Kentucky, in most long-term care facilities, antipsychotic medications are still 
prescribed on a regular basis. Between the end of 2011 and the end of the first quarter of 
2017 roughly 19.1% of persons living in Kentucky long-term care facilities received 
antipsychotic medications compared to the national average of 15.7% (Monroe & 
Ceballos, 2017). The use of antipsychotic medications in nursing facilities in Kentucky 
poses another overarching concern about the state of older adults with AD and other 
forms of dementia. CNAs are also primarily responsible for the care and behavior 
management of these individuals. Therefore, appropriate training of CNAs is warranted 
(Molinari et al., 2017). 
The first medication brought to the market for AD was Cognex (generic: tacrine). 
It was developed by neuroscientist William Summers. Early reports of the medication 
were marked by Summers unconventional approaches to development and research 
(Kolata, 1992; Leary, 1991). From his research, Summers felt that AD needed to be 
targeted with a medication that could block or reduce the production of 
acetylcholinesterase. Without any funders or backing, Summers invested $90,000 of his 
own money into the production of a tacrine pill that could be brought to market. In 1981, 
in an experiment to test the drug, Summers administered the medication to 12 of his 
patients that had AD (Jebelli, 2017). As he did not know what dose would be of benefit to 
the patients, they received varying dosages intravenously (Jebelli, 2017). Hours after 
administering the drug, Summers noted a marked difference in his patient’s cognitive 
abilities (Jebelli, 2017). Despite these findings which were published in 1986, the FDA 
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was initially reluctant to approve the medication, citing its potential for causing liver 
disease (Leary, 1991). Later reports suggested that Summers findings could not be 
replicated (Kolata, 1992).  
Even today, the available options that exist for AD are only for managing the 
effects of the disease, including behaviors, if the patient is in the mild to moderate stages 
of the disease. Medications including Cognex (generic: tacrine), Razadyne (generic: 
galantamine), Exelon (generic: rivastigmine), and Aricept (generic: donepezil) are 
commonly used to treat mild to moderate stage AD. These medications are known as 
cholinesterase inhibitors and work by preventing the breakdown of a specific brain 
chemical, acetylcholine (G. Small & Bullock, 2011). Acetylcholine is critical for the 
processes of memory and thinking. These medications work because they augment 
acetylcholine and act as neurotransmitter augmentation therapy (G. Small & Bullock, 
2011; Wattmo, Minthon, & Wallin, 2016). However, as the disease progresses, it is not as 
affected by these medications.  
For persons progressing to the moderate to severe stages of the disease, there is 
another medication known as Namenda (generic: memantine) that are commonly 
prescribed. Both Namenda and Aricept are used for the severe stages of the disease 
(Plosker & Lyseng-Williamson, 2005). Namenda is an N-methyl D-aspartate (NMDA) 
antagonist. The basis of Namenda is that it contributes to the regulation of glutamate, a 
brain chemical allowing for better cognition and global functioning (Zhou & Danbold, 
2014). Another pharmaceutical approach to this disease is Namzaric, which is a 
combination of Namenda and Aricept. 
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To summarize, as of 2018, we have 5 medications on the market that are 
available, and this is the extent to which pharmaceutical treatments are available for a 
disease that is the 6th overall leading cause of death in the United States. The medications 
do not stop the disease itself nor do these medications aggressively slow the disease. The 
medications can only show some effects on mitigating the behaviors associated with the 
disease.  
Providing Care to Older Adults: From Home Care to Growth of Institutions 
To fully conceptualize the current status of care for persons with AD in the United 
States, we must understand the origins of caregiving. Care for older adults during much 
of the history has been provided in the home. Families were expected to provide the daily 
care for their older family members. In return, any property or financial means of the 
individual was bequeathed to the family (Gawande, 2014). Often, it was customary for 
generations of one family to live together, or at the very least, within close proximity and 
often, this reflected customs that were derived from the family’s country of origin 
(Benjamin, 1993). Given this arrangement, nearly all care was delivered in the home, and 
in many situations by either family members or other natural caregivers. If persons found 
themselves without family support or care, there were accommodations that could be 
made to assist the aging individual. For example, in some instances, the town would 
supplement another family to provide care. Alternatively, if the individual had their own 
home, they might barter goods for someone to come and provide them with support 
(Lacey, 1999). However, by the mid-19th century, this began to shift due to the 
development of the medical model of care and changes in familial structures (Gawande, 
2014).  
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This shift first began in larger cities in the United States, as the colonial model of 
providing care in-home and development of a barter system were not always possible. 
Moving to a city, however, often required leaving family, and therefore, a support 
system. Furthermore, by the late 1800’s, persons were having fewer children, and 
therefore, less reliable sources of support as they aged (L. E. Jones & Tertilt, 2006). The 
lack of support, particularly as persons aged, would make way for the development of 
almshouses. Almshouses originated in England in the 10th century and were designed to 
be used by the indigent that could not afford other accommodations.  For many centuries 
almshouses were available only for the deserving poor or persons in the community who 
were deemed in good moral standing (Goose, Caffrey, & Langley, 2016). Known for 
being crowded and unsanitary, and with abusive support staff, the almshouse was often 
the last resort for many (S. Katz, 2013). The widely referenced, Quincy Report of 1821, 
offers a description of the care provided to these persons who were often considered the 
lowest of society for they had nowhere else to turn (M. B. Katz, 1984; S. Katz, 2013). 
Furthermore, a review of the 1865 almshouse census records indicates that the average 
age of the institutionalized in the almshouse was just under 50 years of age (Lacey, 
1999). 
 By the late 19th century, there were other options for care in addition to the 
almshouses.  Private, charitable homes began to be developed to provide services in 
many cities across the United States. Furthermore, the rise of mental institutions and 
hospitals were also developing during this time (Trent, 1995). Many of the charitable 
houses of the time that accepted older adults were limited to white persons of the 
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Protestant faith with little or no impairments. There were long waiting lists for rooms at 
these facilities with many persons waiting years to receive support (Lacey, 1999). 
In the United States, home care began to diminish particularly after World War I. 
This period reflected a number of interrelated factors that would change the fabric of care 
provided to older adults, including those with AD. The end of the war brought new 
challenges to public health as returning soldiers presented with disabilities, as a result of 
their service, that needed to be addressed (Linker, 2011; Murphy, 2014). Due to the 
technological advances that resulted from the Industrialization Revolution, persons began 
to live longer. Between1900 and 1920 the older adult population grew dramatically. The 
estimates suggest that this population grew from about 3 million persons to about 5 
million persons (Hobbs & Stoops, 2002). Furthermore, the number of persons aged 85 
years and older increased from 100,000 to 300,000 persons  (Hobbs & Stoops, 2002). 
During this time, public health became an increasing concern due to the rapid 
urbanization that occurred at the beginning of the century. Persons were living in cities in 
increasing numbers, and the concern regarding the spread of infectious disease led to this 
newfound concern (Armstrong, Conn, & Pinner, 1999). Also, the rapid increase in the 
older adult population created a systematic breakdown of the provision of care for this 
population. The increase of older adults coupled with the turbulent financial years of the 
Great Depression created a need for external sources of care as it became increasingly 
difficult for families to provide the support to aging family members as they had once 
done (Haber, 1993).  
The deplorable conditions witnessed in almshouses and mental facilities were also 
a cause for concern. There were limited regulations regarding specific care for older 
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adults, and those with cognitive impairments such as AD. The Social Security Act of 
1932 was developed to pave the way for a better structure for institutionalizing care for 
older adults. Initially, the act was designed to provide independence to the aging 
population of American citizens (Haber, 1993). The Social Security Act of 1932 
contributed to the decline and subsequent closures of almshouses across the United States 
(Haber, 1993; M. B. Katz, 1984).  
In response to the closure of almshouses privately owned boarding houses began 
to develop in each state due to federal funding provisions. While some of these houses 
provided excellent care, this was not always the case with some providing care on par 
with the almshouses that they replaced. Further, the regulations for these care providers 
during this time were limited. In the end, care was inconsistent, and furthermore, there 
was simply not enough privately-owned houses for this to be a sustainable safety net for 
older adults (Lacey, 1999).  
By the 1950’s, this led to housing older adults and those with AD in state mental 
hospitals across the nation even though the initial purpose of these hospitals was to 
provide acute care to persons with psychiatric illness. These facilities were never 
designed to provide long-term care, and therefore, this form of care was ultimately not 
sustainable (Haber, 1993; Haber & Gratton, 1993). This led to the development of 
nursing facilities or skilled nursing facilities, to provide care specifically to older adults 
and those with cognitive impairments such as AD. The need for more sustainable, long-
term care coupled with the growing interest in developing an aging-related industry led to 
a surge in nursing home facilities. Between 1963 and 1980, it is estimated that more than 
one million new nursing home beds were added to provide care to this population (Doty, 
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Liu, & Wiener, 1985; Vladeck, 1980). The original nursing home model was based on the 
institutional care model (E. Goffman, 1968). In this model, emotional and cognitive 
experiences and autonomy were disregarded (Doll, Cornelison, Heath, & Syme, 2017). 
This model promoted uniformity in all aspects of life, was directed by a single authority 
and was conducted in the same place. Staff carried out daily duties that were regimented 
under a single plan that sought to fulfill the official aim of the institution (Wiersma & 
Dupuis, 2010).  
The changes that led to the increases in long-term care facilities did not ensure the 
quality of care. Furthermore, many of these facilities were subsidized with government 
funding. By 1975, Medicaid paid over $5 billion dollars for nursing home care each year 
(Lacey, 1999). During the 1970’s and early 1980’s, there were various published 
accounts that called into question the care that was provided to persons in nursing 
facilities. Stories of nursing home fires, of residents dying from bedsores, and food 
poisoning were widely described in reports given to government officials and in the 
media (Hawes, 2003). Despite the nature of these concerns and the amount of 
government funding allotted to nursing facilities, these facilities remained largely 
unregulated until the late-1980 were when the Nursing Home Reform Provisions of 1987 
were passed in Congress (Zhang & Grabowski, 2004).  
Currently, long-term care for persons with AD has come a long way from the 
unsafe and often-deplorable conditions mentioned in this section. However, this is not to 
suggest that more improvements are not needed. Behaviors such as delusions, outbursts, 
and aggression are symptomatic of AD. Chemical and physical restraints have many 
times been utilized in these situations to make the individual more manageable (Fossey et 
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al., 2006). Furthermore, a large portion of persons with dementia living in nursing 
facilities receives substantial doses of tranquilizers for behavioral symptoms.  This was 
instituted despite the literature suggesting only modest results along with high placebo 
effects and, in some scenarios, adverse side effects for those persons (Fossey et al., 
2006).  
The Development of the Nurse Aide Profession    
The care provided to persons with AD is often characterized as either delivered by 
informal or formal providers. In 2014 alone, nearly 16 million family members and other 
caregivers provided an estimated 18 billion hours of unpaid caregiving to persons with 
AD and other forms of dementia. Although, more persons with AD and other forms of 
dementia are receiving care from formal care providers in nursing home facilities 
(Gaugler et al., 2014).  CNAs make up an estimated 60% of the employees in an average 
nursing home in the United States (Trinkoff et al., 2013).  
In nursing homes, CNAs provide functional assistance to residents in all aspects 
of their daily care. CNAs are charged with completing tasks to support residents with 
activities of daily living. These tasks range from personal care support to administering 
medication. CNAs receive minimal training and low pay for a stressful job many times 
managing problematic symptoms and behaviors. As a result, burnout and turnover are 
common for these front-line workers (J. Rosen, Stiehl, Mittal, & Leana, 2011). Many of 
the issues that are faced by CNAs today are a direct result of their history of volunteer 
service and marginalization within the nurse field which will be discussed next.  
A Volunteer Reserve Is Formed. The need for nurse's aides, the precursor to 
CNAs, developed during the United States entry into World War I in April of 1917. The 
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use of heavy artillery and machine guns posed new challenges as the carnage left soldiers 
with debilitating wounds, fractures, and infection. The American Red Cross, tasked with 
filling positions to take care of the soldiers on the front lines, recruited nurses from across 
the United States (M. M. Jones, 2012). However, the need far exceeded the nursing 
professionals that were available. In Britain, the Voluntary Aid Detachment (VAD was 
developed in 1909 by the Red Cross to fill these gaps in the workforce (While, 2014). It 
would subsequently serve as a model for the volunteers that would be needed in the 
United States. While nurses and other trained medical professionals were actively 
recruited for the war effort, the Red Cross also began to seek volunteers in the form of 
nurse's aides. These volunteers had little or no medical background and were often 
women recruited from middle to upper-class backgrounds (While, 2014).  
The initial criteria for volunteer nurse aides were for practical purposes. All 
applicants had to be between the ages of 25 and 35, unmarried, in good health and 
capable of hard physical labor. Applicants could not have German or Austrian 
relationships by birth or marriage. Furthermore, applicants could not be daughters, 
mothers, or wives of anyone serving in the United States Army, Navy, states or abroad. 
Vaccinations against smallpox along with inoculations against typhoid and paratyphoid 
were required. Prospective nurse aides were also required to have graduated from or be 
willing to take a specific course in elementary hygiene and home care of the sick. These 
were the only required preparation for the role (While, 2014).  
 World War I depleted the number of nurses in the United States that were 
necessary to provide care within hospitals. The drain on human resources required the 
Red Cross to continue to recruit actively and train nurse's aides to fill the roles once 
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occupied by graduate level nurses. Training courses for hospital care for nurse's aides 
were implemented in Red Cross sites across the nation to help prepare nurse aides. Many 
of the requirements that were previously mandated were removed to accommodate those 
persons that might be interested but did not meet the established care criteria (Hallett, 
2014; Yen, 2012).  
From the onset, the utilization of a voluntary force of workers presented unique 
challenges to the American Nursing Association and the Red Cross. The field of nursing 
had established standardization and professional training. Highly regarded institutions of 
education offered nursing degree programs. Yet, many of the volunteer nurse aides had 
little experience in healthcare or any field for that matter. Training for volunteer nurse 
aides was limited during this time. This, in part, can be attributed to the tension between 
wanting to deploy professional, experience nurse aides as opposed to volunteer nurse 
aides. This tension played out between the Red Cross and the Federal government 
throughout the war, and the role of the nurse aide was never clear. The President of the 
American Red Cross, Jane Delano, at the time, was adamant in her opposition to the use 
of volunteer nurse aides from the beginning of the War. However, by the War's end, 
Delano along with key organizations such as the American Hospital Association (AHA) 
understood that the need for nurse aides outweighed the risks of using volunteers. Federal 
provisions were put in place to activate the reserve of volunteer nurse aides that had been 
recruited. These reserves were never used as the War ended after the provisions were 
enacted. Nurse aides, after the War, remained a volunteer position that fell within the 
purview of the Red Cross. After WWI, many of the training programs enacted by the Red 
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Cross throughout the United States remained inactive until there was cause for their need 
during the beginning of WWII (Hallett, 2014; Irwin, 2013).  
Current Training and Workforce Development for Nurse Aides.  Due to their 
status as volunteer workers, nurse aides did not emerge as a profession with rules or 
formal training until the mid-20th century. The profession was formalized by the Nursing 
Home Reform Provisions of the Omnibus Budget Reconciliation Act of 1987 (known as 
OBRA-87) (Code of Federal Regulations, 2012).  OBRA-87 established the requirement 
for a 75-hour nurse aide training that included at least 12 hours of continuing education 
and competency evaluation program for those persons employed as nurse aides in long-
term care facilities (Han, Trinkoff, Storr, & Lerner, 2014; Klauber & Wright, 2001). Each 
state was tasked with creating and implementing its own curriculum and testing system 
(Klauber & Wright, 2001). In Kentucky, this has been implemented as a 75-hour course 
along with 16 hours of hands-on clinical training. Currently, only 4 of the 75 mandatory 
hours focus on dementia care.   
 With the introduction of the Affordable Care Act of 2010, more mandated 
education was required. Specifically, section 6121 requires six 1-hour modules, known as 
Hand in Hand, covering 7 areas including: 1) understanding the world of dementia; 2)  
the person and the disease; 3) what is abuse; 4) listening and speaking; 5) being a person 
with dementia, actions and reactions; 6) preventing abuse; and 7) being with a person 
with dementia making a difference (Patient Protection and Affordable Care Act, 2010). 
Table 1 delineates an overview of the current curriculum mandates in each state and 
how they are implemented. This table does not include the Hand in Hand training that is 
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a requirement in all long-term care facilities that receive federal funding and review. 
Only additional dementia training to Hand in Hand is included in the table. 
Table 1 
CNA Training by State 
CNA Training by State (Patient Protection and Affordable Care Act, 2010) 
State  Statute or Regulations Related to Nurse 
Aide Training Citations  
 
Hours Required for Nurse 
Aide Certification  
Dementia Training Required?  
Alabama 1. Federal Code of Regulations: CFR Title 
42, Vol. 3, 483.  
Total Instruction: 75 
hours                 
Includes: 16 hours of clinical 
experience  
N/A 
Alaska  1. Alaska Administrative Code, Title 12, 
44.835.  
Total Instruction: 140 
hours                     
 
N/A 
Arizona  1. Arizona Admin Code § R4-19-802 
(2014) 
Total Instruction: 120 hours             
Includes: 40 hours of classroom 
instruction, 20 hours of instructor-
supervised skills practice and 40 
hours of instructor-supervised 
clinical experience  
N/A 
Arkansas  1. Ark. Code Ann. § 20-10- 705 
(2005)                                        
 2. Ark. Code R. 016.06.07-IV (2012)   
Total instruction: minimum of 90 
hours  
15 hours of training related to 
Alzheimer’ disease and dementia if 
working in a long-term care 
facility.   
California  1. Cal. Health. & Safety Code. 1263 
(2002)                                                         
2. Cal. Health. & Safety Code. 1337.1 
(2013)                                                         
3. Cal. Health. & Safety Code. 1337.3 
(2013)                                                       
 4. Cal. Code. Regs. tit. 22 
§ 71835 (2013)                                           
5. Cal. Code Regs. tit. 22 
§ 71847 (1992) 
Total instruction: 150 
hours                
Includes: 100 hours of clinical 
hours         
2 hours initial dementia training for 
nurse aides working in skilled or 
intermediate care facilities and five 
hours annually after the initial 
training.              
Colorado 1. 3 Colo. Code Regs. § 716- 1:11-5 
(2014) 
Total Instruction: 75 
hours                     
Includes: 16 hours of clinical 
experience  
N/A 
Connecticut 1. Connecticut Department of Public 
Health Regulations, Public Health Code, 
Chapter IV, Title 19-13-D8t.   
Total Instruction: 100 
hours                     
Includes: 50 hours of clinical 
experience  
N/A 
Delaware 1. 16-3000-3220 Del. Admin. Code § 2.0 
(2013) 
Total Instruction: 150 
hours                    
 Includes: 75 hours of clinical 
experience  
6 hours of dementia-specific training 




1. D.C. Mun. Regs. tit. 29, § 3204 (2014) Total Instruction: 120 
hours                     
Includes: 75 hours of clinical 
experience  
16 hours of nurse aide training must 
include topics related to Dementia 
care as part of standard certified 
nurse aide training.  
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Florida 1. Florida Administrative Code, Rule 
Chapter: 64B9-15.  
Total Instruction: 120 
hours                     
Includes: 40 hours of clinical 
experience  
N/A 
Georgia  1. Alliant GMCF, Nurse Aide Program 
Overview. 
Total Instruction: 85 
hours                     
Includes: 24 hours of clinical 
experience  
N/A 
Hawaii  1. Hawaii Administrative Rules, Title 16, 
Chapter 89A                                             2. 
Med-QUEST Division, Certification 
Programs, “State Certified Nurse Aide 
Training Program” (May 2004) 
Total Instruction: 100 
hours                    
 Includes: 70 hours of clinical 
experience  
N/A 
Idaho  1. Health Professions Program, Idaho 
Division of Professional-Technical 
Education, “How to Start a Nursing 
Assistant Course.” 
Total Instruction: 120 
hours                    
 Includes: 32 hours of clinical 
experience  
N/A 
Illinois 1. Ill. Admin. Code tit. 77, § 395.150 
(2013) 
2. Ill. Admin. Code tit. 77, § 395.300 
(2013) 
Total Instruction: 120 
hours                    
 Includes: 40 hours of clinical 
experience  
12 hours of nurse aide training must 
include topics related to Dementia 
care as part of standard certified 
nurse aide training.  
Indiana 1. 410 Ind. Admin. Code 16.2-3.1- 14 
(2013) 
Total Instruction: 105 
hours                     
Includes: 75 hours of clinical 
experience  
Staff in nursing facilities who have 
regular contact with residents must 
have a minimum of 5 hours of 
dementia-specific training within the 
first 6 months of employment or 
within 30 days for those assigned to 
the Alzheimer’s and dementia 
special care unit. All nurse aides are 
to do three-hours annual dementia 
specific continuing education for 
recertification.  
Iowa 1. 441 Iowa Ad- min. Code r. 81.16 
(2014) 
Total Instruction: 75 
hours                     
Includes: 30 hours of clinical 
experience  
16 hours of nurse aide training must 
include topics related to Dementia 
care as part of standard certified 
nurse aide training.  
Kansas  1. Kansas Administrative Regulations 28-
39-165.   
Total Instruction: 90 
hours                     
Includes: 45 hours of clinical 
experience  
N/A 
Kentucky  1. Kentucky Administrative Regulations, 
Title 907, Chapter 1, Section 450. 
Total Instruction: 75 
hours                     
Includes: 16 hours of clinical 
experience  
N/A 
Louisiana  1. La. Admin. Code tit. 48, § 10015 (2012) Total Instruction: 80 
hours                     
Includes: 40 hours of clinical 
experience  
Dementia training must be included 
in nurse aide training but hours are 
not specified.  
Maine  1. 10-144 Me. Code R.110, § 8.C (2014) Total Instruction: 180 
hours                     
Includes: 70 hours of clinical 
experience  
12 hours per year in-service training, 
which must include some training in 
providing services to residents with 
cognitive impairment.  
Maryland  1. Md. Code Regs. 10.07.02.40 (2014) Total Instruction: 100 
hours                     
Includes: 40 hours of clinical 
experience  
N/A 
Massachusetts  1. Code of Massachusetts Regulations, 
Title 105.156.320.   
Total Instruction: 75 
hours                    




CNA Training by State (Patient Protection and Affordable Care Act, 2010) 
Michigan  1. Michigan Department of Community 
Health, Bureau of Health Professions, 
Nurse Aide Training Curriculum.   
Total Instruction: 75 
hours                    
 Includes: 16 hours of clinical 
experience  
N/A 
Minnesota 1. Follows Federal Code of Regulations: 
CFR Title 42, Vol. 3, 483.   
Total Instruction: 75 
hours                    
 Includes: 16 hours of clinical 
experience  
N/A 
Mississippi 1. Follows Federal Code of Regulations: 
CFR Title 42, Vol. 3, 483.   
Total Instruction: 75 
hours                     
Includes: 16 hours of clinical 
experience  
N/A 
Missouri  1. Mo. Rev. Stat. § 198.082 
(1988)           2. Mo. Code Regs. Ann. Tit. 
19 § 30-84.010 (2014) 
Total Instruction: 175 
hours                     
Includes: 100 hours of clinical 
experience  
Dementia training must be included 
in nurse aide training, but hours are 
not specified.  
Montana  1. Montana Department of Public Health 
and Human Services, Quality Assurance 
Division, Certification Bureau, State Plan 
for the Nurse Aide Training and 
Competency Testing Program.   
Total Instruction: 75 
hours                     
Includes: 25 hours of clinical 
experience  
N/A 
Nebraska  1. 172 Neb. Admin. Code ch. 108 § 003 
(2014) 
Total Instruction: 75 
hours                     
Includes: 16 hours of clinical 
experience  
N/A 
Nevada  1.Nev. Admin. Code § 632.758 (1992) Total Instruction: 75 
hours                    
N/A 
New Hampshire 1. New Hampshire Code of 
Administrative Rules, Chapter Nur 10, 
Section Nur 704.09  
Total Instruction: 100 
hours                     
Includes: 60 hours of clinical 
experience  
N/A 
New Jersey 1. N.J. Stat. Ann. § 26:2M-7.2 (2012) Total Instruction: 90 
hours                    
 Includes: 40 hours of clinical 
experience  
N/A 
New Mexico  1. New Mexico Administrative Code, 
8.312.2.21  
Total Instruction: 75 
hours                    
N/A 
New York  1. 10 N.Y. Comp. Codes. R. & Regs. § 
415.26 (2010) 
Total Instruction: 100 
hours                     
Includes: 30 hours of clinical 
experience  
Dementia training must be included 
in nurse aide training, but hours are 
not specified.  
North Carolina  1. North Carolina Department of Health 
and Human Services, Division of Health 
Service Regulation, Center for Aide 
Regulation and Education, State Approved 
Curriculum for Nurse Aide I Training.   
Total Instruction: 75 
hours                     
Includes: 16 hours of clinical 
experience  
N/A 
North Dakota  1. North Dakota Administrative Code, 
33.07.06.02.   
Total Instruction: 75 
hours                     
Includes: 16 hours of clinical 
experience  
N/A 
Ohio  1. Ohio Admin. Code 3701-17- 07.1 
(2012) 
Total Instruction: 75 
hours                     
Includes: 16 hours of clinical 
experience  
For nurse aides working in specialty 
units, 12 hours per year including 
dementia-related continue education 
is required.  
Oklahoma  1. Okla. Stat. Ann. tit. 63, § 1-1951 (2013) 
2. Okla. Admin. Code § 310:677-11-4 
(2009) 
Total Instruction: 75 
hours                     




CNA Training by State (Patient Protection and Affordable Care Act, 2010) 
Oregon  1. Oregon Administrative Code, 851-061-
0090.   
Total Instruction: 150 
hours                     
Includes: 75 hours of clinical 
experience  
N/A 
Pennsylvania  1. Pennsylvania Department of Education, 
Application for Approval of Nurse Aide 
Training and Competency Evaluation 
Program, June 2012 
Total Instruction: 80 
hours                     
Includes: 37.5 hours of clinical 
experience  
N/A 
Rhode Island  1. R.I. Admin. Code 31-5-26 Appendix II 
(2012) 
Total Instruction: 100 
hours                     
Includes: 20 hours of clinical 
experience  
Dementia training must be included 
in nurse aide training but hours are 
not specified.  
South Carolina  1. South Carolina Department of Health 
and Human Services, Department of 
Facility Services, South Carolina Nurse 
Aide Training Program Packet, 
“Guidelines for Nurse Aide Program 
Training Approval.”  
Total Instruction: 75 
hours                     
Includes: 16 hours of clinical 
experience  
N/A 
South Dakota  1. Admin. R. S.D. 44:04:18:15 (1995) Total Instruction: 75 
hours                    
Includes: 16 hours of clinical 
experience  
Dementia training must be included 
in nurse aide training, but hours are 
not specified.  
Tennessee  1. Tennessee Annotated Code 68-11-209 
 
Total Instruction: 75 
hours                    
Includes: 35 hours of clinical 
experience  
N/A 
Texas  1. Tex. Health & Safety Code Ann. § 
250.0035 (2011) 
2. 40 Tex. Ad- min. Code § 94.3 (2013) 
3. 40 Tex. Ad- min. Code § 94.9 (2013) 
4. 40 Tex. Ad- min. Code § 1.1929 (2004) 
Total Instruction: 100 
hours                    
Includes: 40 hours of clinical 
experience  
Nurse aides are required to complete 
24 hours in-service education every 
two years which includes training in 
the care of patients with Alzheimer’ 
disease.  
Utah  1. Utah Administrative Code, Rule R432-
45. 
Total Instruction: 100 
hours                     
Includes: 24 hours of clinical 
experience  
N/A 
Vermont  1. Vermont Board of Nursing, 
Administrative Rules, Part 16.12. 
Total Instruction: 80 
hours                     
Includes: 30 hours of clinical 
experience  
N/A 
Virginia  1. 18 Va. Ad- min. Code § 90-25-140 
(2014) 
2. 18 Va. Ad- min. Code § 90-26-40 
(2014) 
Total Instruction: 120 
hours                     
Includes: 40 hours of clinical 
experience  
Dementia training must be included 
in nurse aide training, but hours are 
not specified.  
Washington  1. Wash. Ad- min. Code § 246-841-100 
(2008) 
2. Wash. Ad- min. Code § 246-842-100 
(1991) 
Total Instruction: 85 
hours                     
Includes: 50 hours of clinical 
experience  
N/A 
West Virginia  1. West Virginia Department of Health 
and Human Resources, Bureau for Public 
Health, Office of Health Facility 
Licensure and Certification, Nurse Aide 
Educational Program, Criteria and 
Guidelines. 
Total Instruction: 120 
hours                     




Wisconsin  1. Wis. Admin. Code Trans. § 129.07 
(2008) 
2. Wis. Admin. Code Trans. § 129.08 
(2011) 
Total Instruction: 120 
hours                     
Includes: 32 hours of clinical 
experience  
Dementia training must be included 
in nurse aide training, but hours are 
not specified.  
Wyoming  1. Wyoming State Board of Nursing, 
Administrative Rules and Regulations, Ch. 
II, Section 5(b) 
Total Instruction: 75 
hours                     




 This analysis shows that 31 states along with the District of Columbia are more 
than meeting the federal requirements training. This analysis also illustrates that the state 
of Kentucky still lacks in terms of consideration of updating nurse aide training. In a 
review of other states, most have updated state CNA training regulations in the last 10-15 
years to reflect best practices. In Kentucky, the last changes that were implemented to 
nurse aide training on a state-wide level were with the provisions that were included in 
OBRA-87  in 2006 (Hawes, 2003). It is also important to consider that there have been 
numerous changes in terms of our understanding of the impact and nature of AD since 
the time that OBRA-87 was implemented. Several states have addressed this by requiring 
that nurse aide training to include hours and clinical supervision in providing care for 
persons with AD. Other states not only include AD training at the onset of nurse aide 
training but also require continuing education each year. It has been shown that better 
trained CNAs who are more capable of performing tasks provide better care (Han et al., 
2014). The Institute for Medicine recommended that training hours for CNAs should at a 
minimum be 120 hours and that the certified nursing assistant certification exam directly 
assesses competence in the care of older people (Institute of Medicine, 2008).  
Summary 
Alzheimer’s is a devastating disease that affects over 5 million persons in the 
United States, and it will continue to increase as the baby boomer generation ages 
(Alzheimer’s Association, 2018). It is a disease without a cure or validated ways to slow 
down its progression (Alzheimer’s Association, 2018). The challenges faced today in 
providing care for persons with AD are very much rooted in the historical 
characterizations of the disease. This has affected the care of persons and even the way 
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that medications are developed for those facing the disease. CNAs have emerged as the 
primary caregivers for persons with AD living in nursing home settings. The education 
provided to CNAs, while adequate in understanding the basic nursing care of persons 
with AD fails to teach CNAs how to provide compassionate care. This new level of 
training is needed in order to give CNAs the tools to overcome the societal stigma that 
follows the disease and develop a stronger bond with patients and their workplace.   
While this chapter served as an introduction to the challenges of the disease and 
furthermore, provided a foundation for understanding its’ unique complexities, 
subsequent chapters will focus on building a new approach to providing compassionate 









CHAPTER II: LITERATURE REVIEW  
 This chapter introduces a theoretical framework for conceptualizing AD. It 
provides insight into the need for compassionate care and the stress associated with CNA 
caregiving. Specifically, theories of disablement and symbolic interactionism are 
discussed. The chapter also includes learning theories that were used to inform the 
development of the compassionate care curriculum, specifically cognitive learning theory 
and social learning theory. Also, Kirkpatrick’s evaluation model is discussed as a 
framework for the evaluation of the new curriculum. The chapter concludes with a 
conceptual hypothetical model that was used to investigate the effectiveness of the 
compassionate care curriculum in reducing the stress levels of persons with AD in 
nursing facilities. 
 It should be noted that the theoretical framework explored does not reflect all the 
major paradigms that exist related to AD, the nature of the disease as a disability, 
learning about caregiving or the actual process of caregiving. However, the theories that 
were selected for inclusion provide a solid foundation for conceptualizing the 
complexities of providing compassionate care.  
Theoretical Frameworks for Conceptualizing Alzheimer’s disease 
AD is both debilitating and disabling for the individual suffering from the disease. 
Understanding how persons with AD respond to physical and mental changes and their 
new identity becomes an important aspect of any AD-related social research. Hence, 
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understanding the perspective of persons with AD, provided the foundation for 
developing a compassionate care curriculum that could provide tools and skills to CNAs 
to care for persons with AD.  
 Theories examined included theories of disablement and symbolic interactionism.  
These theories were chosen because they conceptualize the complexities that contribute 
to the environment of the individual living with AD. Both theories conceptualize AD as a 
disability and a loss of the individual’s personhood. Theories of disablement focus 
primarily on the process that the individual undergoes from being a functional, 
productive member of society to becoming a person with a disability (S. Nagi, 1964, 
1991). Symbolic Interactionism (SI) provides a conceptualization of how persons with 
AD and those around them interact post-diagnosis of AD (Blumer, 1969; Stryker, 1980).  
Theories of disablement 
A progressive disease, Alzheimer’s impacts the individual in a way that is 
particularly devastating. Persons with AD are not only confronted with the challenges of 
the disease but also with the feelings associated with loss of functions. Theories of 
disablement provide a framework within the field of disability research to give an 
understanding regarding the process of change that occurs as an individual is faced with 
their disability.   
Saeed Nagi was the first to conceptualize disability as a process (S. Nagi, 1964). 
In Nagi’s model, disablement is defined as any chronic or acute condition that has an 
impact on the individual’s performance and functioning (S. Nagi, 1964, 1991; S. Z. Nagi, 
1976). This framework is based on four interrelated concepts termed active pathology, 
impairment, functional impairment, and disability (S. Nagi, 1964, 1991). Active 
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pathology is the result of trauma, infection or illness, neurological diseases or any other 
etiology. In this case, active pathology includes AD. Impairment is the resulting loss or 
the abnormality of the anatomical, physiological, mental or emotional nature. For AD, 
this would include many of the symptoms of the disease such as memory loss, confusion, 
and disruption of sleep patterns due to the histological abnormalities of AD. Functional 
limitations refer to the restrictions in performing basic activities of daily living. This 
would include the limitations that are often faced by persons with AD as the disease 
progresses. It includes the loss of participating in personal care, shopping, and even 
eating. In Nagi’s model, the culminating process of these factors leads to disability (S. 
Nagi, 1964, 1991; Saad & Judith, 1980). 
Framing the development of AD as a process that leads to disability provides an 
understanding of how a person with AD might conceptualize the disease as it progresses. 
Faced with the prospect of disability due to AD, the individual processes the change in 
status within their world, from an able-bodied person to a person living with a disability. 
For the person with AD this can also contribute to a feeling of loss of self, particularly as 
the disease progresses (S. Nagi, 1964, 1991). For example, persons with AD may not 
have the capacity to complete the activities that once provided them with enjoyment. 
Additionally, persons may be viewed by their family as needing increased support and 
care. The increased loss of independence can be overwhelming to the person with AD. 
Overall, in the early stages of the disease, while the person is still very much aware of 
their situation, this can contribute to depression and behaviors associated with this loss of 
identity (Hausner, 2004).  
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Nagi’s model is limited in several areas that need to be addressed. At the time of 
its development, the model did not account for external factors such as environment or 
the societal implications of disability. Initially, the model did not focus on the effects that 
disablement had on a persons’ health (Jette, 1997). Furthermore, Nagi’s model has not 
been specifically applied to AD research, only general forms of disability. The model 
also does not focus on any of the precipitating factors that lead to a person’s disability.  
However, Nagi’s model provides a foundation for understanding the internal process that 
the person with AD undergoes related to their disease. Since its original introduction to 
the scholarly work in the field of disability and disablement, it has been modified to 
address some of the limitations associated with the model.  
One limitation of Nagi’s model was addressed in the 1990’s by scholars 
Verbrugge and Jette (Branch, 1996). While the original model provides a foundational 
understanding of the disablement process, Verbrugge and Jette expounded upon this by 
examining the precipitating factors that lead to a persons’ disability (Verbrugge & Jette, 
1994). Through this adaptation, disability or disabling conditions such as AD are 
classified as dysfunctions within the human body. However, externalities or internal 
crises could either speed up the decline in functioning or stabilize it depending on the 
nature of the situation (Verbrugge & Jette, 1994). This provides a foundation for 
understanding how persons faced with impending loss of function can manage given their 
environment in addition to the actual physical and biological concerns that are brought 
upon by the disease (Verbrugge & Jette, 1994). 
As an individual with AD faces their eventual prognosis, understanding the 
transition to disability becomes important in providing care and support to not only the 
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individual but their family as well (Verbrugge & Jette, 1994). In order to understand this 
transitional process, theories of disablement provide a foundation for conceptualizing the 
imminent disability that one faces (Verbrugge & Jette, 1994). Furthermore, these 
frameworks also address the significant stigma that is often associated with cognitive 
decline and loss of function within society (Verbrugge & Jette, 1994). 
Symbolic interactionism   
Theories of disablement provide a foundation for understanding how an 
individual undergoes the journey from functioning to disability. However, how the 
individual interacts and responds to their situation is also an essential consideration that 
must be made when conceptualizing the impact of AD. Symbolic Interactionism (SI) 
focuses on how the individual interacts within their own unique system (Blumer, 1969; 
Stryker, 1980).  AD affects the ability to perform activities of daily living and erases 
many memories, which, in turn, can also strip away the sense of identity. Take, for 
example, a 68-year old grandmother that has recently been diagnosed with AD. Although 
she may have cared for her grandchildren for a number of years, as the disease progresses 
she won’t be able to continue in the same way she did in the past. The loss of memory 
and ability to function in activities of daily living creates a loss of a sense of self. 
Utilization of the theory of SI can provide an understanding of this individual’s journey 
and how she attributes meaning to her life and interactions with her family given her 
diagnosis (Ariotti, 1999).  
To understand the way in which a person interacts with their environment, SI 
provides both a foundation and an intricate understanding of the social interaction process 
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that humans engage in. SI also provides an understanding of how these interactions can 
change over time given the progression of the disease (Blumer, 1969).  
 First developed by George Herbert Meade and later articulated and expanded 
upon by his student, Herbert Blumer, SI was first introduced in the 1920’s (Blumer, 
1969). However, its origins reside in the work of renowned sociologist Max Weber 
(Segre, 2014). Given its origins in sociological theory, SI, at its core emphasizes the 
interactions and their subsequent meanings between individuals. SI has applicability for 
many populations and is not solely focused on persons with AD. However, it provides a 
deeper understanding of how the individual is involved in their environment. SI is 
predicated on the understanding that all persons engage in their environment in some way 
(Blumer, 1969; Stryker, 1980).  
SI is the process in which persons make meaning of their circumstances through 
interactions with the systems that surround them. Underlying SI is the emphasis not 
simply on social behavior, but on a deeper level, how the behavior is constructed 
(Stryker, 1980). SI provides an in-depth understanding of social interaction (Blumer, 
1969; Stryker, 1980). It is not viewed as a byproduct of an individual’s need to attribute 
meaning to the world around them (Dennis, 2011). From engagement with others, the 
individual develops and attributes meaning to actions, items and even other humans in 
their environment (Blumer, 1969; Stryker, 1980). 
  It is important to consider that the foundations of SI are built upon three separate, 
yet interrelated concepts (Blumer, 1969; Stryker, 1980). The first concept is that human 
beings act towards items in their environment based on the meanings attributed to these 
items (Dennis, 2011). For example, all humans respond accordingly to their mothers or 
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fathers since there is meaning associated with these persons within society (Dennis, 
2011). The second concept of SI posits that the meaning attributed to humans and objects 
is derived from social interaction (Blumer, 1969; Stryker, 1980). The meaning attributed 
to these figures (mother and father) arises from the social engagement process. Lastly, 
these meanings undergo a process of continuous revision as the individual continues to 
engage within their environment (Blumer, 1969; Stryker, 1980). 
This brings us back to the example of the recently diagnosed 68-year old with 
AD. Through her interactions with her family, she had conceptualized her role as being 
that of a caregiver to both her adult children and her grandchildren. These social 
interactions gave her purpose and meaning in her life. Hence, when the disease renders 
her unable to do these activities any longer, she not only loses these interactions but loses 
her role within her family as well. The disease in effect informs the way she will define, 
interpret and react to the new situation and make meaning based on her perceptions. This 
is an example of how symbolic interactionism can help in understanding the roles or 
identity that persons attribute to themselves, and the loss that AD inflicts as it progresses 
(Waldrop, Clemency, Lindstrom, & Clemency, 2015).  
From this perspective, persons are rational actors that continuously engage with 
each other. Given these circumstances, individual’s behavior will be shaped by these 
interactions. Furthermore, given this emphasis on interaction, it is assumed that social 
actions are representations of the social structures that are prevalent within the societal 
system. Hence, these are hidden motivations that contribute to one’s construction or 
meaning-making. The process of meaning-making is viewed on a continuous spectrum. 
Interactions change over time between actors within the system. Therefore, this alters the 
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meaning that the individual attributes to the circumstance. Meaning making is as much a 
contextual phenomenon as it is continuous (Blumer, 1969). Within different interactions 
with different actors, persons can take on new roles or gain new perceptions about 
oneself (Blumer, 1969). 
From the lens of SI, social interaction is a cornerstone of the world in which we 
live (Dennis, 2011).  Humans engage with each other through verbal and non-verbal 
contact. For an individual with AD, this process takes on new meaning. Communication 
and ways of self-expression increasingly deteriorate as the disease progresses. Thus, AD 
can have a powerful impact on the role of the individual within society as well as how 
persons with AD interact and engage with those around them.   
Symbolic interactionism and stigma. The concept of stigma was first developed 
in depth by Goffman (Erving Goffman, 1986). His work has been applied to many 
different conditions including mental illness, AIDS and epilepsy. Goffman posits that 
stigma originates when an individual has an undesirable attribute that discredits them 
within society (Erving Goffman, 1986). For persons with AD, the disease becomes an 
attribute from which they cannot separate and contributes to them experiencing stigma 
within society. The stigmatization of persons with AD, as outlined in Chapter 1, is rooted 
in the historical conceptions of dementia and the way that person with AD are treated in 
society can be described in more depth using symbolic interactionism.  
As previously stated, humans engage with each other in a constant loop of 
communication where interactions are being perceived in different ways by all parties 
that are engaged in the interaction (Blumer, 1969).As the disease progresses, persons 
living with AD do not meet the norms of society. They often behave in ways that are 
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challenging for others. This impacts the person’s ability to interact with others. For 
example, an individual with AD may be unwilling to shower regularly. Norms of our 
culture dictate that this is an activity of daily living that is important and is valued. When 
others in society encounter the un-showered, perhaps disheveled individual, then they do 
not know how to respond. This challenges the way that they believe that person typically 
behave.  
 For caregivers, the stigma associated with the disease is often profound and 
results in what Goffman defines as affiliate stigma (Erving Goffman, 1986).  Caregivers 
derive their role from essentially providing care to the person with Alzheimer’s disease. 
This means that the individual, while not directly inflicted with the disease, feels the 
stigma associated with providing care to someone with the disease. This can be a 
contributing factor to the caregiver’s burnout and their feelings of frustration as they too 
feel stigmatization. This, in turn, affects the quality of care that the individual with AD 
receives.  
Theoretical Frameworks for Understanding Learning Processes 
While the previous section explored two theories that provide a theoretical 
framework to understand persons living with AD, it is also important to consider how to 
implement curriculum and training for working with persons with the disease. CNAs are 
charged with providing direct care to persons with AD in nursing home settings. 
Understanding how these professionals develop skills disseminated through training is 
important. Theories of learning provide a framework for understanding how persons 
process information and provide a framework for best practices in disseminating 
information that can be retained and utilized (Spring, 2010). 
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Learning is a complex process that requires not only obtaining information but 
also the transference of the information into tangible, measurable behaviors (Hergenhahn, 
1976). Hence, learning should not simply involve passive dissemination of information 
from instructor to the learner. Instead, learning is characterized primarily by changes in 
behavior (Spring, 2010). Hence, for learning to be successful, the learner must not only 
process the information provided but also translate it into observable behaviors. Learning 
theories are cogent frameworks consisting of established concepts and ideas that provide 
explanations of how people learn (Spring, 2010).  
Within educational psychology, there exist several types of theories of learning 
that present different perspectives and highlight different components that are viewed as 
critical to the learning process. The utilization of contrasting learning theories is useful in 
the development of curriculum (Spring, 2010). The following section will highlight two 
theories of learning, cognitive and social, how the theory conceptualizes learning, and the 
processes involved in learning to be effective. Moreover, these particular theories were 
chosen due to their contributions to conceptualizing motivation and learning.  
Cognitive Learning Theory  
The cornerstone of cognitive-based learning theory rests on the notion that to 
change an individual’s behavior; their cognition must first be changed (Bush, 2006). 
Therefore, foundations of cognitive learning theory focus primarily on the learner and 
their internal processes of learning (Braungart & Braungart, 2003). Since learning is 
viewed as an internal process, persons in the learning environment will process the 
information provided differently and in their own way due to their own, unique set of 
experiences (Bush, 2006). Under cognitive-based learning, transference of learning is 
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achieved through understanding, with an emphasis on the notion of learning to learn 
(Braungart & Braungart, 2003). Once this process is changed through a learning 
experience, it becomes an inherent process by which the learner begins to implement the 
tools or strategies that have previously been disseminated through education or training 
(Braungart & Braungart, 2003). 
Given the emphasis on the internal processes of the learner, it might be assumed 
that individual reward is necessary to reinforce the transition from taking knowledge and 
implementing it into practice, however, this is not the case. Instead, it is more important 
to consider the learner’s motivation for learning and furthermore, their overall goals as it 
relates to the material at hand (Braungart & Braungart, 2003; Bush, 2006). Understanding 
this information about the learner requires an understanding of the experiences and 
unique skill set that the individual brings to the learning process. Without these insights, 
the instructor will not be able to engage with the learner. This has obvious implications 
for the utilization of the material disseminated.  
Within cognitive based theories, there exist different models to explain how 
information is retained and applied by the learner. One model, known as the information-
processing model of memory functioning, offers a schema of memory organization that 
follows a path of linear stages (Leonard, 2002). The first stage, operationalized as 
attention, requires that the learner engages in the external stimuli provided in the 
educational opportunity. In this stage, the learner should be able to respond to the 
instructor with feedback, questions, and overall engage in behaviors that illustrate their 
attention to the material (Braungart & Braungart, 2003). If the learner is not engaged in 
the attention stage or seemingly receptive to the material, it is suggested that the 
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instructor try again later when the learner is more apt to be attentive to the material. The 
second stage of the model is characterized as processing (Braungart & Braungart, 2003). 
During this stage, the learner is processing the information using their preferred mode of 
learning. Hence, it becomes increasingly important to understand whether the learner 
aligns more with audio, visual, or application modes of learning.  In the third stage, the 
learner moves from processing the information provided to storing information into their 
short-term memory, known as memory storage (Braungart & Braungart, 2003). At this 
stage, information is ascertained through learning and either disregarded or moved into 
long-term memory for utilization. The final stage within this model is the action phase. 
This stage is predicated on the previous stage in that learners will either eliminate the 
information learned or put it into action (Braungart & Braungart, 2003). However, the 
model does not end in the final stage. The learner may find that after some time they have 
issues with retrieving the learned material or that they have retrieved the information 
incorrectly (Leonard, 2002). This requires part of the process to start over, as the learner 
will need to modify the information if this happens and an instructor or another learner 
corrects them (Braungart & Braungart, 2003).  Understanding this process is useful in the 
creation of curriculum since it provides a framework for how the learner processes and 
retrieves information and converts this into actions.  
Under the cognitive learning framework, it should also be noted that persons are 
thought to understand and process the information provided through making meaning and 
relating the information to experiences or other portions of information that have already 
retained (Leonard, 2002).  This becomes helpful in understanding how the individual 
retains the information that is provided.   
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Cognitive-based learning theories have relevance to this study in that it provides a 
framework for understanding the motivation for learning and how learned behaviors 
become a continuous, inherent mechanism. Through this framework, it is important to 
provide learners with a clear understanding of why the material is important. For CNAs 
working with persons with AD, this will be emphasized through the need to provide 
compassionate care to the individual. Furthermore, cognitive theories of learning reiterate 
the importance of understanding the learner’s motivations, goals, and life experiences. 
These have an impact on the way in which the learner not only processes information but 
also how information is translated into actions. 
Social Learning Theory 
In contrast to the internal processes that are emphasized in cognitive-based 
learning, theories of social learning postulate that persons learn through their social 
environment. First developed by Albert Bandura, the foundations of social learning 
theory are built on the understanding that the learner’s environment and interactions with 
other learners is most important in building a body of knowledge that can be transferred 
into behaviors (Bandura, 1977, 1986). With the emphasis on the learner’s environment, 
social learning theory suggests that modeling from others is the most important impetus 
to changing behavior (Bandura, 1986). Furthermore, the individual learner does not have 
to be reinforced under this framework. Known as vicarious reinforcement, the theory 
posits that if a learner witnesses a role model or other learner in their environment 
receiving praise or positive attention, then this will reinforce the behavior. Reward, 
however, is not always necessary for the learner to adopt the behavior since viewing the 
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action will undoubtedly have an impact regardless of whether the role model receives 
praise or reinforcement (Bandura, 1977, 1986).  
In his seminal work, Bandura outlined a four-step model that delineates the 
process of social learning (Bandura, 1977, 1986). Given that it focuses on the internal 
processes that an individual learner undergoes to participate in and benefit from social 
learning, it is aligned with models under cognitive forms of learning as previously 
elucidated. The first step in Bandura’s model is the attentional phase (Bandura, 1977). 
This phase is necessary for learning to occur and is the point at which the individual 
learner observes a role model engaging in the behavior. The role model is an individual 
that the learner views as a competent and reliable leader in the environment (Bandura, 
1986). The next step is the retention phase in which the learner observes the role model in 
action and then processes the behavior observed. The third step is the reproduction phase.  
The learner copies the behaviors that have been observed from the role model. 
Reproduction of the behaviors in this phase are strengthened if the learner goes through 
the process of mental rehearsal, an immediate reenactment of the behavior, and if the 
learner receives corrective feedback from the role model (Bandura, 1977). The final step 
is the motivation phase where the learner is motivated to complete the behavior. This 
model reflects Bandura’s conception of the learner as being the primary agent in the 
social environment by which all the observations and subsequent behaviors are filtered 
given the learner’s experiences and motivations (Bandura, 1977, 1986). 
For developing a curriculum that CNAs can use effectively, social learning theory 
provides an understanding of how persons perceive their environment as a tool of 
learning. Persons observe behaviors of others within the environment and depending on 
 80 
the feedback of the observable behavior, will implement it. Furthermore, social learning 
theory highlights the need for going further than simply disseminating information to 
learners. Instead, learners can actively observe behaviors in their environment and then, 
implement these behaviors if they seem appropriate. 
Kirkpatrick Model of Evaluation  
The purpose of this dissertation study is to introduce a CC curriculum that 
incorporates the theories of learning and therefore a model for evaluation is needed. The 
Kirkpatrick Model of Evaluation was first introduced in the late 1950’s by David 
Kirkpatrick as a process of evaluation to determine whether newly adopted models of 
training or a new curriculum produces the intended results and objectives (D. L. 
Kirkpatrick, 1959a, 1960). The structure of the model allows for understanding how 
learners understand and adopt the curriculum to their practice. The model was later 
expanded on and refined through a number of scholarly literature by Kirkpatrick and his 
son (D. L. Kirkpatrick & Kirkpatrick, 2005; J. Kirkpatrick, 2005). The model is widely 
used in evaluation studies (Campbell & Mather, 2018; Farjad, 2012; C. Jones, Fraser, & 
Randall, 2018; Praslova, 2010; Simpson & Scheer, 2016). The Kirkpatrick model can be 
applied during any stage of evaluation, including before, during or after the 
implementation of training (C. Jones et al., 2018).  
The Kirkpatrick model denotes 4 levels of evaluation that will be utilized in the 
study (D. L. Kirkpatrick, 1960; J. Kirkpatrick, 2005). They are as follows: Level 1-
Reaction, explores to what degree participants react favorably to the learning event; 
Level 2- Learning, explores to what degree participants acquire the intended knowledge, 
skills, and attitudes based on their participation in the learning event; Level 3- Behavior, 
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explores to what degree participants apply what they learned during the training when 
they are back on the job; and, Level 4- Results, explores to what degree outcomes occur 
as a result of the learning event and subsequent reinforcement (D. L. Kirkpatrick, 1960; J. 
Kirkpatrick, 2005).  
The first level, reaction, focuses on the reaction of the learners to the delivered 
content (D. L. Kirkpatrick, 1959b). Reaction to the training is important for two primary 
reasons. First, it enables the learners to become part of the process. Second, the feedback 
solicited from learners can be used in future iterations of the development of the content 
(D. L. Kirkpatrick, 1959b; J. Kirkpatrick, 2005). Given the research discussed in the 
aforementioned section, empowering CNAs to provide feedback to the content that is 
provided in the curriculum will become a valuable asset, particularly during the pilot-
testing phase.  
After determining the learners’ reaction to the training, learning is the second 
level of evaluation (D. L. Kirkpatrick, 1959a). It is important to measure how learners 
understand the concepts and techniques that were provided in training. This can often be 
achieved through a skill-based knowledge test that is taken at the pre- and post-time 
intervals (Reio, Rocco, Smith, & Chang, 2017).   
In level three of Kirkpatrick’s model, there is a shift in focus from learning to 
transfer (J. Kirkpatrick, 2005). The focus of this level is on the job performance of the 
learner and how they were able to implement the material that was delivered through the 
training (Reio et al., 2017). This level is critical as results cannot be assessed (level 4) if 
the learners have not transferred their learning in behavior changes that are measured by 
the organization (Reio et al., 2017). This level is considered more time consuming than 
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the previous levels since it requires the organization to examine the behaviors of the 
learners and assess whether transference of learning has occurred (J. Kirkpatrick, 2005).  
Finally, the model culminates with the fourth level- results. In this context, results 
mean the assessment of the desired outcomes of the curriculum. (C. Jones et al., 2018). 
This can be the most challenging level of the model to assess and measures the actual 
organizational change that occurred as a result of the training (Reio et al., 2017). Studies 
that utilize all four levels of the model provide comprehensive evaluations (C. Jones et 
al., 2018). 
Conceptual Hypothetical Model 
 Utilizing the presented theories as a foundation, a conceptual hypothetical model 
was developed. The purpose of this proposed model is to provide an understanding of 
how the stress of persons with AD living in nursing facilities can be improved by the 
implementation of a compassionate care curriculum for CNAs.  Figure 1 shows the 
proposed model along with an overview of the variables that are included in the model.  




Figure 1. Conceptual Hypothetical Model  
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Operationalization of Conceptual Model Variables  
 The following provides an overview and justification for all variables that were 
included in the conceptual hypothetical model.  
Control Variables.  To focus on the impact of a CC curriculum in how to care 
for residents with AD living in nursing facilities, a variety of variables served as control 
variables for the study. These variables were divided into those that focused specifically 
on CNA characteristics and those that focused specifically on the characteristics of 
persons with AD.  
CNA characteristics. The following CNA characteristics were controlled for:  
Age of CNAs. It is important to control for age of the CNAs that are providing 
care to persons with AD. Age-related values exist within helping professions including 
CNAs.  Persons from younger age cohorts tend to be more open to change, while older 
age cohorts report being more set in their current ways of providing care (Caplan & Bull, 
1992). Age is also related to job and training experience (Onnismaa, 2008).  CNAs that 
are older, by virtue, had more experience and therefore, are more likely to respond to 
difficult situations in a more positive way (Onnismaa, 2008). 
CNA Gender. Gender could influence the way in which the CC curriculum is 
implemented, and persons with AD are cared for. The CNA workforce is predominately 
comprised of females (United States Department of Health and Human Services Centers 
for Disease Control, 2018). Females in helping professions, such as CNAs, tend to 
exhibit higher levels of empathy than their male colleagues (Williams, 1989). 
Furthermore, this level of empathy displayed can lead to higher rates of emotional fatigue 
and exhaustion (Williams, 1989). Females often choose to enter into helping professions, 
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such as the CNA profession, for different reasons than men (Byrne, 2008). This could 
potentially impact care because females and males could interact differently with the 
residents with AD.    
CNA Race/Ethnicity. Reports have indicated that while persons of color make up 
roughly one-quarter of the total United States workforce across all fields and professions, 
within the CNA workforce, African Americans make up over one-third of the workforce 
(United States Department of Health and Human Services Centers for Disease Control, 
2018). It has also been suggested that factors related to disparities between races can 
increase job strain (Chaudhuri, Yeatts, & Cready, 2013; Hurtado, Sabbath, Ertel, Buxton, 
& Berkman, 2012). In a study specifically looking at factors of jobs strain, it was found 
that there were differences in black CNAs and white CNAs. More specifically, black 
CNAs felt they had less control over their work (Hurtado et al., 2012). Furthermore, 
black CNAs in the study reported earning $2.58 less per hours than white CNAs (Hurtado 
et al., 2012). These factors contributed to higher feelings of job strain  that could lead to 
differential interactions with residents with AD (Hurtado et al., 2012).  
Years of experience working in nursing facilities. For nursing facility staff and 
administrators, experience in the field is often correlated to higher scores on the core 
quality measures as stipulated by CMS (Krause, 2012). In general, within the nursing 
profession, years of experience is correlated to higher feelings of competency in 
providing care (Takase, 2013). Hence, overall years of work experience can have an 
impact on the care that residents in the facility receive on a daily basis.  
Years of experience in specified nursing facility. The number of years that the 
CNAs worked in the specified nursing facility was seen as important, particularly 
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considering the impact that staffing turnover has on the structure of the facility and the 
care received by residents (Castle, Engberg, R., & Men, 2007). This should be 
differentiated from the number of years that the individual has worked in the field in total 
since turnover and facility changes are common within the CNA profession. Furthermore, 
it is assumed that each facility has its own culture, work environment, and expectations. 
Becoming a part of this unique culture is important to both workers and the residents they 
serve. Studies have shown that the number of years working in a specific nursing home 
settings can have a positive impact on nursing facility workers perceived feelings of self-
efficacy (Pfister et al., 2013). 
Educational attainment. Education attainment included only formal education 
received by the CNAs (Griscti & Jacono, 2006). CNAs are required to have a high school 
diploma (Montgomery, Holley, Deichert, & Kosloski, 2005), with some being more 
qualified. Education attainment impacts the care they provide to persons with AD, with 
more education providing a positive effect on the quality of care (Coogle, Parham, & 
Rachel, 2011).  
Characteristics of residents with Alzheimer’s disease. As with the considerations 
to control for variables related to the CNAs, there are important control variables to 
consider in relation to the characteristics of residents with AD.   
Age of persons with AD. As people age, they are more predisposed to having AD. 
Both gender and age are the most significant predictors of developing the disease (Vina 
& Lloret, 2010). Thus, the prevalence rate of the disease is much higher for those persons 
aged 85 and older than it is for persons 65 and older (Centers for Disease Control and 
Prevention, 2017 ). Furthermore, it has been shown that persons with AD  who are 85 
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years and older are more prone to exhibit the various behavioral symptoms that are often 
associated with the disease (Furuta, Mimura, Isono, Sugai, & Kamijima, 2004). Hence, 
the older the residents with AD, the more complicated the care can be. Age is also 
connected to other chronic conditions that the individual may be predisposed to in 
addition to AD, including, cataracts, hearing loss, high blood pressure, or cardiovascular 
disease (Salive, 2013). If a person with AD has one or more other chronic conditions, this 
will require increased care.  
Gender of persons with AD. From the onset of AD research, it was established 
that the disease disproportionately affects women (Farrer et al., 1997). This early research 
has been expounded upon in subsequent decades, making it clear that while there is a 
debate about why more women are diagnosed with AD, the fact remains that there is a 
difference between genders (Vina & Lloret, 2010).  
Gender has an impact on the interactions between residents in a nursing home and 
staff. In a study of interactions between staff and residents, it was noted that female 
residents did not initiate interactions with male staff (Lindesay & Skea, 1997). Some 
critical feminist gerontological theories suppose that women spend most of their lives 
feeling disenfranchised and not valued within society (hooks, 2000). These feelings of 
inferiority might transfer into their lives within any long-term care facility (Lindesay & 
Skea, 1997). 
Race/ethnicity of persons with AD. An individual’s race/ethnicity may have an 
impact on their care. Minorities in society are often marginalized and these disparities 
extend to the care that they receive in the nursing facility. One study focused on social 
engagement showed that while a majority of nursing home residents showed low social 
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engagement, there was a difference for racial/ethnic minorities. When compared to white 
residents, minority residents were between 30% and 40% less likely to show overall high 
social engagement (Y. Li & Cai, 2014).  
Cognitive Functioning. Identifying cognitive functioning assists in understanding 
where the person with AD is in the trajectory of the disease (Silverberg et al., 2011). 
More care is needed for those with higher levels of cognitive decline (Silverberg et al., 
2011). The goal is to ensure that all residents receive the same quality of care, regardless 
of their mental acuity.  
Predictor Variables. Predictor variables include changes in knowledge of 
Alzheimer’s disease; changes in confidence in performing restorative care activities; 
changes in caregiver satisfaction; and, changes in affiliate stigma. They are explained in 
more detail below.  
Changes in knowledge of Alzheimer’s disease. According to the Kirkpatrick 
model after the reaction to the curriculum, learning is the second level of evaluation (J. 
Kirkpatrick, 2005). It is important to measure how learners understood the concepts and 
strategies for providing care that was included in the delivered curriculum. It was 
anticipated that an increase in knowledge would have an impact on care. From the 
literature, we know that education has a direct positive impact on the quality of care 
provided by CNAs (Trinkoff et al., 2017; Yeatts, Cready, Swan, & Shen, 2010).  
Changes in confidence in performing restorative care activities. Following 
Kirkpatrick’s model, there is a shift in focus from learning to the transference of skills 
through behavior (J. Kirkpatrick, 2005). The focus on this variable was to determine if 
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CNAs moved past the learning processes to utilize the information that they were 
provided via the curriculum.  
From the literature, we know that an increase in education and experience 
correlated with higher performance in restorative care activities (Castle et al., 2007). 
Based on increased training and more experience with working with the needs of this 
population, it was anticipated that CNAs would have more confidence in their abilities to 
provide compassionate care.   
Changes in confidence in performing restorative care activities are connected to 
Bandura’s social cognitive theory (Bandura, 1986). It was posited that self-efficacy is an 
important factor for behavioral change to occur. Through the process of feeling more 
confident in their abilities, it was assumed that nurse aides would want to use the skills 
they developed during their exposure to the curriculum.  
Changes in Caregiver Satisfaction. The relationship between the care receiver 
and the caregiver can be a special bond, one that the caregiver will cherish long after the 
care receiver has passed away. However, in those moments when caregiving is 
particularly difficult when the individual with AD is at their lowest moment, caregiving 
can be particularly challenging. All of this can have an impact on caregiver satisfaction. 
The conceptual model included the impact that caregiver satisfaction from the 
perspective of the CNAs would have on the care of residents in the nursing facilities.  
Caregiver satisfaction is the alternative to caregiver fatigue (Figley, 1995). Figley 
states that caring comes with a cost that can manifest in a negative way that includes 
fatigue (Figley, 1995). Therefore, fatigue often is the direct result of trauma and stress-
related exhaustion that occurs in helping professions such as that of CNAs (Sabo, 2006). 
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This is particularly true as the caregiver’s life becomes more intertwined with the 
individual that they are providing care to and can intensify based on the circumstances. 
For example, caregivers can experience secondary trauma based on the individual’s 
circumstances (Sabo, 2006). Fatigue can be related to many of the activities that nursing 
aides are faced with, including providing care to persons with AD when they are not 
adequately educated with tools and techniques to help in this care. This fatigue can 
contribute to negative care for persons with AD, particularly if the CNA does not have 
the adequate skills to cope with their feelings. Adequate skills, in this context, are those 
skills that are needed to provide a truly compassionate approach to caregiving. Thus, 
caregiver satisfaction is achieved when the CNA is equipped to deal with the exhaustion 
and stress that is accompanied by the process of providing care to persons with AD. 
Satisfaction is not limited to the opposite of compassion fatigue. Satisfaction also 
includes the feelings of reward that are often accompanied by caregiving. Thus, for 
caregivers, there is also this understanding that while caregiving can be burdensome and 
difficult, that it also provides a rewarding experience. 
Changes in Affiliate Stigma. Stigma is defined as an “attribute, behavior, or 
reputation which is socially discrediting in a particular way: it causes an individual to be 
mentally classified by others in an undesirable, rejected stereotype rather than in an 
accepted, normal one” (Erving Goffman, 1986). Goffman described not only the 
stigmatization that persons with disabilities, such as AD suffer, but also the stigma that 
extends to persons that associated with stigmatized persons; this is known as affiliate 
stigma.  
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It has been shown that caregivers and family members experience stigma and both 
function and wellness are affected (Kahn, Wishart, Randolph, & Santulli, 2016).It has 
also been found that stigma by association related to AD is especially high in the delivery 
of services and in the lives of persons with AD (Werner & Heinik, 2008). The purpose of 
the compassionate care curriculum was to contribute to a decrease in the affiliate stigma 
of the CNAs.  
Moderator Variable. The curriculum served as the moderator variable in this 
study. The control group continued with their traditional care and the experimental group 
engaged with the compassionate care curriculum.  
Traditional Curriculum. The control group received no additional training and 
continued with care per norm. This included providing residents with AD basic nursing 
care. All CNAs went through the mandatory certification program which included 75 
hours of basic nursing care and had participated in Hand in Hand training through CMS 
(Kentucky Adminstrative Regulations, 2006; Patient Protection and Affordable Care Act, 
2010). As it is mandated that basic nursing care is supplemented with 12 hours of training 
each year, CNAs at the control facility participated in required training on topic areas 
such as lifting, toileting, administering medication, and other areas that would assist them 
in providing the task-specific areas of basic nursing care.  
Compassionate Care Curriculum. The development of the curriculum followed a 
problem-based learning approach (Barrows & Tamblyn, 1980), presented in a format that 
allowed for collaborative adult learning to take place (Schapiro, 2003), within the context 
of on-the-job learning (Khan, Khan, & Khan, 2011).  Problem-based learning has two 
fundamental assertions: 1) learning through problem-solving is more effective for 
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creating a body of knowledge usable in the future than traditional memory-based 
learning; and 2) health team skills most important for patients are problem-solving skills, 
not memory skills (Barrows & Tamblyn, 1980). Adult learning is guided by the 
assumptions that for learning to be meaningful and significant, it should be self-directing, 
draw on past and present experiences as a resource for learning, address problems, and 
situations learners are currently facing, be based in relationship and in community, and be 
both a cognitive and an affective experience (Schapiro, 2003). On-the-job learning is 
focused on supporting the organization to increase performance and develop workers that 
will be satisfied with their jobs and stay in the job for a longer period of time  (Khan et 
al., 2011).  
 The content was presented in an online modular format, starting with didactic 
overviews, and then followed by case studies to highlight the content. Eight online 
modules were developed that focused on three primary areas: 1) the disease and its 
impact; 2) compassionate caregiving for persons with Alzheimer’s disease; and 3) caring 
for the caregiver. For all CNAs that participated in the study, it took approximately 8 
hours spread out across one week for the modules to be completed. 
After the completion of the online modules, all CNAs participated in hands-on 
learning and support, by participating in compassionate care groups. These groups were 
held at the nursing facility where the CNAs were employed in order to receive additional 
on-the-job support.  Each hour-long group session began with a brief didactic focused on 
a set of difficult behaviors the CNAs in the facility decided they needed the most help 
with. As part of the brief 15-minute didactic presentation, interventions were discussed 
that could be used to address these behaviors. The rest of the hour was used to discuss 
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specific residents who were demonstrating these behaviors. Strategies that could work for 
the specific residents were explored in the context of group learning where everyone 
contributed to the discussion and provided insight. A specific behavior management care 
plan for the residents discussed was then written up and shared with all CNAs. During the 
first month, these groups were held twice a week at different times to allow for as many 
CNAs to participate as possible. The next two months, these groups were held once a 
week on different days, again to allow for as many CNAs to participate as possible. 
These compassionate care groups allowed for the development of a strong care 
community within the nursing home and better collaboration between CNAs in the 
coordination of care for persons with AD at the facility. 
Outcome Variables. The following are the two outcome variables in the 
conceptual model defining the stress of persons with AD.  
Stress of Person with AD: Agitation. The model culminates in an examination of 
the stress of the person with AD living in the nursing facilities and receiving care from 
CNAs. Stress of the person with AD was measured by agitation and levels of salivary 
cortisol. When a person with AD is stressed, this can manifest as agitation (Hooker et al., 
2002). Agitation is attributable to the stress a person feels as they begin to decline as a 
result of the disease. Personhood is the very embodiment of the individual’s character, 
and often with AD, this is stripped away, making it particularly difficult for caregivers to 
deal with the AD patient. If a person with AD feels as though their needs are not being 
met or if they are challenged to do certain tasks that make them feel uncomfortable, this 
could result in anxiety. Take, for example, a resident that no longer prioritizes showering 
or bathing. When they were fully functioning, prior to the disease, this was more than 
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likely a priority and part of their activities of daily living. However, as the disease 
progresses, they might no longer value participation in this activity. Or the act of taking a 
shower or bath might be so physically difficult for them that they might fear participation 
in this activity. If the individual is pushed to engage in this activity, this could cause 
anxiety that results in negative behaviors. Thus, the purpose of the CC curriculum was to 
generate a decrease in stress for the resident by introducing a more compassionate 
approach rather than forcing the individual to engage in the activity because of technical 
and administrative procedural rules.  
Stress of Person with AD: Salivary Cortisol. Lastly, levels of salivary cortisol 
were measured in the person of AD.  Cortisol is an essential hormone in the regulation of 
the stress response along the hypothalamic-pituitary-AD renal (HPA) axis, and salivary 
cortisol has been used as a measure of free circulating cortisol levels (Maruyama et al., 
2012; Smith & Vale, 2006). Measuring cortisol levels in persons with AD has been 
established as a way to better understand the stress that the person is undergoing on a 
biological level (Woods et al., 2008). As a biomarker, salivary cortisol is a simple and 
non-invasive way of measuring a persons’ level of stress. Salivary cortisol testing has 
been a successful way to measure emotional variables in patients with AD (de la Rubia 
Orti et al., 2018).  
Summary 
 This chapter provided an overview of the literature that was relevant to the 
primary components of this dissertation. Overviews of established theoretical 
perspectives were discussed as it pertains to persons with AD, CNAs that are providing 
care to persons with AD and theories of learning to assist in the development of the 
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project. Furthermore, a hypothetical, theoretical model was developed to conceptualize 





















CHAPTER III: METHODOLOGY  
The aim of this study was the implementation and evaluation of a newly 
developed CC curriculum for CNAs.  This chapter focuses on the methodology of the 
study. In order to evaluate the effectiveness of the compassionate care curriculum, the 
study was broken down into two parts. The first part of this study focused on the 
evaluation of CNA training in nursing facilities, specifically the first three levels of 
Kirkpatrick’s model, namely Reaction, Learning, and Behavior. The second part of this 
study focused on level four of the Kirkpatrick model, which examined results in the form 
of the stress outcomes of residents with AD.  
 Study #1: Evaluation of the Compassionate Care Curriculum (Kirkpatrick 
Levels One, Two, and Three) 
Research Design and Hypothesis 
 Study #1 utilized a quantitative pre-post control group design to examine changes 
in CNAs knowledge, self-efficacy, caregiver satisfaction and affiliate stigma over a 12- 
week period. The experimental group was exposed to the newly developed compassionate 
care curriculum, with the control group being exposed to the standard curriculum that is 
currently used in Kentucky. The following specific aim and research hypothesis guided 
study #1: 
Aim 1: To determine if the CNA compassionate care curriculum for nursing home 
residents with AD is better than the current standard curriculum to increase the following 
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attributes of CNAs: knowledge of AD, caregiving self-efficacy, feelings of caregiving 
satisfaction, and feelings of affiliate stigma. 
Hypothesis 1: After completion of the CNA compassionate care curriculum by the 
experimental group, CNAs will show a significantly higher increase in knowledge, 
caregiving self-efficacy, caregiving satisfaction and a significantly higher reduction in 
feelings of affiliate stigma than the CNAs who completed the current standard curriculum.  
Sample  
This study included an experimental facility and a control facility in Kentucky, 
both part of Signature HealthCARE which is a healthcare and rehabilitation company 
with 118 locations in 10 states and over 17,000 employees. Both facilities were urban, 
with the experimental facility located in Jefferson County, and the control facility in 
Fayette County. Both were small size nursing facilities.  According to the CMS quality 
measures, both the experimental and control facility scored 4 out of 5 on staffing at 
baseline. For quality of resident care, both facilities scored 4 out of 5 at baseline. Neither 
facility had any penalties for the past 3 years.  All CNAs at these two facilities who took 
care of the residents with AD that took part in the study were included in the sample for a 
total of 99 CNAs, 48 in the experimental group and 51 in the control group. 
Measures 
Demographics. The following demographics of CNAs were collected to ensure 
equivalency between the CNAs in the experimental and control groups:  
Age. The age of the CNA.  
Gender. The gender of the CNA.  
Race/Ethnicity. The race/ethnicity of the CNA.  
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Years of experience working in nursing facilities. The number of years that the 
CNA has worked specifically in nursing facilities.  
Number of years’ experience in specified nursing facility. The number of years 
that the CNA has worked in the current facility that is a part of the study.  
Educational attainment. The number in years that the CNAs received formal 
educational training.  
  Learner outcome measures. The following measures were used to examine 
CNA learner specific attributes and changes: 
Learner Satisfaction. The learner satisfaction survey was administered after the 
completion of the curriculum program to determine CNAs satisfaction with the program. 
This was only administered to CNA learners that were part of the experimental group. 
The learning satisfaction survey consisted of 3 items, rated on a scale ranging from 1 (not 
satisfied at all) to 5 (very satisfied). 
AD knowledge. AD knowledge was measured using the AD Knowledge Scale 
(ADKS). The ADKS is a 30-item, true/false scale and covers the following topic areas: 
risk factors, assessments, and diagnosis, symptoms, course, life impact, caregiving, 
treatment and management. Reliability for the ADKS has shown that reliability is 
acceptable (test-retest correlation = .81; internal consistency reliability = .71) and has 
been validated as a tool for assessing knowledge of all types of caregivers and in different 
settings (Carpenter, Balsis, Otilingam, Hanson, & Gatz, 2009). 
CNA Self-Efficacy. Self-efficacy was measured using the Nursing Assistants’ 
Self-Efficacy for Restorative Care Activities (NASERC). The NASERC is a measure that 
determines nursing assistants’ confidence in performing restorative care activities in 
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nursing home settings.  This is a 10-item measure that was administered to CNAs after 
they have completed the curriculum to determine their confidence in performing tasks in 
working with residents with AD. Alpha coefficients for the NASERC ranged from .80 to 
.91 (Resnick & Simpson, 2003).  
Caregiving Satisfaction. Caregiving satisfaction was measured by the Revised 
Caregiving Appraisal scale also known as the RCAS (Lawton, Kleban, Moss, Rovine, & 
Glicksman, 1989). It measures the extent to which caregiving is a source of fulfillment 
and self-esteem by examining the acceptance of subjective burden, caregiver satisfaction, 
and caregiving impact. The reliability of the RCAS is high for the general population 
(Cronbach alpha=.90).  
Affiliate Stigma. Affiliate stigma was measured using the Affiliate Stigma Scale. 
The Affiliate Stigma Scale emanates from Goffman’s understanding of stigma (Erving 
Goffman, 1986). Affiliate stigma is defined as self-stigmatization that an individual faces 
when they associate or affiliate with a stigmatized population (Mak & Cheung, 2008). 
For CNAs, this is the feeling of the stigma that they feel by working with a marginalized 
population. The Affiliate Stigma Scale contains three unidimensional domains: cognition 
(7 items), affect (7 items) and behavior (8 items), rated on a 4-point Likert scale. A 
higher score on the scale indicates a higher level of affiliated stigma. The use of this scale 
to determine self-stigma with caregivers has been supported with a Cronbach alpha for 
this population ranging between .85 and .94. (Chang, Su, & Lin, 2016).  
Data Collection    
At baseline, prior to the implementation of the curriculum, and after 12-weeks, 
data were collected on the demographics of the CNAs along with their pre-test on AD 
                              
100 
knowledge, self-efficacy, caregiving satisfaction, and affiliate stigma for both the 
experimental and control groups. At the 12-week period, after the curriculum and care 
community meetings were implemented, data on AD knowledge, self-efficacy, 
caregiving satisfaction, and affiliate stigma were collected again for both groups. During 
this time, data were also collected on learning satisfaction, only for the CNAs in the 
experimental group. 
Power Analysis  
An a priori power analysis was performed with G*Power (Faul, Erdfelder, 
Buchner, & Lang, 2009) with the alpha level for the MANOVA analysis set to .05 and a 
correlation of .50 to achieve power of .80 and a medium effect size, which suggested a 
total sample size of 76 (38 in the experimental group and 38 in the control group) to 
detect a significant model. For this study, we had 48 CNAs that were part of the 
experimental group and 51 CNAs that were part of the control group for a total of 99 
CNAs in the study. Therefore, we met the power requirement for the study. 
Analysis 
 Analysis of this study used a repeated measures approach. This type of analysis is 
appropriate when the same group of people are pre-tested and post-tested on a dependent 
variable.  
All data collected was examined for missing values, outliers and distribution 
form, to determine if it would meet the assumptions of the appropriate tests for the 
planned analysis. As this is a study utilizing a control group, it was first important to test 
for equivalence between the two groups at baseline. Where appropriate, either Chi-square 
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tests or independent samples t-tests were completed on all the demographic and 
dependent variables at baseline. 
After equivalency was tested, a two-way mixed design MANOVA was utilized to 
examine how scores changed for all of the dependent variables after implementation of 
the CC curriculum. A two-way mixed design MANOVA is appropriate when there is 
both within-subjects and between-subject’s factors. For this study, the focus of the 
analysis was to examine whether there was a significant difference over time (within-
subjects), whether there were differences between the control and experimental groups 
(between-subjects), and whether there was an interaction effect between time and group, 
indicating if the groups change differently over time.  
For this study, there were two points of data collection: at baseline and 12 weeks 
after the beginning of the curriculum and compassionate care group. There were four 
dependent variables: knowledge of AD, self-efficacy of restorative care activities, 
caregiving satisfaction, and affiliate stigma.  
Study #2: Evaluation of the Compassionate Care Curriculum (Kirkpatrick Level 
Four) 
Research Design and Hypothesis  
The second study examined the final element of the Kirkpatrick model, namely 
stress levels of residents with AD. This study was conducted by testing a hybrid 
multilevel growth model, as detailed in Chapter 2 Figure 10, with a three-nested level 
structure. According to Singer and Willet (2003), a study examining growth over time 
must include at least 3 waves of data collection. This study fulfills this requirement as it 
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utilized data collected from residents with AD that looked at changes between baseline, 6 
weeks and 12 weeks.   
The outcome variable used in this model was operationalized as stress 
experienced by residents with AD over a 12-week period. Stress was operationalized as 
agitation and salivary cortisol levels. Therefore, the model was treated as a hybrid model 
where the model was first built with agitation as the outcome variable of interest. After 
this model was built, agitation was moved to a predictor and tested in the second model 
where salivary cortisol levels became the outcome variable. 
Multilevel modeling, many times referred to as hierarchical linear modeling, is an 
appropriate statistical technique to analyze data that is clustered. Multilevel modeling 
assumes that there is a hierarchical structure in the data set and that units of observation 
fall into groups or clusters. For this study, the three clusters or levels were as follows: 
level 1 referred to the three measurement occasions for each resident with AD, level 2 
referred to the residents with AD, and level 3 referred to the CNAs providing care to the 
residents with AD.  Figure 13 illustrates the levels of the model. The advantage for using 
multilevel modeling in data that is clustered like this is the ability to examine the distinct 
effect of the predictors at each level, by allowing for the separation of the variance that is 
occurring at each level.  
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Figure 2. Data Structure 
Traditional multilevel modeling is used to analyze data that is purely hierarchical 
in nature meaning that each lower-level unit belongs to a single higher-level unit (Chung 
& Beretvas, 2012). However, this approach ignores the fact that often, longitudinal data 
is not structured in a pure hierarchical way.  Given that within each nursing facility, 
residents with AD are cared for by many different CNAs, this is a multiple membership 
model (Chung & Beretvas, 2012). In multiple membership models, the lower level units 
do not belong to only one higher level unit. Instead, the lower level units are nested 
within multiple higher-level units. Thus, the residents with AD were nested within the 
CNAs. This specific type of multiple membership model is also referred to as a two-way 
cross-classified data structure. It is important to note that in multiple membership models, 
data will vary dependent on the degree to which the lower level units belong to the 
higher-level units.  
In clustered data, it is important to account for dependence or correlation among 
responses in the same unit or cluster. Utilizing multilevel modeling allows this 
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dependence or correlation to be explicitly modeled. One primary difference between 
multilevel modeling and traditional regression analysis is that multilevel modeling allows 
random effects such as random intercept and slopes or random coefficient for each unit.  
Multilevel modeling can also make use of all available outcomes data in the estimation of 
the model parameters because it treats time in a flexible manner (J. D. Singer & Willett, 
2003). This is particularly important given the type of study subject, namely persons with 
AD at the end of life. It was, therefore, possible to keep data from study participants, 
even if circumstances might change and they had to end their participation within the 12-
week period of the study. However, all study participants were able to remain in the 
study.  
The study analysis followed a two-step approach. As part of step 1, we identified 
an aim 1 that focused only on a two-level multilevel structure where measurement points 
over time were identified as level 1 and persons with AD identified as level 2. The only 
level 2 predictor that was added in the model was group status. This same analysis could 
have been completed as part of a time series mixed ANOVA analysis where time is 
treated as the within effect, and the group status is treated as the between effect.  
As part of step 2, the researcher identified an aim 2 that focused on a three-level 
cross-classified structure where level 1 and level 2 stayed the same as in step 1. However, 
in this step, level 3 was added and included the impact of the CNAs on the outcome 
variables connected to the residents. This type of analysis can only be completed in a 
multilevel model environment. The reason for this two-step approach was to illustrate the 
power of multilevel modeling in this type of dataset where data from both residents and 
CNAs need to be considered for a complete understanding of change in the outcome 
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variable. Not only can the effect of changes in CNA knowledge, self-efficacy, caregiver 
satisfaction, and affiliate stigma be evaluated without any variance constraints but also 
CNA impact on each individual resident can be weighted according to the time spent with 
each resident over the 12-week period.  
The following research hypotheses were tested, which captured the multilevel 
growth aspects of the CNAs and persons with AD. Aim 1 focused on the two-level 
multilevel structure while aim 2 focused on the three-level cross-classified model.  
Aim 1: To determine if residents with AD from an experimental nursing facility differ in 
their stress levels from residents with AD from a control nursing facility, after the 
implementation of a compassionate care curriculum in the experimental nursing facility.   
Hypothesis 1a: Residents with AD from the experimental nursing facility will have a 
different 12-week agitation change trajectory than the residents with AD from the control 
nursing facility.  
Hypothesis 1b: Residents with AD from the experimental nursing facility will have a 
different 12-week salivary cortisol change trajectory than the residents with AD from the 
control nursing facility. 
Aim 2: To determine if differences in change in CNAs knowledge of Alzheimer’s 
disease, caregiver confidence, caregiver satisfaction, and stigma will have a differential 
effect on the 12-week stress trajectories of residents with AD in the experimental and 
control nursing facilities. For the hypotheses related to aim 2, the background 
characteristics for CNAs and residents with AD were controlled for, when the model 
required it. 
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Hypothesis 2a: Differences in change in CNAs knowledge, confidence, satisfaction and 
affiliate stigma will have a differential effect on the 12-week agitation trajectories of 
residents with AD in experimental and control nursing facilities.  
Hypothesis 2b: Differences in change in CNAs knowledge, confidence, satisfaction and 
stigma and differences in residents with AD agitation will have a differential effect on the 
12-week salivary cortisol trajectories of residents with AD in experimental and control 
nursing facilities.  
Sampling  
The CNA sample for study #2 included all the CNAs that took part in study #1.  
The resident sample for study #2 was drawn from residents with AD in the two nursing 
homes where the CNAs worked. In the experimental facility there was a total of 50 
residents with AD, and in the control facility, there was a total of 45 residents with AD. 
The sample from each nursing home included a convenience sample of 25 residents from 
the experimental group and 27 residents from the control group, for a total of 52 residents 
from both nursing homes. The selection of participants was based on their availability 
and the willingness of their caregiver or legal authorized representative to consent to their 
participation. For the purposes of selecting the sample, Rapid Cognitive Screening (RCS) 
was used. As described in the measures section, this screening tool score is between 0 
and 10, with 0 indicating severe dementia and 10 indicating normal cognitive 
functioning. The original intention of using the RCS was only to include residents that 
scored 0-5 (indicating dementia) on the RCS. However, in our control group, there was 
one individual that scored a 6. After further discussion with the facility, it was determined 
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that this individual would remain a part of the study sample, due to concerning behavior 
manifestations.  
Power Analysis 
 In multilevel modeling, there exist sample size requirements for each level of the 
model (Snijders, 2005). In terms of power, while higher samples sizes at all levels are 
important, the primary concern is the sample size at the highest level. Power for level 1 
depends on the number of measurement occasions, while power for level 2 depends on 
the number of residents with AD, and power for level 3 depends on the amount of CNAs 
that participate (Snijders, 2005).  
Statistical power concerns in multilevel modeling are complicated as the power 
differs for fixed effects vs. random effects as a function of effect size, intraclass 
correlation, and the number of groups and cases per group (J. Cohen, Cohen, West, & 
Aiken, 2003). With the significance level set at 0.05, the intra-class correlation at a small 
size of 0.05, which is recommended for health and mental health research (Spybrook, 
Raudenbush, Liu, Congdon, & Martinez, 2008), the model wanted to detect at least a 
medium effect size (0.04) and achieve at least 80% power. At the highest level of the 
model, at least 20 units were needed for adequate power (Kreft & De Leeuw, 1998). For 
this study, level 3 (CNAs) included 99 CNAs, meeting the main requirement for power. 
Level 2 (residents) included 52 residents and level 1 (time) had 156 measurement 
occasions.  
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Operationalization of variables 
The variables included in this study were provided a priori as part of the 
development of a conceptual framework that was delineated in Chapter 2. In this chapter, 
the variables are operationalized. 
Control variables. To focus solely on the impact of enhanced training on the care 
of residents with AD living in nursing facilities, a variety of control variables formed part 
of the study. These variables were divided into segments that focus specifically on CNA 
characteristics and the characteristics of the persons with AD.  
Nursing Aide Characteristics. The same CNA demographics that were described 
in Study #1 were used as control variables in this study, namely: age, gender, 
race/ethnicity, years of experience as a CNA, number of years’ experience in specified 
nursing facility and number of years of formal education.  
Residents with AD Characteristics. The following characteristics of the residents 
with AD were controlled for:  
Age. The age of the residents with AD.  
Gender. The gender of the residents with AD.  
Race/ethnicity. The race/ethnicity of the residents with AD.  
Cognitive Functioning. Cognitive functioning was measured by the Rapid 
Cognitive Screen (RCS), a brief screening tool consisting of 5 questions that is used in a 
variety of settings for the detection of cognitive impairment (Malmstrom et al., 2015). 
Scores on the RCS range from 0 -10, with 0 indicating severe dementia and 10 indicating 
normal cognitive functioning. A score between 0-5 indicates dementia, a score between 
6-7 indicates mild cognitive impairment, and a score between 8-10 indicates normal 
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cognitive functioning. The RCS includes 3-items from the St. Louis University Mental 
Status (SLUMS) exam, which is a commonly used assessment tool for determining 
cognitive decline. Validation studies show that the RCS predicts dementia with a 
sensitivity of 0.89 and a specificity of 0.94  (Malmstrom et al., 2015). 
Predictor Variables. The following training related CNA variables have been 
noted to impact the stress of residents with AD. The CNA predictor variables included 
changes in AD knowledge, self-efficacy, caregiving satisfaction, and affiliate stigma. All 
these variables were operationalized as part of Study #1. 
Moderator Variable. The moderator variable was defined as the following 
between the experimental and control groups.  
Traditional Curriculum. This included all of the basic nursing care curriculum 
and training that CNAs received in the control group.  
Compassionate Care (CC) Curriculum. In addition to the basic nursing care 
training that all CNAs receive, the CC curriculum focused specifically on AD and 
consisted of 8 online modules and participate in the care groups. All the CNAs in the 
experimental group participated in the CC curriculum.  
Outcome Variables. The following measures were utilized to determine if there 
was a reduction of stress for residents with AD.  
Agitation. The Cohen-Mansfield Agitation Inventory (CMAI) was used to 
measure agitation. This rating inventory was developed in 1986, consisting of 29 agitated 
behaviors each on a 7-point scale. The CMAI has been used in nursing home settings 
(Cohen- Mansfield, Marx, & Rosenthal, 1989).The CMAI is considered a reliable scale 
with a Cronbach’s alpha score of .92 (Zare, Shayeghian, Birashk, & Afkham, 2012). 
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Subscales include disruptiveness, aggressive behavior, physically non-aggressive 
behavior and verbally non-aggressive behavior (Whall et al., 1999). Each person’s 
subscale scores can be combined into a total score (Whall et al., 1999). For the purposes 
of this study, a total score was used. On the CMAI, scoring ranges from a 1 indicating 
that the behavior has never occurred to a 7 indicating that the behavior occurs several 
times an hour.  
Salivary cortisol levels. Salivary cortisol has recently emerged as a novel 
biomarker for psychosocial stress responsiveness within the sympathetic 
adrenomedullary (SAM) system (Maruyama et al., 2012; Smith & Vale, 2006). The 
literature supports the use of these tests in that it is relatively inexpensive and non-
invasive when compared to other biomarker testing.  Salivary cortisol levels were 
collected using a testing kit from Peak Biometrics (PeakBiometrics, 2018). The kit 
utilized a smartphone and adaptive equipment that quickly analyzed each sample on site.  
Data Collection   
The same data that were collected from CNAs during study #1 was used for study 
#2.  For the residents with AD, data were collected at baseline that included the resident 
demographics, CMAI scores, and cortisol levels. The demographics of the residents were 
collected from the nursing facility administration. As the CMAI is an inventory that uses 
a rating scale, CNAs that worked with the residents that were part of the study were 
asked to complete the measure based on the resident’s behaviors. The facility 
administrator determined which CNA would be the most appropriate person to complete 
the inventory. The same CNA was used to complete the CMAI at baseline, six weeks and 
12 weeks after the implementation of the curriculum. For the cortisol testing, each 
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resident’s saliva was collected using a salivette that the resident was able to bite onto and 
produce a small amount of saliva. The salivette was then placed in a secured Ziplock bag 
labeled with the resident’s confidential ID and no other identifying information. After 
samples were collected from each resident participating in the study, the samples were 
analyzed at the facility. The analysis involved taking the saliva sample and piping it on to 
a test strip. The test strip was then placed in a smartphone reader that was connected to an 
iPhone with an app designed by Peak Biometrics to read the cortisol levels from the test 
strip. After the read-out was produced from the app, the sample was discarded onsite in 
one of the facility’s biohazard containers.  
Analysis  
 Initial descriptive analysis of the data was conducted using IBM SPSS Statistics 
25. To prepare the data for analysis, the data were organized into three files that included 
the following: the CNA data, the resident data and another file that included the weights 
for the amount of time each CNA worked with each resident. To correctly fit the CNA 
data to the resident data, it was important to track the proportion of time each CNA 
worked with each resident. Therefore, each resident with AD had 5 columns (the 
maximum number of CNAs working with one resident) reserved containing the 
identification codes for each CNA that provided care along with a proportion of time 
spent with the resident. These proportions were referred to as weights. The data were 
collected from the facility administrators.  
The three files were merged into one file and then restructured to a vertical file, 
where each resident in the study had multiple cases in the file that represented each 
measurement occasion where data were collected. Final model variables in the vertical 
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file were inspected for the form by inspecting the distribution of CNA-level and resident-
level variables. The data were then analyzed with MLwiN 3.2, a program designed 
specifically for this type of analysis (Rabash, Steele, Browne, & Goldstein, 2009).  
Model fit was accomplished with Bayesian modeling. First, Iterative Generalized 
Least Squares (IGLS) was used, followed by Markov Chain Monte Carlo (MCMC) 
estimation to estimate a baseline (Kreft & De Leeuw, 1998). MLwiN utilizes a 
Metropolis Hastings sampling method to sample diffuse preceding distributions. For the 
chains to converge to the distribution of interest, a burning period was used. The chains 
were then a dependent sample of values from the distribution of interest. In accordance 
with using Markov chain Monte Carlo (MCMC) estimation, a burn-in of 500 and a chain 
of 20,000 (Chung & Beretvas, 2012) were used. As a result of dependence, a suggested 
effective sample size (ESS) of 250 is a statistical convention for model convergence 
(Steele, 2008).  With the 20,000 chain, the ESS of 250 was met.  
After the data was restructured, aim 1 and aim 2 were met by first building a two-
level model (Model 1a and 1b) and then building a three-level model (Model 2a and 2b). 
Both these models were developed using a random intercept model. The following steps 
were used: a) Fitting the unconditional model which described the level of 
agitation/saliva cortisol across all residents (Model 2Aa and 2Ab); b) fitting the 
unconditional growth model depicting the extent of agitation/cortisol  across all residents 
across time (Model 2Ba and Model 2Bb); c) fitting the main effects to explain the 
changes in the dependent variables (Model 2Ca and Model 2Cb); and d) fitting the 
interaction effects of time with the main effects to explain the change over time (Model 
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2Da and Model 2Db); To create a parsimonious model, control variables and predictor 
variables that did not contribute to the model were removed.  
Human Subjects Protection 
 The study was approved by the Institutional Review Board at the University of 
Louisville, as well as the Signature Healthcare research committee. The approved 
informed consent and assents contained detailed information about the study, the possible 
risks and benefits and the amount of time it would take to complete the survey. The study 
did not involve the use of deception, drugs or devices, covert observation, special 
participant populations, induction of mental and/or physical stress, procedures that may 
cause physical harm to the participant, issues commonly regarded as socially 
unacceptable, or procedures that might be regarded as an invasion of privacy.  
 At the beginning of the program, at the experimental nursing facility, prior to 
starting the implementation of the curriculum, a member of the research team took as 
much time as needed to explain the informed consent to the CNAs and then had them 
sign the document. A copy of the informed consent was provided to each CNA. The 
process was the same for CNAs at the control nursing facility. The exception was that 
they did not receive the curriculum and they were only asked to participate in the surveys.  
 For the residents with AD, an assent was used. The study was explained to the 
resident prior to the beginning of the study. Due to the nature of the residents 
participating in this study, the study was explained again at the beginning of each session. 
When a resident with AD could not verbalize their consent, a member of the research 
team contacted the legally authorized representative (LAR). The LAR was a member of 
the resident’s family. The LAR was asked to participate in the informed consent 
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procedures. The same procedure was used to explain the study to the LAR that was used 
to explain the study to the participants. It was explained to all participants that they were 
not going to be compensated for their participation. They were also told that they might 
withdraw from the study at any time without penalty.  
 Once data were collected from a participant, a unique identifying number was 
assigned to the participant at the time of enrollment in the study, to ensure confidentiality. 
Data from this study were not shared outside of the research team.  
 All methods of data collection were done at the convenience of the participants in 
the project. The risks involved in this study were minimal. However, they were 
addressed. The term “risk” refers to psychological or physical injury, social, legal, and 
financial harm (Dunn & Chadwick, 1999).  For the CNA, participation in the curriculum 
and care groups could have contributed to emotional discomfort. The expectation was 
that the curriculum and participation in care groups would contribute to more quality 
care, however, it could have the unintended consequence of making the CNAs more 
aware of limitations in their skill set.  Furthermore, there was a risk that someone might 
have felt uncomfortable answering one or more questions on the surveys that were part of 
the study. For the residents with AD, obtaining their saliva for cortisol testing could have 
caused discomfort and additional stress, depending on where they were at in the 
trajectory of the disease and their behaviors.  
Summary 
 This chapter delineated the methodological approach and analysis plan for the two 
studies through a discussion of the research questions, the research design, sampling, 
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operationalization of measures, and the methods of analysis. The following chapter will 
detail the results of the two separate studies delineated in this chapter.  
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CHAPTER IV: RESULTS 
The aim of this dissertation study was to examine the impact of the 
implementation of a new CC curriculum on the quality of care provided by CNAs to 
residents with AD. More specifically, the study used Kirkpatrick’s model of evaluation to 
assess the reactions, learning, and behavior change of the CHNs exposed to the 
curriculum, and ultimately the impact of the curriculum on the stress levels of residents 
with AD.  
Findings related to the following research aims are described in this chapter: 
Study #1, Aim 1: To determine if the CNA compassionate care curriculum for nursing 
home residents with AD is better than the current standard curriculum to increase the 
following attributes of CNAs: knowledge of AD, caregiving self-efficacy, feelings of 
caregiving satisfaction, and feelings of affiliate stigma; Study #2, Aim 1: To determine if 
residents with AD from an experimental nursing facility differ in their stress levels from 
residents with AD from a control nursing facility, after the implementation of a 
compassionate care curriculum in the experimental nursing facility; Study #2, Aim 2: To 
determine if differences in change in CNAs knowledge of Alzheimer’s disease, caregiver 
confidence, caregiver satisfaction, and stigma will have a differential effect on the 12-
week stress trajectories of residents with AD in the experimental and control nursing 
facilities. This chapter describes data preparation activities and preliminary analysis, 
describes the study sample, details the model building process and presents the results.  
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Data Preparation and Preliminary Analyses 
Data Screening   
 Data was screened for missing values and outliers.  As MLwin cannot handle 
missing data, all data was checked to ensure that there was no missing data from each 
file. All data necessary from each research participant (both CNAs and residents) were 
collected. Therefore there was no need to take any further actions related to missingness. 
No outliers were detected.  
Creating one horizontal data file 
All data from the study were entered into three separate SPSS files. The first 
SPSS horizontal file contained the data from the residents with AD. A horizontal file is 
structured in a way where one participant has one row in the file with all the data over 
time presented on the one row with different labels indicating the different time periods.   
The resident file included the control variables (age, gender, ethnicity, and rapid 
cognitive screening scores) along with the outcome variables (agitation and cortisol 
levels). The residents with AD data file was used to describe the resident sample. 
The second horizontal file contained the CNA specific data and included the 
control variables (number of years working in nursing facilities, number of years working 
in the specific nursing facility, gender, age, and ethnicity) and the predictor variables 
(knowledge, self-efficacy, stigma, and caregiving satisfaction). The CNA file was used to 
answer the questions related to Study #1, and also to describe the CNA sample.  
The third horizontal file contained the CNA weights. The most CNAs one 
resident with AD were exposed to, were five. Therefore, in the CNA file, five variables 
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were created, namely, CNA1, CNA2, CNA3, CNA4, and CNA5. The weights 
represented the proportion of exposure time each CNA had with each resident.  
For the purpose of matching the data, the resident participant ID was used as the 
common identifier in all of these horizontal files. Then, the separate data files were 
merged through an iterative merging process. First, the resident file was merged with 
CNA weights. Then the CNA file was merged with the combined resident CNA weight 
file. This last process was a complicated procedure due to the fact that for each resident, 
data on the CNA predictor and controls had to be calculated as proportional data based on 
the CNA weights.  
Creating the vertical data file  
After the horizontal file was merged, it was necessary to develop a vertical file 
because multilevel modeling requires that data be arranged in a vertical format. 
Therefore, the horizontal data file was restructured to a vertical data file with multiple 
rows for each measurement occasion. Essentially, this means that the vertical file was 
comprised of fewer columns but had more rows than the previous horizontal file.  
The vertical data file had five types of variables: 1) level identifiers for 
measurement occasion (level 1), residents with AD (level 2), and CNAs (level 3); 2) time 
indicator with values from zero to two denoting baseline, 6-week and 12-week data; 3) 
control variables for both the residents with AD and the CNAs; 4) CNA predictor 
variables that included group status, change scores in knowledge, self-efficacy, stigma 
and caregiving satisfaction; and 5) resident outcome variables that included agitation and 
salivary cortisol levels. The final file included 156 Level 1 units (measurement 
occasions) for 52 Level 2 units (residents) being care for by 99 Level 3 units (CNAs). 
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Description of Sample 
 The following is an overview of the sample that was part of the study. First, the 
sample of the CNAs is described after which the sample of residents with AD is 
described.   
Certified Nursing Assistants 
Demographics.  In order to test the assumption of equivalency between the 
experimental and control groups, the demographic variables were compared to each other 
with either an independent sample T-test or a Chi-square test. Table 2 provides an 
overview of the two groups in terms of age, race/ethnicity, gender, number of years 
working in nursing facilities, number of years working in the current facility, and number 
of years of formal education. 
Table 2  
 
Comparison of demographic variables (CNAs)  
  Experimental  Control      
  Mean (SD)/f Mean (SD)/f t/ χ2 P value 
Age  34.66 (7.24) 31.93 (6.02) 2.25 0.01 
Gender   
Female  45 51 
3.28 0.11 
Male  3 0 
Race/Ethnicity   
Black  8 9 
1.17 0.55 White  37 41 
Hispanic  3 1 
# of years working 
in nursing facilities  
6.29 (4.56) 4.55 (3.24) 2.20 0.03 
# of years working 
in current facility  
1.97 (1.29) 1.86 (1.46) 0.38 0.70 
# of years of formal 
education  
12.27 (0.67) 12.21 (0.57) 0.44 0.66 
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 From Table 2 it is clear that the control and experimental groups were similar on 
most demographic variables except for age and the number of years working in a nursing 
facility. The experimental group was older and worked longer in nursing facilities than 
the control group. During model testing, specific attention was given to these two 
variables to investigate if they significantly contributed to the variability in the outcome 
variables.  
Outcome Variables (Study #1). Table 3 shows the comparison of the outcome 
variables in Study #1 between the two groups at baseline, using independent sample t-
tests. As previously denoted, these scores were standardized using a z-score to make for 
more efficient comparison. 
Table 3 
 
Comparison of outcome variables at baseline (CNAs) 
  Experimental  Control      
  Mean (SD)/f Mean (SD)/f t/ χ2 P value  
AD Knowledge  19.58 (3.89) 20.58 (4.08) -1.25 2.14 
Self-efficacy 5.71 (1.19) 5.72 (1.20) -0.36 0.97 
Caregiving 
Satisfaction  3.02 (0.68) 2.71 (0.62) 2.35 0.21 
Affiliate Stigma  2.89 (0.29) 2.93 (0.25) -0.63 0.52 
 
 There were no significant differences between the control and experimental group 
on their AD knowledge, self-efficacy, caregiving satisfaction or affiliate stigma at 
baseline.  
Residents with AD 
Demographic variables. The same equivalency tests were needed to compare the 
demographic variables residents with AD in the experimental and control groups, using 
                              
121 
independent samples T-tests and Chi-Square tests. Table 4 provides an overview of the 
two groups in terms of age, race/ethnicity, gender, and their rapid cognitive scores.  
Table 4 
 
Comparison of demographic variables (Residents with AD) 
  Experimental  Control      
  Mean (SD)/f Mean (SD)/f t/ χ2 
P 
value  
Age  78.47 (7.26) 77.09 (6.01) 0.74 0.46 
Gender      
Female  19 18 0.17 1.00 
Male  8 7 
Race/Ethnicity      
Black  6 3 0.95 0.69 
White  21 22 
Rapid Cognition  2.26 (1.60) 2.76 (1.30) -1.22 0.22 
 
 There were no statistically significant differences between the two groups on any 
of the demographic variables.  
Outcome Variables (Study #2). Table 5 shows the comparison of the outcome 




Comparison of outcome variables at baseline (Residents with AD) 
  Experimental  Control      
  Mean (SD)/f Mean (SD)/f t/ χ2 P value  
Agitation 132.40 (14.67) 133.12 (10.44) -0.2 0.84 
Salivary Cortisol 0.13 (1.03) -0.14 (.94) 0.98 0.33 
 
There were no significant differences between the control and experimental group 
on the agitation of residents with AD as well as their salivary cortisol levels.  
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Description of CNA Workload.   
For the CNAs, an overview of the number of residents that were cared for by each 
CNA and the proportion of time that was spent with each resident with AD is showed in 
Table 6.   
Table 6 
Total Number of Residents Cared for by CNA 
Experimental Group Control Group 
CNA ID Total Number of 
Residents Cared 
for by CNA 
Patients cared for by 
CNA weighted by 
time 
CNA ID Total Number of 
Residents Cared 
for by CNA 
Patients cared for by 
CNA weighted by 
time 
CNA 6 3 0.77 CNA 84 6 3.00 
CNA 7 3 0.38 CNA 68 3 0.72 
CNA 8 3 0.78 CNA 74 3 0.6 
CNA 10 3 0.53 CNA 81 3 0.61 
CNA 13 3 0.71 CNA 83 3 1.22 
CNA 15 3 0.70 CNA 86 3 1.68 
CNA 17 3 1.05 CNA 95 3 1.39 
CNA 22 3 0.44 CNA 49 2 0.47 
CNA 24 3 0.74 CNA 50 2 0.48 
CNA 38 3 1.79 CNA 54 2 0.46 
CNA 1 2 0.67 CNA 55 2 0.87 
CNA 2 2 0.66 CNA 58 2 0.77 
CNA 3 2 0.62 CNA 64 2 0.34 
CNA 4 2 0.90 CNA 70 2 0.41 
CNA 5 2 0.44 CNA 72 2 0.30 
CNA 9 2 1.00 CNA 80 2 0.33 
CNA 11 2 0.9 CNA 82 2 0.78 
CNA 12 2 0.33 CNA 85 2 0.80 
CNA 14 2 0.98 CNA 87 2 0.77 
CNA 16 2 0.50 CNA 88 2 0.65 
CNA 20 2 0.56 CNA 90 2 0.07 
CNA 26 2 0.10 CNA 92 2 0.23 
CNA 28 2 0.22 CNA 51 1 0.23 
CNA 30 2 0.26 CNA 52 1 0.10 
CNA 32 2 0.77 CNA 53 1 0.33 
CNA 34 2 0.28 CNA 56 1 0.33 
CNA 35 2 1.05 CNA 57 1 0.34 
CNA 36 2 0.67 CNA 59 1 0.18 
CNA 37 2 0.75 CNA 60 1 0.43 
CNA 39 2 0.49 CNA 61 1 0.23 
CNA 40 2 0.64 CNA 62 1 0.48 
CNA 41 2 0.71 CNA 63 1 0.16 
CNA 42 2 0.64 CNA 65 1 0.36 
CNA 43 2 0.17 CNA 66 1 0.31 
CNA 44 2 0.53 CNA 67 1 0.19 
CNA 45 2 0.83 CNA 69 1 0.31 
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Experimental Group Control Group 
CNA ID Total Number of 
Residents Cared 
for by CNA 
Patients cared for by 
CNA weighted by 
time 
CNA ID Total Number of 
Residents Cared 
for by CNA 
Patients cared for by 
CNA weighted by 
time 
CNA 46 2 0.31 CNA 71 1 0.07 
CNA 47 2 0.18 CNA 73 1 0.76 
CNA 18 1 0.84 CNA 75 1 0.06 
CNA 19 1 0.35 CNA 76 1 0.23 
CNA 21 1 0.52 CNA 77 1 0.35 
CNA 23 1 0.23 CNA 78 1 0.22 
CNA 25 1 0.19 CNA 79 1 0.17 
CNA 27 1 0.30 CNA 89 1 0.15 
CNA 29 1 0.06 CNA 91 1 0.06 
CNA 31 1 0.15 CNA 93 1 0.25 
CNA 33 1 0.33 CNA 94 1 0.45 
CNA 48 1 0.37 CNA 96 1 0.46  
CNA 97 1 0.19  
CNA 98 1 0.38 
  CNA 99 1 0.50 
Mean 2.00 0.56  Mean 1.63 0.49 
 
The second and fifth columns in Table 6 is the total number of residents that each 
CNA worked with and is irrespective of the proportion of each resident’s care that they 
provided. The third and sixth column examines the number of residents with AD cared 
for by each CNA this time weighted by the proportions of time spent with each resident. 
We see that the number of residents cared for by CNA's in the study ranges from 1 
resident to 6 residents. The majority of the CNA's provided care to one or two residents 
that were in the study. We also see that the number of whole residents with AD by CNAs 
range from 0.07 (CNA 71) to 3.00 (CNA 84).  
Study #1: Evaluation of the Compassionate Care Curriculum (Kirkpatrick Levels 
One, Two, and Three) 
Study #1 focused primarily on the differences in the pre and posttest scores of the 
experimental and control CNA groups, but also investigated the satisfaction of the CNAs 
with the CC curriculum (Level 1 of Kirkpatrick’s model). The hypothesis for study #1 
was as follows: After completion of the CNA compassionate care curriculum by the 
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experimental group, the CNAs will show a significantly higher increase in knowledge, 
caregiving self-efficacy, caregiving satisfaction and a significantly higher reduction in 
feelings of affiliate stigma than the CNAs who completed the current standard 
curriculum.  
Satisfaction of CNAs with the CC curriculum 
The satisfaction of the CNAs is shown in Table 7. 
Table 7 
Satisfaction of CNAs with CC curriculum  
 N Mean SD  
Overall, how satisfied were you with the Alzheimer’s disease curriculum? 48 4.29 0.65 
Has this curriculum met your expectations? 48 4.73 0.54 
Overall, how satisfied were you with the care groups? 48 4.83 0.38 
Overall Mean 48 4.62 0.41 
 
Overall, learners were generally satisfaction with the curriculum (mean=4.29, 
SD=0.65) and the curriculum met their expectations (mean=4.73, SD=0.54).  Learners 
also reported the highest satisfaction with the care groups (mean=4.83, SD=0.38). The 
overall mean across all of the satisfaction questions showed that learners were satisfied 
with the compassionate care curriculum (mean=4.62, SD=0.41).  
Differences between pre- and posttest 
The multivariate test results of the two-way mixed MANOVA is shown in Table 
8.   
 




Multivariate Test Results 
Effect F 
Hypo-






Subjects Group Effect 6.22 4 94 0.001 0.21 0.99 
Within 
Subject  
Time Effect 24.48 4 94 0.001 0.51 1.00 
Group*Time 23.59 4 94 0.001 0.50 1.00 
 
The results of the two-way mixed MANOVA showed that there was a significant 
between subjects group effect between the experimental and control groups, a significant 
within subjects time effect between baseline and 12-weeks and a significant interaction 
effect between group and time, showing a large effect size. The univariate test results for 
the group effect, time effect, and group*time effect are shown in Table 9. Bonferroni 
corrections were applied to the univariate effects (alpha level divided by 4 dependent 
variables), resulting in adjusted alpha levels for interpretation purposes. 
From Table 9 it is clear that all univariate group effects were significant, 
indicating that groups were overall different on AD knowledge, self-efficacy, caregiving 
satisfaction, and affiliate stigma. The effect size was small for all four variables. 
Furthermore, the time effect showed that the sample changed significantly between pre 
and post on all four dependent variables. The effect size for AD knowledge was large, 
and for the other variables, the effect sizes were medium. The experimental and control 
groups changed differently between pre- and posttest on all four dependent variables. 
These differences are shown below in Figures 3-6.  




















Group Effect Knowledge 3.09 1 97 0.08 0.02 0.03 0.41 
Self-Efficacy 4.21 1 97 0.04 0.01 0.04 0.53 
Caregiving 
Satisfaction 
8.13 1 97 0.01 0.003 0.08 0.81 
Affiliate 
Stigma 
4.67 1 97 0.03 0.01 0.05 0.57 
Time Effect Knowledge 45.72 1 97 0.001 0.0003 0.32 1.00 
Self-Efficacy 19.48 1 97 0.001 0.0003 0.17 0.99 
Caregiving 
Satisfaction 
27.21 1 97 0.001 0.0003 0.22 1.00 
Affiliate 
Stigma 
16.71 1 97 0.001 0.0003 0.15 0.98 
Group*Time  AD Knowledge 49.09 1 97 0.001 0.0003 0.34 1.00 
Self-Efficacy 24.96 1 97 0.001 0.0003 0.21 1.00 
Caregiving 
Satisfaction 
1.67 1 97 0.20 0.05 0.02 0.25 
Affiliate 
Stigma 
25.31 1 97 0.001 0.0003 0.21 1.00 
 
As shown in Figure 3 below, at baseline, the experimental group had slightly less 
knowledge than the control group, although the difference was not significant. The AD 
knowledge of the experimental group improved between baseline and 12-weeks. The 
control group showed similar AD knowledge at the 12-week period than what they had at 
baseline. The time*group interaction effect was significant with a large effect size.  
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The self-efficacy of the two groups were similar at baseline. The self-efficacy for 
the experimental group improved between baseline and 12-weeks but deteriorated 
slightly for the control group. The time*group interaction effect was significant with a 
medium effect size.  
At baseline, caregiver satisfaction was slightly higher for the experimental group 
than the control group, although the difference was not significant. For both groups, there 
was a slight improvement at 12-weeks in caregiver satisfaction. This improvement was 
greater for the experimental group. The time*group interaction effect showed a trend 
with a small effect size. 
At baseline, the experimental group felt slightly less affiliate stigma than the 
control group, although the difference was not significant. The feelings of affiliate stigma 
for the experimental group declined between baseline and 12 weeks. For the control 
group, it remained similar at the 12-week period than what they felt at baseline. The time 
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Figure 5. Interaction Effect Between Group and Time for Caregiver Satisfaction 

























                              
130 
Study #2: Evaluation of the Compassionate Care Curriculum (Kirkpatrick Level 
Four) 
Study #2 focused primarily on the impact of the compassionate care curriculum on the 
stress levels of the residents with AD. The hypotheses for study #2 were as follows: 
Hypothesis 1a: Residents with AD from the experimental nursing facility will have a 
different 12-week agitation change trajectory than the residents with AD  from the control 
nursing facility; Hypothesis 1b: Residents with AD from the experimental nursing facility 
will have a different 12-week salivary cortisol change trajectory than the residents with 
AD  from the control nursing facility; Hypothesis 2a: Differences in change in CNAs 
knowledge, confidence, satisfaction, and affiliate stigma will have a differential effect on 
the 12-week agitation trajectories of residents with AD in experimental and control nursing 
facilities; Hypothesis 2b: Differences in change in CNAs knowledge, confidence, 
satisfaction and stigma and differences in residents with AD agitation will have a 
differential effect on the 12-week salivary cortisol trajectories of residents with AD in 
experimental and control nursing facilities.  
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Model Building 
Both agitation and salivary cortisol levels were standardized for this analysis with 
a mean of 0 and a standard deviation of 1, using the z-score formula. Standardizing 
scores was to ensure ease of interpretation of the results and is a standard procedure in 
MLWin.  
Assessing the need for the multilevel model. An efficient way to initially assess 
patterns of change in a study is to graph actual group trajectories for a sample of cases 
and visually inspect them.  For this sample, the whole sample was first graphed 
collectively and compared between the experimental and control groups in terms of 
trajectories for changes in agitation (Figures 7-8) and cortisol levels (Figure 9-10). (J. D. 
Singer & Willett, 2003) 
 
Figure 7. Collected growth trajectories for experimental group on agitation 
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Figure 8. Collected growth trajectories for control groups on agitation 
By looking at these collected growth trajectories, it visually appears that residents 
with AD in the experimental facility where the compassionate care curriculum was 
implemented reduced their agitation levels. However, the residents with AD in the 
control facility showed agitation levels that were similar between pre and post 
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Figure 9. Collected growth trajectories for experimental group on saliva cortisol levels 
 
Figure 10. Collected growth trajectories for control group on saliva cortisol levels 
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By looking at these collected growth trajectories it visually appears that residents 
with AD in the experimental facility where the compassionate care curriculum were 
implemented slightly reduced their salivary cortisol levels, peaking at the 6-week 
assessment. Residents in the control facility showed a slight increase in their salivary 
cortisol levels, also peaking at the 6-week assessment.   
These growth trajectories were also individually plotted and visually inspected for 
a random sample of 8 from each group. For agitation levels, experimental resident 2 and 
experimental resident 3 started slightly higher than the control resident 2 and control 
resident 3. Control resident 2-4 had a slightly flat trajectory compared to some of the 
residents in the experimental group. Experimental residents 6-8 all started high and by the 
6-week time period had agitation levels that decreased and then remained lower at the 12-
week time period. Control resident 6 is notable because their agitation levels increased 
slightly from baseline to 12 weeks. For cortisol levels, experimental residents 15, 18 and 
21 showed a sharp decline from baseline to 6-weeks and then showed a continued decline 
at the 12-week time period. Experimental residents 16 and 17 remained slightly flat 
across the baseline, 6 week and 12-week time periods. Control residents 15, 19, 20 all 
showed a slight increase in cortisol levels. Control residents 16, 18 and 22 all showed a 
slight decline in cortisol levels.  
 



















Figure 11. Empirical growth plots for a sample of the study population 
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Hypothesis 1a: Agitation. Hypothesis 1a focuses on the trajectories of residents 
with AD in terms of agitation compared to the control group of residents with 
Alzheimer’s disease, without taking into effect the impact the different nurses had on the 
residents.  
Unconditional Model.  The first model (Model 1Aa) that was fitted was the 
unconditional model which described the mean agitation score across all residents 






Table 10 reveals the estimated intercept, variance components and model fit for 
the two-level unconditional model using residents with AD at level 2, and measurement 
points at level 1. There were 52 level 2 units, and 156 level 1 units.  
Based on the intercept value, it is estimated that the mean resident with AD is 
predicted a Z agitation score of 0.004. This estimate does not differ significantly from 
zero and is expected as the response variable is approximately standardized and therefore 
has a mean of approximately zero. The between resident variance is estimated at 0.39 









Parameter    Model 1Aa  
Fixed Effects  
ZAgitation    
CONSTANT   0.004 (0.11)  
Random parameters  
Level: Level 2 Resident    
Var (CONSTANT)   0.39 (0.13)  
Level: Level 1 Time    
Var (CONSTANT)   0.63 (0.09)  
DIC:   404.54 
pD:    34.81 
Note: Standard errors are in parentheses. 
***p  < 0.001; **p  < 0.01; *p  < 0.05; ~p<0.10 
 







          =    F.JK
F.JKLF.MJ
 
                                                      =       0.38 
Based on the calculation the ICC is 0.38, suggesting that 38% of the variance in 
agitation levels was between residents with AD. This supports the need for a multilevel 
model which accounts for variance both between and within subjects. 
The Defiance Information Criterion (DIC) is a likelihood-based measure for 
comparing models. The DIC combines goodness of fit with model complexity (the 
number of parameters), to allow for DIC values from different models to be compared 
directly. The model with the lowest DIC is seen as the best model. If the DIC value 
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decreases by approximately 10 points, the smaller value is considered to be a significant 
improvement (Browne, 2009). The DIC for the unconditional model is estimated at 
404.54. It is expected that with more variables added to the model, the between and 
within variances will decrease, and the fit statistic will improve. 
Unconditional Growth Model. The unconditional growth model (Model 1Ba) is 
the unconditional model with the time variable added. It depicts the average agitation 






In Table 11, Model 1Ba is added for comparison with Model 1Aa.  
Table 11 
 
Comparison of Model 1Aa and 1Ba  
Parameter  Model 1Aa  Model 1Ba  
Fixed Effects  
ZAgitation    
CONSTANT  0.00 (0.11)  0.46 (0.13)*** 
Time   -0.45 (0.06)*** 
 Random parameters   
Level: Level 2 Resident   
Var(CONSTANT)  0.39 (0.13)  0.48 (0.13)  
Level: Level 1 Time   
Var(CONSTANT)  0.63 (0.09)  0.42 (0.06)  
DIC:  404.54 348.23 
pD:  34.81 41.8 
Note: Standard errors are in parentheses. 
***p  < 0.001; **p  < 0.01; *p  < 0.05; ~p<0.10 
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Adding time to the model resulted in an improved model fit (DIC = 404.54 for the 
unconditional model versus DIC = 348.23 for the unconditional growth model). Model fit 
was not possible with time as a random effect and had to be added as a fixed effect.  With 
time added to the model, the variance within individuals was reduced from 0.63 to 0.42, 
but the variance between individuals increased 0.39 to 0.48, showing the need to explain 
the differences between residents with AD with additional predictors, specifically the 
intervention that is assumed to have a differential effect on the two groups in the sample. 
Time was a significant predictor in this model. 
Conditional Growth Model.  The conditional growth model (Model 1Ca) added 






Table 12 compares the unconditional model with the unconditional growth model 
and the conditional growth model. 
Adding group status to the model resulted in an improved model fit (DIC = 
348.23 for the unconditional growth model versus DIC = 328.94 for the conditional 
growth model). For this model the within person variance stayed the same, but the 
between person variance was almost all explained by group status. The model also shows 
that group status was a significant predictor, with the experimental group having 
significantly less agitation than the control group across time periods.  




Comparison of Mode1 1Aa, Model 1Ba and Model 1Ca 
Parameter  Model 1Aa  Model 1Ba  Model 1Ca 
Fixed Effects  
ZAgitation     
CONSTANT  0.00 (0.11)  0.46 (0.13)*** 1.09 (0.11)***  
Time   -0.45 (0.06)*** -0.45 (0.06)*** 
Experimental    -1.23 (0.13)*** 
Random parameters  
Level: Level 2 Resident    
Var(CONSTANT)  0.39 (0.13)  0.48 (0.13)  0.06 (0.05)  
Level: Level 1 
Time     
Var(CONSTANT)  0.63 (0.09) 0.42 (0.06)  0.43 (0.06) 
DIC:  404.54 348.23 328.94 
pD:  34.81 41.8 19.05 
Note: Standard errors are in parentheses. 
***p  < 0.001; **p  < 0.01; *p  < 0.05; ~p<0.10 
 
Conditional growth model with Interaction Effects. This final model (Model 
1Da) added the interaction effects between group and time as a final way to account for 
the intervention as the groups were hypothesized to change differently over time. The 






Table 13 compares all models.  
 




Comparison of all models  
Parameter  Model 1Aa  Model 1Ba  Model 1Ca Model 1Da 
Fixed Effects  
ZAgitation  
    
CONSTANT  0.00 (0.11)  0.46 (0.13)*** 1.09 (0.11)***  0.60 (0.11)*** 
Time  
 
-0.45 (0.06)*** -0.45 (0.06)*** 0.04 (0.06)~ 
Experimental  
  
-1.23 (0.13)*** -0.28 (0.15)~  
Experimental.Time  
   
-0.95 (0.08)***  
Random parameters  
Level: Level 2 
Resident  
    
Var (CONSTANT)  0.39 (0.13)  0.48 (0.13)  0.06 (0.05)  0.15 (0.05) 
Level: Level 1 Time  
    
Var (CONSTANT)  0.63 (0.09) 0.42 (0.06)  0.43 (0.06) 0.19 (0.03) 
DIC:  404.54 348.23 328.94 221.25 
pD:  34.81 41.8 19.05 39.94 
Note: Standard errors are in parentheses. 
***p  < 0.001; **p  < 0.01; *p  < 0.05; ~p<0.10 
 
Adding the interaction effect of group status with time, significantly improved the 
model fit (DIC=404.54 for the unconditional model, 348.23 for the unconditional growth 
model, 328.94 for the conditional growth model, and 221.25 for the conditional growth 
model with main and interaction effects). For this model, the within person variance 
greatly reduced and the between person variance increased slightly from the previous 
model. The interaction effect between group status and time was the only significant 
variable driving this model.  
Figure 12 shows the trajectory of agitation over time between the two groups.  
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Figure 12. Trajectory of agitation over time between the two groups 
ICC was calculated on the final model using the same formula as used with the 







                                                                 =    F.WX
F.WXLF.WK
 
                                                                 =       0.44 
This shows that after adding only the group status and time changes to the model, 
the between residents with AD variance increased. Model 1A was able to demonstrate 
that residents with AD in the experimental group had a significantly different agitation 
growth trajectory than the residents with AD in the control group. However, there were 
differences between the residents with AD that could not be explained simply by being in 












Baseline 6  week 12 week 
Model 1A:  Agitation
Experimental Control
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lie with the CNA’s taking care of the residents. Not only was the CNA’s influenced 
differently by the curriculum, but there were also differences in resident characteristics 
that could have provided a barrier to CNA’s to provide compassionate care and rate 
agitation of the patients in a more favorable manner. Model 2A will investigate these 
influences on agitation. 
Hypothesis 1b: Salivary Cortisol. Hypothesis 1b focuses on the trajectories of 
residents with AD in terms of salivary cortisol compared to the control group of residents 
with Alzheimer’s disease, without taking into effect the impact the different CNAs had 
on the residents.  
Unconditional Model.  The first model (Model 1Ab) that was fitted was the 
unconditional model which described the mean salivary cortisol levels across all residents 
irrespective of time. Table 14 reveals the estimated intercept, variance components, and 




Parameter    Model 1Ab  
Fixed Effects  
ZSalivary Cortisol   
CONSTANT   0.007 (0.13) 
Random parameters  
Level: Level 2 Resident    
Var (CONSTANT)   0.73 (0.18) 
Level: Level 1 Time    
Var (CONSTANT)   0.29 (0.04) 
DIC:   292.55 
pD:    46.53 
Note: Standard errors are in parentheses. 
***p  < 0.001; **p  < 0.01; *p  < 0.05; ~p<0.10 
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Based on the intercept value, it is estimated that the mean resident with AD is 
predicted a Z cortisol level of 0.007. This estimate does not differ significantly from zero 
and is expected as the response variable is approximately standardized and therefore has 
a mean of approximately zero. The between resident variance is estimated at 0.73 (level 
2), and the within resident variance is estimated at 0.29 (level 1). The intraclass 







          =    F.ZJ
F.ZJLF.GK
 
                                                      =       0.72 
Based on the calculation the ICC is 0.72, suggesting that 72% of the variance in 
cortisol levels was between residents with AD. This supports the need for a multilevel 
model which accounts for variance both between and within subjects. 
The DIC for the unconditional model is estimated at 292.55. It is expected that 
with more variables added to the model, the between and within variances will decrease, 
and the fit statistic will improve. 
Unconditional Growth Model. The unconditional growth model (Model 1Bb) is 
the unconditional model with the time variable added. It depicts the average salivary 
cortisol levels over time across individuals. For this model, time was allowed to have a 
random intercept and slope on level 2, resulting in a better fit. The model was not able to 
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ZCortisolLevels_`~N(ab,Ω)	
ZCortisolLevels_` = βF_`CONSTANT+ βW`Time_`			
βF_` = βF + cF` + dF_`	








idF_`j	~N(0,ΩE):	ΩE = 	 [DHFG ]			
	
In Table 15, Model 1Bb is added for comparison with Model 1Ab.  
Table 15 
 
Comparison of Model 1Ab and Model 1B 
Parameter    Model 1 Ab  Model 1 Bb 
Fixed Effects  
ZSalivary Cortisol     
CONSTANT   0.007 (0.13)  0.01 (0.14) 
Time    0.003 (0.06) 
Random parameters  
Level: Level 2 Resident     
Var(CONSTANT)   0.73 (0.18) 0.85 (.21) 
Var(Time)    0.11 (0.04) 
Level: Level 1 Time     
Var(CONSTANT)   0.29 (0.04) 0.19 (0.04) 
DIC:   292.55 252.95 
pD:    46.53 75.87 
Note: Standard errors are in parentheses.  
***p  < 0.001; **p  < 0.01; *p  < 0.05; ~p<0.10  
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Adding time to the model resulted in an improved model fit (DIC = 292.55 for the 
unconditional model versus DIC = 252.95 for the unconditional growth model). With 
time added to this model, the variance within the individuals was reduced from 0.29 to 
0.19; however, the variance between persons with AD increased from 0.73 to 0.85. This 
shows the need to explain the differences between persons with AD with additional 
predictors, specifically the intervention that is assumed to have a differential effect on the 
two groups in the sample. 	
Conditional Growth Model.  The conditional growth model (Model 1Cb) added 
group status as a predictor, using the following formula: 
ZCortisolLevels_`~N(ab,Ω)	
ZCortisolLevels_` = βF_`CONSTANT+ βW`Time_` +	βGExperimental`		
βF_` = βF + cF` + dF_`	








idF_`j	~N(0,ΩE):	ΩE = 	 [DHFG ]			
 
Table 16 compares the unconditional model with the unconditional growth model 











Comparison of Model 1Ab, Model 1Bb and Model 1Cb  
Parameter    Model 1 Ab  Model 1 Bb Model 1 Cb 
Fixed Effects  
ZSalivary Cortisol     
CONSTANT   0.007 (0.13)  0.01 (0.14) 0.10 (0.19)  
Time    0.003 (0.06) 0.003 (0.06) 
Experimental     -0.19 (0.30) 
Random parameters  
Level: Level 2 Resident      
Var(CONSTANT)   0.73 (0.18) 0.85 (.21) 0.90 (0.23) 
Var(Time)    0.11 (0.04) 0.11 (0.04) 
Level: Level 1 Time      
Var(CONSTANT)   0.29 (0.04) 0.187 (0.04) 0.19 (0.04) 
DIC:   292.55 252.95 253.98 
pD:    46.53 75.87 75.63 
Note: Standard errors are in parentheses.   
***p  < 0.001; **p  < 0.01; *p  < 0.05; ~p<0.10   
 
Adding group status to the model did not result in an improved model fit (DIC = 
252.95 for the unconditional growth model versus DIC = 253.98 for the conditional 
growth model). For this model, the within person variance stayed the same, but the 
between person variance increased from 0.85 to 0.90. Group status was not a significant 
predictor.  
Conditional growth model with Interaction Effects. This final model (Model 
1Db) added the interaction effects between group and time as a final way to account for 
the intervention as the groups were hypothesized to change differently over time. The 
following formula was used for this model:  
 
 




= βF_`CONSTANT+ 	βW`Time_`+. βGExperimental`
+ βJExperimental. Time_`	
βF_` = βF + cF` + dF_`	








idF_`j	~N(0,ΩE):	ΩE = 	 [DHFG ]			
	
Table 17 compares all models.  
Table 17 
 
Comparison of All Models  
Parameter    Model 1 Ab  Model 1 Bb Model 1 Cb Model 1Db 
Fixed Effects  
ZSalivary Cortisol       
CONSTANT   0.007 (0.13)  0.01 (0.14) 0.10 (0.19)  -0.16 (0.19) 
Time    0.003 (0.06) 0.003 (0.06) 0.26 (0.07)*** 
Experimental     -0.19 (0.30) 0.30 (0.27) 
Experimental.Time     -0.51 (0.10)*** 
Random parameters  
Level: Level 2 Resident       
Var(CONSTANT)   0.73 (0.18) 0.85 (.21) 0.90 (0.23) 0.84 (0.20) 
Var(Time)    0.11 (0.04) 0.11 (0.04) 0.05 (0.03) 
Level: Level 1 Time       
Var(CONSTANT)   0.29 (0.04) 0.19 (0.04) 0.19 (0.04) 0.19 (0.03) 
       
DIC:   292.55 252.95 253.98 243.95 
pD:    46.53 75.87 75.63 66.881 
Note: Standard errors are in parentheses.    
***p  < 0.001; **p  < 0.01; *p  < 0.05; ~p<0.10   
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Adding the interaction effect of group status with time, significantly improved the 
model fit (DIC=292.55 for the unconditional model, 252.95 for the unconditional growth 
model, 253.98 for the conditional growth model, and 243.95 for the conditional growth 
model with main and interaction effects). For this model, the within person variance 
stayed the same from the previous model and the between person variance decreased 
slightly. Time was a significant variable in this model along with the interaction effect 
between group status and time.  
Figure 13 shows the trajectory of salivary cortisol over time between the two 
groups.  
 















Baseline 6 week 12 week
Model 1B: Salivary Cortisol Levels
Experimental Control
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ICC was calculated on the final model using the same formula as used with the 







                                                                 =    F.kl
F.klLF.WK
 
                                                                 =       0.48 
This shows that after adding only the group status and time changes to the model, 
the between residents with AD variance decreased over time. Model 1b was able to 
demonstrate that persons with AD in the experimental group had a significantly different 
salivary cortisol growth trajectory than the persons with AD in the control group. The 
experimental group showed a decrease in cortisol levels over 12 weeks, with the control 
group showing an increase in cortisol levels. 
Hypothesis 2a: Agitation. Hypothesis 2a focuses on the trajectories of persons 
with AD in terms of agitation compared to the control group, while taking into effect the 
impact of the different CNAs on the persons with AD. 
Unconditional Unclassified Null Model. The first model (Model 2Aa) that was 
fitted was the unconditional unclassified model. This model only fits the effect of the 
CNA that had the highest weighted time with a specific resident. The reason for building 
this model first was to investigate if a classified model where the effect of all CNA’s 
working with a specific resident was modeled, would be a better fitted model. If not, only 
the effect of one CNA needed to be modelled, resulting in a less complicated model. The 
following equation was used to fit this model:  
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ZAgitation_`m	~	N(ab,Ω) 
ZAgitation_`m = 	nF_`mCONSTANT 
nF_`m = 	nF + νFm + cp`m + dF_`m  
[νFm]	~	q	(0, 	Ωr):		Ωr = [DrF
G ] 
iuF`mj	~	q	(0, 	ΩE):		ΩE = [DEF
G ] 
ieF`mj	~	q	(0, 	ΩH):		ΩH = [DHF
G ] 
Table 18 shows the estimated intercept, variance components, and model fit for 
the three-level unconditional unclassified model using CNAs at level 3, persons with AD 
at level 2, and measurement points at level 1. There were 50 level 3 units, 52 level 2 




Parameter  Model 2Aa  
Fixed Effects  
ZAgitation 
 
CONSTANT  -0.004(0.11) 
Random parameters  
Level: Level 3 CNA 
 
Var(CONSTANT)  0.23 (0.19) 
Level: Level 2 Resident  
Var(CONSTANT)  0.19 (0.19) 
Level: Level 1 Time  
 
Var(CONSTANT)  0.63 (0.09)  
Var(Time)  
 
DIC:  403.89 
pD:  34.90 
Note: Standard errors are in parentheses. 
***p  < 0.001; **p  < 0.01; *p  < 0.05; ~p<0.10 
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Based on the intercept value, it is estimated that the mean resident with AD is 
predicted a Z agitation score of -0.004. This estimate does not differ significantly from 
zero and is expected as the response variable is approximately standardized and therefore 
has a mean of approximately zero. The between CNA variance is estimated at 0.23 (level 
3), the resident with AD variance is estimated at 0.19 (level 2), and the within resident 
variance is estimated at 0.63 (level 1). The DIC for the unconditional model is estimated 
at 403.89. 
 Classified Unconditional Model.  The next model that was built was the 
classified unconditional model. Unlike the unclassified unconditional model, this model 
took into consideration that one resident received care from multiple CNAs. The 
following formula was used for this model:  
ZAgitationij~N	(XB,	Ω)		
ZAgitationij	=	β0ijCONSTANT	
nF_ = 	nF	 +	Σ̀ tuvwW(_)	x_,`
(J)cF`
(J) + cF,yz{zyG|}(_)











[dF_]	~N(0,ΩH):	ΩH = [ΩHF,F] 
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Using a classified model resulted in an improved model fit (DIC = 403.89 for the 
unclassified unconditional model versus DIC = 395.79 for the classified unconditional 
model). Given that this model produced a better fit, it was better to build a classified 
model instead of an unclassified model.   
Based on the intercept value, it is estimated that the mean resident with AD is 
predicted a Z agitation level of 0.002. This estimate does not differ significantly from 
zero and is expected as the response variable is approximately standardized and therefore 
has a mean of approximately zero. The between CNA variance is estimated at 0.93 (level 
3), the between resident variance is estimated at 0.04 (level 2), and the within resident 
variance is estimated at 0.61 (level 1). Table 19 shows the classified unconditional model 
compared to the unclassified unconditional model.  
Table 19 
 
Comparison of Model 2Aa (i) and Model 2Aa (ii) 
  Parameter  Model 2Aa (i) Model 2Aa (ii) 
Fixed Effects  
ZAgitation   
CONSTANT  -0.004(0.11) 0.002 (0.13) 
Random parameters  
Level: Level 3 CNA   
Var(CONSTANT)  0.23 (0.19) 0.93 (0.35) 
Level: Level 2 
Resident    
Var(CONSTANT)  0.19 (0.19) 0.04 (0.05) 
Level: Level 1 Time    
Var(CONSTANT)  0.63 (0.09)  0.61 (0.08) 
Var(Time)    
DIC:  403.895 395.79 
pD:  34.90 31.91 
Note: Standard errors are in parentheses.  
***p  < 0.001; **p  < 0.01; *p  < 0.05; ~p<0.10 
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          =    F.KJ
F.KJLF.FlLF.MW
 
                                                      =       0.59 









          =    F.Fl
F.KJLF.FlLF.MW
 
                                                      =       0.03 
Based on the calculation the ICC for level 3 is 0.59, suggesting that 59% of the 
variance in agitation was between CNAs, with the ICC for level 2 showing that there was 
very little variance between residents left to explain. The reason for this may lie in the 
fact that the CNAs were responsible for rating the agitation levels of the residents, and 
that the ratings were more a result of their view on agitation than “true agitation levels” 
for the residents. The ICC supports the need for a multilevel model which accounts for 
variance not only between and within residents, but also between CNAs providing care.  
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The DIC for the unconditional model is estimated at 395.79. It is expected that 
with more variables added to the model, the between and within variances will decrease, 
and the fit statistic will improve. 
Classified Unconditional Growth Model. The unconditional growth model 
(Model 2Ca) is the unconditional model with the time variable added. It depicts the 
average agitation scores over time across individuals. The formula used to fit this model 
is shown below:  
ZAgitationij	~N	(XB,	Ω)		
ZAgitationij	=	β0ijCONSTANT+	β1iTimei	
nF_ = 	nF	 +	Σ̀ tuvwW(_)	x_,`
(J)cF`
(J) + cF,yz{zyG|}(_)













Table 20 shows the classified unconditional model (Model 2Aa) compared to the 










Comparison of Model 2Aa (ii) and Model 2Ba 
Parameter  Model 2Aa (ii) Model 2Ba 
Fixed Effects  
ZAgitation   
CONSTANT  0.002 (0.13) 0.01 (0.18) 
Time   -0.21 (0.04)*** 
Random parameters  
Level: Level 3 
CNA   
Var(CONSTANT)  0.93 (0.35) 2.40 (0.54) 
Level: Level 2 Resident   
Var(CONSTANT)  0.04 (0.05) 0.03 (0.04) 
Level: Level 1 
Time    
Var(CONSTANT)  0.61 (0.08) 0.75 (0.06) 
Covar (Time/CONSTANT -0.55 (0.06) 
Var(Time)   0.38 (0.04) 
DIC:  395.79 136.01 
pD:  31.91 364.14 
Note: Standard errors are in parentheses. 
***p  < 0.001; **p  < 0.01; *p  < 0.05; ~p<0.10 
 
Adding time to the model resulted in an improved model fit (DIC = 136.01 for the 
unconditional growth model versus DIC = 395.79 for the unconditional model). 
compared to the unconditional model. Time was added as a random effect on level 1. For 
this model, the between CNA variance increased from 0.93 to 2.40, the between resident 
variance stayed the same, and the within person variance increased from 0.61 to 0.77. 
This model showed that time was a significant variable. 
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 Classified Conditional Growth Model with CNA Predictors. A model was built 
where both the CNA and resident control variables were added to the unconditional 
growth model. However, this model showed a worst fit than the unconditional growth 
model, and none of the control variables were significant. Therefore, this model was not 
included. The next model built was the conditional growth model with the CNA 
predictors. Only the predictors that showed significance were included. The following 




nF_ = 	nF	 +	Σ̀ tuvwW(_)	x_,`
(J)cF`
(J) + cF,yz{zyG|}(_)













Table 21 shows the comparison of the conditional growth model with predictors added in 









Comparison of Model 2Aa (ii), Model 2Ba, and Model 2Ca  
Parameter  Model 2Aa (ii) Model 2Ba Model 2Ca 
Fixed Effects  
ZAgitation    
CONSTANT  0.002 (0.13) 0.01 (0.18) -0.05 (0.13) 
Time   -0.21 (0.04)*** -0.18 (0.04)*** 
ZKnowledge   -0.54 (0.17)***  
ZSelfEfficacy   -0.47 (0.19)*** 
Random parameters  
Level: Level 3 CNA    
Var(CONSTANT)  0.93 (0.35) 2.40 (0.54) 1.02 (0.70) 
Level: Level 2 Resident     
Var(CONSTANT)  0.04 (0.05) 0.03 (0.04) 0.20 (0.20) 
Level: Level 1 Time     
Var(CONSTANT)  0.61 (0.08) 0.75 (0.06) 1.29 (0.09) 
Covar (Time/CONSTANT -0.55 (0.06) -0.96 (0.06) 
Var(Time)   0.38 (0.04) 0.65 (0.04) 
DIC:  395.79 136.01 111.33 
pD:  31.91 34.14 31.58 
Note: Standard errors are in parentheses.  
***p  < 0.001; **p  < 0.01; *p  < 0.05; ~p<0.10   
 
Adding in the predictor variables of the change scores of knowledge and self-
efficacy to the model resulted in an improved model fit (DIC =111.33 compared to the 
previous model where DIC=136.01). For this model, the between CNA variance 
decreased from 2.40 to 1.02, the between resident variance increased from 0.03 to 0.20, 
and the within person variance increased from 0.75 to 1.29. This model showed that time, 
and knowledge change scores and self-efficacy change scores were significant variables.  
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Classified Conditional Growth Model with CNA Predictors and Interactions. 
The final model included the predictor variables in the previous model but added in the 




nF_ = 	nF	 +	Σ̀ tuvwW(_)	x_,`
(J)cF`
(J) + cF,yz{zyG|}(_)













 Table 22 compares the final model (Model 2Da) to the previous models.  
Adding in the main effects in addition to the interaction effects significantly 
reduced the DIC for an overall better fit (DIC of 93.57 compared to a DIC of 111.33 for 
Model 2Ca). For this model, the between CNA variance slightly decreased from 1.02 to 
0.99, the between resident variance stayed the same, and the within person variance 
decreased from 1.29 to 1.18. This model showed that time, knowledge, along with the 
interaction effect of self-efficacy with time were all significant. The interaction effect of 
knowledge change with time showed a trend. 
 




Comparison of all models  
Parameter  Model 2Aa (ii) Model 2Ba Model 2Ca Model 2Da 
Fixed Effects  
ZAgitation     
CONSTANT  0.002 (0.13) 0.01 (0.18) -0.05 (0.13) -0.03 (0.14) 
Time   -0.21 (0.04)*** -0.18 (0.04)*** -0.18 (0.04)*** 
ZKnowledge   -0.54 (0.17)***  -0.44 (0.19)*** 
ZSelfEfficacy   -0.47 (0.19)*** -0.27 (0.21) 
ZKnowledge.Time   -0.08  (0.05)~ 
ZSelfEfficacy.Time   -0.14 (0.05)*** 
Random parameters  
Level: Level 3 CNA     
Var(CONSTANT)  0.93 (0.35) 2.40 (0.54) 1.02 (0.70) 0.99 (0.71) 
Level: Level 2 Resident     
Var(CONSTANT)  0.04 (0.05) 0.03 (0.04) 0.20 (0.20) 0.20 (0.20) 
Level: Level 1 Time      
Var(CONSTANT)  0.61 (0.08) 0.75 (0.06) 1.29 (0.09) 1.18 (0.06) 
Covar (Time/CONSTANT  -0.55 (0.06) -0.87 (0.04) 
Var(Time)   0.38 (0.04) 0.65 (0.04) 0.58 (0.03) 
DIC:  395.79 136.01 111.33 93.57 
pD:  31.91 34.14 31.58 32.11 
Note: Standard errors are in parentheses.    
***p  < 0.001; **p  < 0.01; *p  < 0.05; ~p<0.10    
 
Figure 14 shows the knowledge change scores over time for those with change at 
the 10th and 90th percentile.  




Figure 14. The effect of knowledge change scores and time on agitation 
Figure 14 shows even for the CNAs where their change in knowledge was the 
smallest, agitation levels of residents decreased as a result of this knowledge change. 
Because these were standardized values, it can be concluded that for CNAs at the 10th 
percentile of knowledge increase, there was a 0.25 standard deviation decrease in 
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Baseline Six Months Twelve Months
Model 2a: Knowledge 90th percentile
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of residents decreased more from -0.65 to -1.25, therefore a 0.60 standard deviation 
decrease in agitation levels. This differential change in agitation levels showed a trend.  
Figure 15 shows the self-efficacy change scores over time for those with change 
at the 10th and 90th percentile. 
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Baseline Six Months Twelve Months
Model 2a: Self-Efficacy 90th percentile
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Figure 15 shows for the CNAs where their change in self-efficacy were the 
smallest, agitation levels of residents decreased slightly, from 0.14 to -005 as a result of 
this self-efficacy change. This change equals a 0.19 standard deviation decrease from 
baseline to twelve months in agitation levels. For those where the self-efficacy change 
was the highest, agitation levels of residents decreased more from -0.34 to -1.01 for a 
standard deviation decrease of 0.67. This differential change in agitation levels was 
significant.  
Hypothesis 1 already showed that CNAs in the experimental groups showed a 
significantly higher increase in knowledge and self-efficacy over time than the CNAs in 
the control group who showed almost no change in knowledge and self-efficacy over 
time. Also, model 1a showed the experimental group had a significant decrease in 
agitation levels, with the agitation levels for the control group staying the same. From 
Model 2a it was possible to conclude that the compassionate care curriculum was able to 
change the knowledge and self-efficacy of CNAs resulting in a decrease in agitation 
levels for residents with AD. 
ICC for level 3 was calculated on the final model using the same formula as used 









          =    F.KK
F.KKLF.GFLW.Wk
 
                                                      =       0.42 
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          =    F.GF
F.KKLF.GFLW.Wk
 
                                                      =       0.08 
This shows that after adding the CNA predictors to the model, the between CNA 
variance was reduced from 0.59 (null model) to 0.42. The between resident variance 
slightly increased from 0.03 (null model) to 0.08. However, this between resident 
variance is much less than the variance that still existed after Model 1a was completed. It 
is clear that the between resident variance was a product of the characteristics of the 
CNAs taking care of the residents. The CNAs were influenced differently by the 
curriculum or lack of exposure to the curriculum. Once these differences were accounted 
for in the model, the between resident variance decreased. 
Hypothesis 2b: Salivary Cortisol Levels. Hypothesis 2b focuses on the 
trajectories of persons with AD in terms of salivary cortisol compared to the control 
group, while taking into effect the impact of the different CNAs on the persons with AD. 
Unconditional Unclassified Null Model.  The first model (Model 2Ab (i)) that 
was fitted was the unconditional unclassified model. This model only fits the effect of the 
CNA that had the highest weighted time with a specific resident. The reason for building 
this model first was to investigate if a classified model where the effect of all CNA’s 
working with a specific resident was modeled, would be a better fitted model. If not, only 
the effect of one CNA needed to be modeled, resulting in a less complicated model. The 
following equation was used to fit this model: 
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ZSalivaryCortisolLevels_`m	~	N(ab, Ω) 
ZSalivaryCortisolLevels_`m = 	nF_`mCONSTANT 
nF_`m = 	nF + νFm + cp`m + dF_`m  
[νFm]	~	q	(0, 	Ωr):		Ωr = [DrF
G ] 
iuF`mj	~	q	(0, 	ΩE):		ΩE = [DEF
G ] 
ieF_`mj	~	q	(0, 	ΩH):		ΩH = [DHF
G ] 
Table 23 shows the estimated intercept, variance components and, model fit for 
the three-level unconditional unclassified model using CNAs at level 3, persons with AD 
at level 2, and measurement points at level 1. There were 50 level 3 units, 52 level 2 
units, and 156 level 1 units.  
Table 23 
 
Model 2Ab  
Parameter  Model 2Ab (i)  
Fixed Effects  
ZSalivary Cortisol  
CONSTANT -0.002 (0.13) 
Random Parameters  
Level: Level 3 CNA  
Var(CONSTANT) 0.04 (0.07) 
Level: Level 2 Resident   
Var(CONSTANT) 0.70 (0.17) 
Level: Level 1 Time   
Var(CONSTANT) 0.29 (0.04) 
DIC:  292.61 
pD:  46.67 
Note: Standard errors are in parentheses. 
***p  < 0.001; **p  < 0.01; *p  < 0.05; ~p<0.10 
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Based on the intercept value, it is estimated that the mean resident with AD is 
predicted a Z salivary cortisol levels score of -0.002. This estimate does not differ 
significantly from zero and is expected as the response variable is approximately 
standardized and therefore has a mean of approximately zero. The between CNA 
variance is estimated at 0.04 (level 3), the resident with AD variance is estimated at 0.70 
(level 2), and the within resident variance is estimated at 0.29 (level 1). The DIC for the 
unconditional model is estimated at 292.61.   
Classified Unconditional Model.  The next model that was built was the 
classified unconditional model. Unlike the unclassified unconditional model, this model 
took into consideration that one resident received care from multiple CNAs. The 
following formula was used for this model:  
ZSalivaryCortisolLevelsij~N	(XB,	Ω)		
ZSalivaryCortisolLevelsij	=	β0ijCONSTANT	
nF_ = 	nF	 + 	 Σ̀ tuvwW(_)	x_,`
(J)cF`
(J) + cF,yz{zyG|}(_)











[dF_]	~N(0,ΩH):	ΩH = [ΩHF,F] 
 
Table 24 shows the classified unconditional model (Model 2Ab (ii)) compared to 
the unclassified unconditional model (Model 2Ab (i)).  
 




Comparison of Model 2Ab(i) and Model 2Ab(ii)  
Parameter  Model 2Ab (i)  Model 2Ab (ii)  
Fixed Effects  
ZSalivary Cortisol   
CONSTANT -0.002 (0.13) -0.004 (0.13) 
                                    Random Parameters  
Level: Level 3 CNA   
Var(CONSTANT) 0.04 (0.07) 0.17 (0.29)  
Level: Level 2 Resident    
Var(CONSTANT) 0.70 (0.17) 0.67 (0.18)  
Level: Level 1 Time    
Var(CONSTANT) 0.29 (0.04) 0.29 (0.04) 
DIC:  292.61 292.48 
pD:  46.67 46.64 
Note: Standard errors are in parentheses.  
***p  < 0.001; **p  < 0.01; *p  < 0.05; ~p<0.10 
 
Using a classified model did not result in an improved fit (DIC = 292.61 for the 
unclassified unconditional model versus DIC = 292.48 for the classified unconditional 
model). Given that the unclassified unconditional model produced a better fit, it was 
better to build a simpler unclassified model instead of a classified model.  
For the unclassified, unconditional model, the intraclass correlation for level 3 








          =    F.Fl
F.FlLF.ZFLF.GK
 
                                                      =       0.04 
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          =    F.ZF
F.FlLF.ZFLF.GK
 
                                                      =       0.68  
Based on the calculation the ICC for level 3 was 0.04, suggesting that 4% of the 
variance in salivary cortisol levels was between CNAs, while the ICC for level 2 was 
0.68, suggesting that 68% of the variance was explained by the residents with AD. The 
reason for this may be attributed to the fact that salivary cortisol is a biomarker, unlike 
the agitation scores which were measured on a rating scale by the CNAs, and therefore 
much more subject to CNA influences.  
The DIC for the unconditional model was estimated at 292.61. It was expected 
that with more variables added to the model, the between and within variances would 
decrease, and the fit statistic would improve. 
Unclassified Unconditional Growth Model. The unconditional growth model 
(Model 2Bb) is the unconditional model with the time variable added. It depicts the 
average salivary cortisol levels over time across individuals. 
The formula used to fit this model is shown below: 
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ZSalivaryCortisolLevels_`m	~	N(ab, Ω) 
ZSalivaryCortisolLevels_`m = 	nF_`mCONSTANT +		nW_Time_`m  
nF_`m = 	nF + νFm + cp`m + dF_`m  
nW_ = 	nW + dW_`m  
[νFm]	~	q	(0, 	Ωr):		Ωr = [DrF
G ] 











Table 25 shows the classified unconditional model (Model 2Ab (i)) compared to 
the classified unconditional growth model (Model 2Bb).  
Table 25 
 
Comparison of Model 2Ab (i) and Model 2Bb  
Parameter  Model 2Ab (i)  Model 2Bb  
Fixed Effects  
ZSalivary Cortisol   
CONSTANT -0.002 (0.13) -0.01 (0.15) 
Time  	 0.001 (0.06) 
Random Parameters  
Level: Level 3 CNA   
Var(CONSTANT) 0.04 (0.07) 0.04 (0.07) 
Level: Level 2 Resident    
Var(CONSTANT) 0.70 (0.17) 0.77 (0.19) 
Level: Level 1 Time    
Var(CONSTANT) 0.29 (0.04) 0.46 (0.11) 
Covar(Time/CONSTANT) -0.26 (0.11) 
Var(Time)  0.22 (0.09) 
DIC:  292.61 269.43 
 
pD:  46.67 44.89 
Note: Standard errors are in parentheses.  
***p  < 0.001; **p  < 0.01; *p  < 0.05; ~p<0.10 
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Adding time to the model resulted in an improved model fit (DIC = 269.43 for the 
unconditional growth model versus DIC = 292.61 for the unconditional model). Time 
was added as a random effect on level 1. For this model, the between CNA variance 
stayed the same, the between resident variance increased from 0.70 to 0.77, and the 
within person variance increased from 0.29 to 0.46. Time was not a significant variable.  
Unclassified Conditional Growth Model with CNA Predictors.  A model was 
built where both the CNA and resident control variables were added to the unconditional 
growth model. None of the control variables were significant, so this model is not shown. 
The next model built was Model 2Cb, where CNA predictor variables were added. None 
of the predictors were significant, but the change in knowledge was kept, as the 
interaction between knowledge and time was significant in later models. The following 
formula was used to build this model:   
ZSalivaryCortisolLevels_`m	~	N(ab, Ω) 
ZSalivaryCortisolLevels_`m
= 	nF_`mCONSTANT +		nW_Time_`m + 	nGKnowledge`m 
nF_`m = 	nF + νFm + cp`m + dF_`m  
nW_ = 	nW + dW_`m  
[νFm]	~	q	(0, 	Ωr):		Ωr = [DrF
G ] 











Table 26 shows the comparison of the conditional growth model with CNA 
predictors added in (Model 2Cb) to the previous models.  




Comparison of Model 2Ab (i), Model 2Bb, and Model 2Cb  
Parameter  Model 2Ab (i)  Model 2Bb Model 2Cb  
Fixed Effects  
ZSalivary Cortisol    
CONSTANT -0.002 (0.13) -0.01 (0.15) -0.01 (0.15) 
Time  	 0.001 (0.06) 0.001 (0.06) 
ZKnowledge 	  -0.20 (0.16) 
Random Parameters  
Level: Level 3 CNA    
Var(CONSTANT) 0.04 (0.07) 0.04 (0.07) 0.04 (0.6) 
Level: Level 2 Resident     
Var(CONSTANT) 0.70 (0.17) 0.77 (0.19) 0.77 (0.19)  
Level: Level 1 Time     
Var(CONSTANT) 0.29 (0.04) 0.46 (0.11) 0.50 (0.10)  
Covar(Time/CONSTANT)  -0.26 (0.11) -0.29 (0.09) 
Var(Time)  0.22 (0.09) 0.24 (0.09) 
DIC:  292.61 269.43 268.88 
pD:  46.67 44.89 45.48 
Note: Standard errors are in parentheses.   
***p  < 0.001; **p  < 0.01; *p  < 0.05; ~p<0.10  
 
Adding the knowledge change score CNA predictor variable to the model did not 
result in an improved model fit (DIC =268.88 compared to the previous model where 
DIC=269.43). For this model, the variance components stayed the same.  
Unclassified Conditional Growth Model with CNA Predictors and Agitation.  
The next model included knowledge from the previous model with the addition of the 








= 	nF_`mCONSTANT +		nW_Time_`m + 	nGKnowledge`m	
+ 	 	nJAgitation_`m	 
nF_`m = 	nF + νFm + cp`m + dF_`m  
nW_ = 	nW + dW_`m  
nJ` = 	nJ + cJ`m  



















Table 27 compares the model (Model 2Db) to the previous models. 
Adding agitation to the model produced a significantly better overall model fit 
(DIC= 268.88 for Model 2Cb compared to 252.32 for Model 2Db). Agitation produced a 
better fit when it was allowed to vary between residents (Level 2). For this model, the 
between CNA variance stayed the same, the between resident variance decreased from 
0.77 to 0.74 and the within resident variance decreased from 0.50 to 0.31. This model 










Comparison of Model 2Ab (i), Model 2Bb, Model 2Cb, and Model 2Db 
Parameter  Model 2Ab (i)  Model 2Bb Model 2Cb  Model 2Db  
Fixed Effects  
ZSalivary Cortisol 
    
CONSTANT -0.002 (0.13) -0.01 (0.15) -0.01 (0.15) -0.15 (0.15) 
Time  
	
0.001 (0.06) 0.00 (0.06) 0.15 (0.06)** 
ZKnowledge 
	  
-0.20 (0.16) -0.03 (0.17) 
ZAgitation 
	   
0.34 (0.08)*** 
Random Parameters  
Level: Level 3 CNA 
    
Var(CONSTANT) 0.04 (0.07) 0.04 (0.07) 0.04 (0.6) 0.04 (0.07) 
Level: Level 2 Resident  
    





   
0.03 (0.02) 
Level: Level 1 Time  
    
Var(CONSTANT) 0.29 (0.04) 0.46 (0.11) 0.5 (0.10)  0.31 (0.09)  
Covar(Time/CONSTANT) 
 
-0.26 (0.11) -0.29 (0.09) -0.02 (0.09) 
Var(Time) 
 
0.22 (0.09) 0.24 (0.09) -0.01 (0.09) 
DIC:  292.61 269.43 268.88 252.32 
pD:  46.67 44.89 45.48 50.33 
Note: Standard errors are in parentheses. 
   
***p  < 0.001; **p  < 0.01; *p  < 0.05; ~p<0.10 
   
 
Unclassified Conditional Growth Model with CNA Predictors and Interactions. The 
final model included the predictor variables in the previous model but added the 
interaction effect between knowledge change and time. The following formula was used 










= 	nF_`mCONSTANT +		nW_Time_`m +	 	nG_ZKnowledge`m
+	 	nJ`ZAgitation_`m + 	nlZKnowledge. Time_`m	 
nF_`m = 	nF + νFm + cp`m + dF_`m  
nW_ = 	nW + dW_`m  
nJ` = 	nJ + cJ`m  


















Adding in the interaction between knowledge change and time significantly 
reduced the DIC for an overall better fit (DIC of 244.23 compared to a DIC of 252.43 for 
Model 2Db). For this model, the between CNA variance stayed the same, the between 
resident variance stayed the same, and the within person variance increased slightly from 
0.31 to 0.34. This model showed that agitation, along with the interaction effect of 
knowledge with time were significant. Time as a variable showed a trend towards 









Comparison of All Models  
Parameter  Model 2Ab (i)  Model 2Bb Model 2Cb  Model 2Db  Model 2Eb  
Fixed Effects  
ZSalivary Cortisol     
CONSTANT -0.002 (0.13) -0.01 (0.15) -0.01 (0.15) -0.15 (0.15) -.08 (0.15) 
Time		 	 0.001 (0.06) 0.00 (0.06) 0.15 (0.06)** 0.10 (0.06)~ 
ZKnowledge	 	  -0.20 (0.16) -0.03 (0.17) 0.15 (0.18) 
ZAgitation	 	   0.34 (0.08)*** 0.22 (0.09)* 
ZKnowledge.Time	         -0.19 (0.07)** 
Random Parameters  
Level: Level 3 
CNA      
Var(CONSTANT) 0.04 (0.07) 0.04 (0.07) 0.04 (0.6) 0.04 (0.07) 0.04 (0.07) 
Level: Level 2 
Resident       
Var(CONSTANT) 0.70 (0.17) 0.77 (0.19) 0.77 (0.19)  0.74 (0.18) 0.74 (0.18) 
Covar(ZAgitation/CONSTANT)   0.06 (0.06) 0.06 (0.05) 
Var(ZAgitation)    0.03 (0.02) 0.03 (0.02) 
Level: Level 1 
Time       
Var(CONSTANT) 0.29 (0.04) 0.46 (0.11) 0.5 (0.10)  0.31 (0.09)  0.34 (0.12) 
Covar(Time/CONSTANT) -0.26 (0.11) -0.29 (0.09) -0.02 (0.09) -0.09 (0.12) 
Var(Time)  0.22 (0.09) 0.24 (0.09) -0.01 (0.09) 0.04 (0.09) 
DIC:  292.61 269.43 268.88 252.32 244.23 
pD:  46.67 44.89 45.48 50.33 51.56 
Note: Standard errors are in 
parentheses.     
***p  < 0.001; **p  < 0.01; *p  < 0.05; ~p<0.10    
 
Figure 16 shows the knowledge change scores over time for those with change at 
the 10th and 90th percentile. 




Figure 16. The effect of knowledge change scores and time on salivary cortisol levels 
Figure 16 shows that for the CNAs where their change in knowledge was the 
smallest (10th percentile), salivary cortisol levels of residents increased. Because these 
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knowledge increase, there was a 0.42 standard deviation increase in salivary cortisol 
levels. For those where the knowledge change was the highest, salivary cortisol levels of 
residents decreased from 0.14 at baseline to -0.22 at 12 weeks, therefore a 0.36 standard 
deviation decrease in agitation levels. This shows the importance of understanding AD 
disease and increased knowledge of CNAs in reducing the stress of AD residents. 
Figure 17 shows the agitation scores over time for those with agitation at the 10th 
and 90th percentile.  
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Figure 17 shows that for persons with agitation levels in the 10th percentile, their 
salivary cortisol levels were lower. For those where agitation levels were the highest (90th 
percentile), salivary cortisol levels were higher.  
Hypothesis 1 already showed that CNAs in the experimental groups showed a 
significantly higher increase in knowledge than the CNAs in the control group who 
showed almost no change in knowledge over time. Also, model 1b showed the 
experimental group had a significant decrease in salivary cortisol levels, with the salivary 
cortisol levels increasing for the control group. From Model 2b it is possible to conclude 
that the CC curriculum was able to change the knowledge of CNAs resulting in a 
decrease in agitation levels, and subsequently a decrease in saliva cortisol levels for 
residents with AD. 
ICC for level 3 was calculated on the final model using the same formula as used 








          =    F.Fl
F.FlLF.ZlLF.Jl
 
                                                      =       0.03 
 
 
ICC for level 2 was calculated on the final model as well: 









          =    F.Zl
F.FlLF.ZlLF.Jl
 
                                                      =       0.66 
This shows that after adding the CNA predictors to the model, the between CNA 
variance reduced slightly from 0.04 (null model) to 0.03. The between resident variance 
also reduced slightly from 0.68 (null model) to 0.66. However, the between resident 
variance left with Model 2b was higher than what was left after Model 1b was completed 
(0.48 for Model 1b compared to 0.66 for Model 2b). More analysis will be needed with 
additional potential predictors than what was measured with this study to investigate what 
other predictors could potentially explain these differences between salivary cortisol 
levels of AD residents. What is, however, clear is that positive changes in knowledge led 
to significant reductions in agitation, that in turn resulted in reduced salivary cortisol 
levels. These results showed the value of the CC curriculum to improve the abilities of 
the CNAs to better care for residents with AD. 
Summary 
 This study utilized the Kirkpatrick model to evaluate the effectiveness of the 
compassionate care curriculum. The first half of this chapter focused on the first three 
levels of the Kirkpatrick model of evaluation, namely, reaction, learning, and behavior. 
To understand the impact of the compassionate care curriculum on the CNAs, we 
examined changes in their knowledge of AD, self-efficacy, caregiver satisfaction and 
affiliate stigma at baseline and then after completing the 12-week compassionate care 
curriculum and participating in the care groups. For AD knowledge, a significant increase 
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was seen in scores from baseline to 12 weeks for the experimental group while the 
control group remained the same over the 12-week period. Self-efficacy for the 
experimental group improved between baseline and 12-weeks but deteriorated slightly for 
the control group. Caregiver satisfaction showed a slight improvement at 12-weeks for 
both groups, yet the experimental group showed a trend of greater improvement than the 
control group. For the experimental group, feelings of affiliate stigma declined between 
baseline and 12- weeks, while the control group remained similar at the 12-week period.    
From the Kirkpatrick model, level 4 examined outcomes. For this study, the focus 
was on the stress outcomes of the residents with AD, specifically as it relates to agitation 
and salivary cortisol levels.  Two models were built that were able to show that the 
residents with AD in the experimental group improved in terms of their agitation and 
salivary cortisol levels after 12 weeks. These two models did not include the impact of 
the CNAs. This helped us establish that there were changes between the two groups 
(experimental and control) as a result of the curriculum they were exposed to. The final 2 
models were then built that showed the role of the CNAs and how they had an impact on 
the two groups. We saw that knowledge changes and self-efficacy changes had an impact 
on the agitation levels of residents with AD. For salivary cortisol levels, it was 
knowledge changes and agitation scores that had an impact.  
Chapter 5 discusses the implications of this study in greater detail.  Furthermore, 
the strengths and limitations, as well as ideas for future research, are described. 
 
 





CHAPTER V: DISCUSSION  
 Using the Kirkpatrick model of evaluation and a multilevel modeling 
methodology, this study examined the use of a CC curriculum with CNA support groups 
and its’ impact on persons with AD living in an experimental and a control nursing 
facility. The control facility CNAs provided care to persons with AD as usual with no 
additional training other than the state mandated CNA training program. The 
experimental nursing facility allowed their CNAs to participate in the CC curriculum. 
After 12-weeks, this study demonstrated that differences existed between the 
experimental and control nursing facilities as a result of the introduction of the CC 
curriculum.   
 At baseline, before the curriculum was introduced to the experimental facility, 
analysis was completed to determine if there were differences between the control and 
experimental groups. For the CNAs in the study, we looked at age, race/ethnicity, gender, 
number of years working in nursing facilities, number of years working in the current 
facility, and number of years of formal education. Analysis showed that the control and 
experimental groups were similar on most demographic variables except that the 
experimental group was older and worked longer in nursing facilities than the control 
group. Between the two groups, there were no significant differences between the control 
and experimental group on their AD knowledge, self-efficacy, caregiving satisfaction or 
affiliate stigma at baseline. 
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For the residents with AD, there were no differences in the demographics of the 
control and experimental group, namely in terms of their age, gender, race/ethnicity, and 
rapid cognitive screening scores. Furthermore, in terms of the outcome variables at 
baseline, there were no significant differences between the control and experimental 
group on the agitation of residents with AD as well as their salivary cortisol levels.  
 In looking first at the CNAs change scores from baseline to 12 weeks, we saw a 
significant change in terms of AD knowledge, self-efficacy, caregiver satisfaction and 
affiliate stigma for those working in the experimental facility compared to those that were 
at the control facility and not participating in the CC curriculum.  
 Multilevel models were first built by examining the outcome measures, agitation, 
and salivary cortisol, without including the impact of the CNAs. By building the models 
independent of the CNA measures, we were able to demonstrate that the persons with AD 
in the experimental group showed improvements in terms of their agitation and salivary 
cortisol levels over the 12 weeks the study took place.  
 Additional models were constructed to show that the CNAs contributed to this 
difference between the experimental and control facilities. No control CNA or resident 
with AD variables were controlled for in the model, as they did not show to have any 
significant impact on the final outcome. In terms of agitation, analysis showed that 
knowledge and self-efficacy were the strongest CNA predictors of a decrease in the 
resident’s agitation over time.  
 In the final salivary cortisol model, we were able to show that knowledge and 
agitation were the strongest predictors of a decrease in salivary cortisol levels.  
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Implications for CNA Training in Kentucky  
This study has the potential to impact the way we conceptualize the care provided 
by CNAs. Our current structure of training is rather limiting to the CNAs in that they are 
not provided with any skill development related to understanding persons with AD and 
the disease. As a result, we marginalize CNAs in that we do not fully allow them to 
explore all that the profession can offer. By incorporating the CC curriculum, we can 
change the conceptualization of care that currently exists within the profession and affect 
the way persons with AD are cared for. 
Changing the Conceptualization of Care  
As previously elucidated in Chapters 1 and 2, the way we conceptualization care 
in the United States in nursing facilities has been largely basic nursing care. We have 
ignored the relationship between the CNA and the person with AD. Even the movement 
towards more person-centered care is more focused on the journey of the person and 
leaves no room for the relationship between these two persons. This mode of thinking 
ignores the bond that is formed between the CNA and the person with AD. Part of the 
intent of the CC curriculum is to acknowledge that there is a bond between the CNA and 
the person with AD and to focus on how to help turn that bond into better care.  
We know that conceptualizing care solely as basic nursing care is not working, as 
evidenced by the current state of long-term care in Kentucky. In terms of long-term care 
measures, Kentucky is ranked 50th in the nation (AARP, 2017). Unlike other states, such 
as California and Minnesota, Kentucky does not offer additional training for CNAs 
working with persons with AD (AARP, 2017). This study demonstrates that with more 
training and support, the care that CNAs provide can positively affect persons with AD 
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living in nursing facilities. In particular, this study has policy implications for training 
regulations for CNAs in Kentucky. As previously stated, the current CNA training in 
Kentucky follows the minimum training regulations set for by OBRA in 1987 (Code of 
Federal Regulations, 2012; Hawes, 2003). This training is predicated on basic nursing 
care, meaning that CNAs are charged with providing care that meets the needs of the 
persons with AD in terms of their ADLs. 
It is also important to note that the purpose of the CC curriculum is not to replace 
the current trainings that are required for CNAs. Basic nursing care is a necessary 
component of care. The purpose of this study was to show how care can be enhanced to 
include compassionate care and the impact that this can have on persons with AD living 
in nursing facilities. This training adds further content to the CNA training structure. 
Adding more hours to the certification requirements would be an important step in 
assisting CNAs with developing the skills that they need to work with persons with AD. 
Therefore, in addition to advocating for more training for CNAs, we hope to advocate at 
a state level that the incorporation of more compassionate care, in addition to the current 
training that is received, would be important for CNAs and the people they care for. 
Currently, there is no legislative agenda in Kentucky that includes a focus on the amount 
of training or type of training that CNAs receive.  
Future Research  
The original research design proposed using eight experimental and eight control 
facilities for a larger sample. However, due to a number of factors, namely, funding and 
time limitations we had to reduce the sample size. Furthermore, the original proposal 
included a sample strategy that focused on exploring the impact of the profit status and 
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the size of the facility on the outcomes. The outcomes of this study have opened up 
several areas of future research that will be explored, using the original proposal as a 
guideline for examining different types of nursing facilities. Therefore, moving forward, 
it will be important to establish facilities of different sizes and profit status. For this 
study, we only used facilities that were part of the same health care system and were both 
considered medium in size. However, to understand further applications of this program, 
it will be beneficial to compare groups based on profit status and size and to expand the 
program to other healthcare systems.  
 In addition to expanding this to nursing facilities in other health care systems, we 
want to use this information to build a certificate program for compassionate care 
curriculum designed specifically for CNAs caring for persons with AD. We have 
explored opportunities on how to offer this with a local technical and community college; 
therefore, future research of the impact of the curriculum could be tied to this particular 
set of courses that CNAs from multiple healthcare systems would attend. The premise of 
this expansion would be to use a micro-credentialing approach to learning care and 
strategies for working with persons with AD. Micro-credentialing is a competency-based 
approach to skill development where learners participate in mini or short modules and 
then demonstrate competency in an area (Berry & Cator, 2016).  
 Expansion of this project will also include a Project Echo focused on the 
compassionate care of persons with AD. Project Echo is a telementoring program where 
professionals interested in learning more about a particular area such as AD can join via a 
teleconferencing program Zoom (University New Mexico School of Medicine, 2018). 
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This will allow for the dissemination of the compassionate care curriculum to a wider 
audience.  
 Understanding the long-term impact of the compassionate curriculum and the 
establishment of care groups is also an important area of research that was not addressed 
in this study. For the purposes of this dissertation, data collection stopped after 12-weeks. 
Conducting further data collection on the persons from this study will be useful in 
determining if the introduction of the compassionate care curriculum and the care groups 
were, in fact, a way to provide better care to persons with AD. Adding this data to the 
current study will provide a greater understanding of how the CNAs were able to transfer 
the curriculum into behaviors and the impact that it has on persons with AD.  
  a include this measure and moreover, examine if CNA stress has an impact on the 
outcomes of the persons with AD. Given the effective use of salivary cortisol testing for 
persons with AD in this study, it will be interesting to also examine CNA stress by 
measuring the cortisol levels of the CNAs that participated in the study.   
Conclusion  
Strengths of the Study   
 This study contributes to the research focused on training of CNAs in their work 
with persons with AD in several critical ways. This study shows that basic nursing care 
training as mandated by state agencies is only one aspect of the training that CNAs need 
to for their work at nursing facilities. The results of this study indicate that enhancing 
mandatory training with a compassionate care curriculum creates a deeper connection 
between CNA and persons with AD. This connection can improve care delivery and the 
stress of persons with AD.  
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Using a control/experimental group design was also a strength in this study. This 
design allowed a clear understanding of the effect of the intervention and thereby 
increasing the reliability of the study.  
 At the beginning of this study, there were concerns that retention would be an 
issue for the CNAs in the study. However, for this study, we did not have the retention 
problems that are problematic for many studies involving CNAs.  
 This study was also strengthened by the collaboration with the healthcare system 
that we partnered with for the project. From the beginning of the project, the 
administrators were as accommodating to the project needs as possible. Data were 
collected without resistance from the administrators. We believe that this allowed us to 
have a complete set of data without any missingness for both the CNA sample and the 
persons with AD sample.  
Limitations of the Study  
 While this study contributes to an understanding of the significance of including 
compassionate care into the training of CNAs working with persons with AD, there are 
limitations that must be addressed. First, due to time and setting restrictions, we were 
only able to include two facilities in this study. While we were able to meet the power 
requirements for our research design, including more facilities in the study will 
strengthen our findings.  
 Second, after CNAs at the experimental site were enrolled to participate in this 
program, we had to close the participation after a certain point despite a desire from more 
CNA participants to join in the study. While this will be rectified moving forward by the 
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introduction of a new session of the program at the experimental facility identified in this 
study, it did limit participation from some CNAs that enrolled in the program late.  
 Third, the care groups for CNAs were limited in both size and the times they were 
offered. Arrangements had to be made for the CNAs to come to the sessions and this 
required coordination with the nursing facility to provide coverage for those attending as 
it was assumed that this would be part of their shifts at the nursing facility. This meant 
that not every CNA in the study was available to attend every session.  
Summary  
The results of this study showed that integrating compassionate care into the work 
that CNAs do with persons with AD can lead to positive outcomes for CNAs in terms of 
improved AD knowledge, caregiver self-efficacy, caregiving satisfaction and affiliate 
stigma. The implementation of compassionate care also greatly impacts the agitation and 
cortisol levels of persons with AD. This has implications for the way we conceptualize 
the type of care that is provided by CNAs to persons with AD. Traditional basic nursing 
care focuses primarily on the basic needs of the person such as attending to activities of 
daily living. CNAs are trained to only provide this care and other areas are considered 
outside of their scope. While traditional basic nursing care is important, it should be 
supplemented with compassionate care for persons with AD. Compassionate care (CC) 
emphasizes the bond between the caregiver (the CNA) and the care receiver (the person 
with AD) and their journey together. CC can also provide CNAs with skills to respond to 
the changes that the person with AD undergoes as they decline.  
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Subject Informed Consent Document and Research Authorization 
 
FOSTERING COMPASSIONATE CARE FOR INDIVIDUALS WITH 
ALZHEIMER’S DISEASE   
 
Investigator(s) name & address: Anna C. Faul, PhD & Samantha Cotton, MSSW, 300 E 
Market St, Suite 200, Louisville KY 40222.  
Site(s) where study is to be conducted: Institute for Sustainable Health & Optimal Aging 
  
Phone number for subjects to call for questions: 502-852-5629  
 
Introduction and Background Information 
 
You are invited to participate in a research study that focuses on compassionate care in 
nursing home settings, specifically focusing on residents with Alzheimer’s disease.  The 
purpose of this study is to evaluate a curriculum designed for nurse aides working with 
residents with Alzheimer’s disease. The study is being conducted by Dr. Anna C. Faul, 
PhD and Sam Cotton, MSSW, ABD. The study will take place at eight different nursing 
facilities in Kentucky.  
 
Approximately 300 subjects will be invited to participate.   
 
Purpose 
The purpose of this study is to evaluate a training curriculum delivered to state registered 
nurse aides (SNRA’s) in nursing homes.  
 
Procedures 
In this study, you will be asked to participate in eight online modules that will provide 
you with a foundation about Alzheimer’s disease; these modules will focus on three 
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primary areas: 1.) the disease and its impact, 2.) Compassionate caregiving for 
individuals with Alzheimer’s disease and 3.) Caring for the caregiver. After the 
completion of these eight modules, you will have the opportunity to participate in hands-
on learning and support, known as care groups, within the nursing home where you work. 
As part of this study, you will complete pre and post-test surveys about your experience 
with curriculum, your knowledge of Alzheimer’s disease and related dementias, and your 
confidence in performing activities with residents with Alzheimer’s disease.  
 
Potential Risks 
There are no foreseeable risks other than possible discomfort in answering personal 
questions. There may be unforeseen risks.   
 
Benefits 
Nurse aides may increase their understanding of working with residents with Alzheimer’s 
disease, which could contribute to a transformation within the nursing home towards 
more compassionate care. The information collected may not benefit you directly. The 
information learned in this study may be helpful to others. 
 
Payment 
You will not be compensated for your time, inconvenience, or expenses while you are in 
this study.     
 
Revocation of Research Authorization 
 
You may cancel the permission you have given to use and share your protected health 
information at any time.  This means you can tell us to stop using and sharing your 
protected health information.  If you cancel your permission: 
 
• We will stop collecting information about you. 
• You may not withdraw information that we had before you told us to stop. 
o We may already have used it or shared it. 
o We may need it to complete the research. 
• Staff may ask your permission to follow-up with you if there is a medical reason 
to do so. 
 
To cancel your permission, you will be requested to complete a written “Revocation of 
Research Authorization” form located at the end of this document.  You may also obtain 
a copy from your study doctor, designated personnel or from the Human Subjects 
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Total privacy cannot be guaranteed.  We will protect your privacy to the extent permitted 
by law.  If the results from this study are published, your name will not be made public. 
Once your information leaves our institution, we cannot promise that others will keep it 
private.   
 
Your information may be shared with the following: 
• Organizations that provide funding at any time for the conduct of the 
research. 
• The University of Louisville Institutional Review Board, Human Subjects 
Protection Program Office, Privacy Office, others involved in research 
administration and compliance at the University, and others contracted by 
the University for ensuring human subjects safety or research compliance 
• The local research team 
• Researchers at other sites participating in the study (if applicable) 
• People who are responsible for research, compliance and HIPAA 
oversight at the institutions where the research is conducted 
• People responsible for billing, sending and receiving payments related to 
your participation in the study  
• Government agencies, such as:  
o Office for Human Research Protections  
o Office of Civil Rights  
 
Security  
Your information will be kept private. Any data collected will be stored at the Institute 
for Sustainable Health & Optimal Aging in secure area in a locked file cabinet.   
 
Voluntary Participation 
Taking part in this study is voluntary. You may choose not to take part at all. If you 
decide to be in this study, you may stop taking part at any time. If you decide not to be in 
this study or if you stop taking part at any time, you will not lose any benefits for which 
you may qualify.   
 
You will be told about any changes that may affect your decision to continue in the study.  
 
Contact Persons 
If you have any questions, concerns, or complaints about the research study, please contact 
Samantha Cotton at 502-852-5629.  
 
Research Subject’s Rights 
 
If you have any questions about your rights as a research subject, you may call the 
Human Subjects Protection Program Office at (502) 852-5188.  You may discuss any 
questions about your rights as a research subject, in private, with a member of the 
Institutional Review Board (IRB).  You may also call this number if you have other 
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questions about the research, and you cannot reach the study doctor, or want to talk to 
someone else. The IRB is an independent committee made up of people from the 
University community, staff of the institutions, as well as people from the community not 
connected with these institutions.  The IRB has approved the participation of human 
subjects in this research study.  
   
 
Concerns and Complaints 
 
If you have concerns or complaints about the research or research staff and you do not 
wish to give your name, you may call the toll-free number 1-877-852-1167.  This is a 24-
hour hot line answered by people who do not work at the University of Louisville. 
 
Acknowledgment and Signatures 
 
This informed consent document is not a contract.  This document tells you what will 
happen during the study if you choose to take part.  Your signature indicates that this 
study has been explained to you, that your questions have been answered, and that you 
agree to take part in the study.  You are not giving up any legal rights to which you are 
entitled by signing this informed consent document.  You will be given a copy of this 












Printed Name of Legally  Signature of Legally  
 Date Signed Authorized Representative (if 
applicable)  Authorized Representative 
     
 
__________________________________________________ 
Authority of Legally Authorized Representative to act on behalf of Subject 
*Authority to act on behalf of another includes, but is not limited to parent, guardian, or durable power of 
attorney for health care. 
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____________________________________________________________________________________ 
Printed Name of Person Explaining Consent Form Signature of Person Explaining   Date Signed                                                                               
Consent Form (if other than the Investigator) 
 
Printed Name of Investigator   Signature of Investigator                   Date Signed 
List of Investigators:    Phone Numbers: 
Anna Faul, PhD     502-852-1981  
Sam Cotton, MSSW    502-852-5629   
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REVOCATION OF AUTHORIZATION FOR USE AND DISCLOSURE OF 





To Whom It May Concern: 
 
I would like to discontinue my participation in the research study noted above. I understand 
that health information already collected will continue to be used as discussed in the 
Authorization I signed when joining the study. 
 
Your options are (choose one): 
 
□ Withdraw from Study & Discontinue Authorization: 
Discontinue my authorization for the future use and disclosure of protected health 
information. In some instances, the research team may need to use your information even 
after you discontinue your authorization, for example, to notify you or government agencies 
of any health or safety concerns that were identified as part of your study participation.  
 
□ Withdraw from Study, but Continue Authorization: 
Allow the research team to continue collecting information from me and my personal health 
information. This would be done only as needed to support the goals of the study and would 








Signature of Subject’s Legal Representative (if subject is unable to sign)  Date Signed 
 
Printed Name of Subject’s Legal Representative      
 
Optional: 
PI Address: 300 E Market St. Suite 200  
Louisville KY 40222          
PI Phone:   502-852-5629   
Institutional Review Board 
MedCenter One, Suite 200 
501 E. Broadway 
Louisville, KY 40202 
OR 
Do not sign this letter unless you are withdrawing from this research.   You will be 
sent confirmation that this notice was received. 
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CNA Baseline Survey (Experimental Group) 
Participant ID: __________________ 
 
Part I: Demographics 
Please answer the following questions about yourself.  
 
1.) Date of Birth:  ____ /_____ /____  
 
2.) Gender:  
 
3.) Do you consider yourself Hispanic? Yes____ No_____ 
 










5.) Number of years working in nursing facilities: __________ 
 
6.) Number of years working in this specific facility: _______ 
 












Part II: Alzheimer’s Disease Knowledge Scale (ADKS)  
Please answer each question by indicating whether the statement is true or false.  
 
1. People with Alzheimer’s disease are particularly prone to depression.  
a. True  
b. False  
2. It has been scientifically proven that mental exercise can prevent a person from 
getting Alzheimer’s disease.  
a. True  
b. False  
3. After symptoms of Alzheimer’s disease appear, the average life expectancy is 6 to 
12 years.  
a. True 
b. False  
4. When a person with Alzheimer’s disease becomes agitated, a medical 
examination might reveal other health problems that caused the agitation.  
a. True  
b. False 
5. People with Alzheimer’s disease do best with simple instructions given one step 
at a time.  
a. True  
b. False  
6. When people with Alzheimer’s disease begin to have difficulty taking care of 
themselves, caregivers should take over right away.  
a. True  
b. False 
7. If a person with Alzheimer’s disease becomes alert and agitated at night, a good 
strategy is to try to make sure that the person gets plenty of physical activity 
during the day.  
a. True  
b. False  
8. In rare cases, people have recovered from Alzheimer’s disease.  
a. True  
b. False  
9. People whose Alzheimer’s disease is not yet severe can benefit from 
psychotherapy for depression and anxiety.  
a. True  
b. False  
10. If trouble with memory and confused thinking appears suddenly, it is likely due to 
Alzheimer’s disease.  
a. True  







11. Most people with Alzheimer’s disease live in nursing homes.  
a. True  
b. False  
12. Poor nutrition can make the symptoms of Alzheimer’s disease worse.  
a. True  
b. False  
13. People in their 30’s can have Alzheimer’s disease.  
a. True  
b. False  
14. A person with Alzheimer’s disease becomes increasingly likely to fall down as 
the disease gets worse.  
a. True  
b. False  
15. When people with Alzheimer’s disease repeat the same question or story several 
times, it is helpful to remind them that they are repeating themselves.  
a. True  
b. False  
16. Once people have Alzheimer’s disease, they are no longer capable of making 
informed decisions about their own care.  
a. True  
b. False  
17. Eventually, a person with Alzheimer’s disease will need 24-hours supervision.  
a. True  
b. False  
18. Having high cholesterol may increase a person’s risk of developing Alzheimer’s 
disease.  
a. True  
b. False  
19. Tremor or shaking of the hands or arms is a common symptom in people with 
Alzheimer’s disease.  
a. True  
b. False  
20. Symptoms of severe depression can be mistaken for symptoms of Alzheimer’s 
disease.  
a. True  
b. False  
21. Alzheimer’s disease is one type of dementia.  
a. True  
b. False  
22. Trouble handling money or paying bills is a common early symptom of 
Alzheimer’s disease.  
a. True  
b. False  
 
 230  
23. One symptom that can occur with Alzheimer’s disease is believing that other 
people are stealing one’s things.  
a. True  
b. False  
24. When a person has Alzheimer’s disease, using reminder notes is a crutch that can 
contribute to decline.  
a. True  
b. False  
25. Prescription drugs that prevent Alzheimer’s disease are available.  
a. True  
b. False  
26. Having high blood pressure may increase a person’s risk of developing 
Alzheimer’s disease.  
a. True 
b. False  
27. Genes can only partially account for the development of Alzheimer’s disease.  
a. True  
b. False  
28. It is safe for people with Alzheimer’s disease to drive, as long as they have a 
companion in the care at all times.  
a. True  
b. False  
29. Alzheimer’s disease cannot be cured.  
a. True  
b. False  
30. Most people with Alzheimer’s disease remember recent events better than things 
that happened in the past.  
a. True  
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Part III: Self-Efficacy for Restorative Care Activities  
These questions are about your confidence in your ability to provide restorative care at 
this present time. For each question, there is a scale from 1 to 10, with 1 representing no 
confidence and 10 representing total confidence. Please circle the number that best 
represents your feelings. 
I feel confident that I can provide restorative care activities related to: 
                                                                 1=   No confidence                                            10= Total Confidence  
Having residents participate in bathing. 
1 2 3 4 5 6 7 8 9 10 
Having residents participate in dressing. 
1 2 3 4 5 6 7 8 9 10 
Having residents participate in eating. 1 2 3 4 5 6 7 8 9 10 
Having residents participate in a walking 
program.  1 2 3 4 5 6 7 8 9 10 
Having residents participate in a specific 
exercise program.  1 2 3 4 5 6 7 8 9 10 
Having residents participate in toileting 
activities.  1 2 3 4 5 6 7 8 9 10 
Episodes when the resident refuses to 
participate in specific activities.   1 2 3 4 5 6 7 8 9 10 
Days when I am assigned more residents than 
usual because of staffing issues.  1 2 3 4 5 6 7 8 9 10 
When the residents are anxious to get ready 
for an appointment or a visit from someone.  1 2 3 4 5 6 7 8 9 10 
When the family wants me to provide total 














Not at all  
2 




Quite a bit  
5 
A great deal  
Your health has suffered because of the care 
you must give to the nursing home residents 
with Alzheimer’s disease.  
1 2 3 4 5 
You are isolated and alone as a result of 
your caring for the nursing home residents 
with Alzheimer’s disease. 
1 2 3 4 5 
You will be unable to take care of the 
nursing home residents with Alzheimer’s 
disease much longer.   
1 2 3 4 5 
You are very tired as a result of your caring 
for the nursing home residents with 
Alzheimer’s disease. 
1 2 3 4 5 
Taking care of the nursing home residents 
with Alzheimer’s disease gives you a 
trapped feeling.  
1 2 3 4 5 
Your social life has suffered because you 
care for nursing home residents with 
Alzheimer’s disease.    
1 2 3 4 5 
Because of the time you spend with the 
nursing home residents with Alzheimer’s 
disease, you don’t have enough time for 
yourself.  
1 2 3 4 5 
You really enjoy being with the nursing 
home residents with Alzheimer’s disease.   1 2 3 4 5 
The nursing home residents with 
Alzheimer’s disease pleasure over some 
little things gives you pleasure.  
1 2 3 4 5 
Helping the nursing home residents with 
Alzheimer’s disease has made you feel 
closer to them.  
1 2 3 4 5 
Taking responsibility for the nursing home 
residents with Alzheimer’s disease. Gives 
your self-esteem a boost.  
1 2 3 4 5 
You get a sense of satisfaction from caring 
for the nursing home residents with 
Alzheimer’s disease. 
1 2 3 4 5 
Caring for the nursing home residents with 
Alzheimer’s disease gives more meaning to 
your life.  
1 2 3 4 5 
You feel about to handle most problems in 
the care of the nursing home residents with 
Alzheimer’s disease. 
1 2 3 4 5 
You are pretty good at figuring out what to 
do about the nursing home residents with 
Alzheimer’s disease. 
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Part II: Alzheimer’s Disease Knowledge Scale (ADKS)  
Please answer each question by indicating whether the statement is true or false.  
 
1. People with Alzheimer’s disease are particularly prone to depression.  
a. True  
b. False  
2. It has been scientifically proven that mental exercise can prevent a person from 
getting Alzheimer’s disease.  
a. True  
b. False  
3. After symptoms of Alzheimer’s disease appear, the average life expectancy is 6 to 
12 years.  
a. True 
b. False  
4. When a person with Alzheimer’s disease becomes agitated, a medical 
examination might reveal other health problems that caused the agitation.  
a. True  
b. False 
5. People with Alzheimer’s disease do best with simple instructions given one step 
at a time.  
a. True  
b. False  
6. When people with Alzheimer’s disease begin to have difficulty taking care of 
themselves, caregivers should take over right away.  
a. True  
b. False 
7. If a person with Alzheimer’s disease becomes alert and agitated at night, a good 
strategy is to try to make sure that the person gets plenty of physical activity 
during the day.  
a. True  
b. False  
8. In rare cases, people have recovered from Alzheimer’s disease.  
a. True  
b. False  
9. People whose Alzheimer’s disease is not yet severe can benefit from 
psychotherapy for depression and anxiety.  
a. True  
b. False  
10. If trouble with memory and confused thinking appears suddenly, it is likely due to 
Alzheimer’s disease.  
a. True  







11. Most people with Alzheimer’s disease live in nursing homes.  
a. True  
b. False  
12. Poor nutrition can make the symptoms of Alzheimer’s disease worse.  
a. True  
b. False  
13. People in their 30’s can have Alzheimer’s disease.  
a. True  
b. False  
14. A person with Alzheimer’s disease becomes increasingly likely to fall down as 
the disease gets worse.  
a. True  
b. False  
15. When people with Alzheimer’s disease repeat the same question or story several 
times, it is helpful to remind them that they are repeating themselves.  
a. True  
b. False  
16. Once people have Alzheimer’s disease, they are no longer capable of making 
informed decisions about their own care.  
a. True  
b. False  
17. Eventually, a person with Alzheimer’s disease will need 24-hours supervision.  
a. True  
b. False  
18. Having high cholesterol may increase a person’s risk of developing Alzheimer’s 
disease.  
a. True  
b. False  
19. Tremor or shaking of the hands or arms is a common symptom in people with 
Alzheimer’s disease.  
a. True  
b. False  
20. Symptoms of severe depression can be mistaken for symptoms of Alzheimer’s 
disease.  
a. True  
b. False  
21. Alzheimer’s disease is one type of dementia.  
a. True  
b. False  
22. Trouble handling money or paying bills is a common early symptom of 
Alzheimer’s disease.  
a. True  
b. False  
23. One symptom that can occur with Alzheimer’s disease is believing that other 





a. True  
b. False  
 
24. When a person has Alzheimer’s disease, using reminder notes is a crutch that can 
contribute to decline.  
a. True  
b. False  
25. Prescription drugs that prevent Alzheimer’s disease are available.  
a. True  
b. False  
26. Having high blood pressure may increase a person’s risk of developing 
Alzheimer’s disease.  
a. True 
b. False  
27. Genes can only partially account for the development of Alzheimer’s disease.  
a. True  
b. False  
28. It is safe for people with Alzheimer’s disease to drive, as long as they have a 
companion in the care at all times.  
a. True  
b. False  
29. Alzheimer’s disease cannot be cured.  
a. True  
b. False  
30. Most people with Alzheimer’s disease remember recent events better than things 
that happened in the past.  
a. True  
















Part III: Self-Efficacy for Restorative Care Activities  
These questions are about your confidence in your ability to provide restorative care at 
this present time. For each question, there is a scale from 1 to 10, with 1 representing no 
confidence and 10 representing total confidence. Please circle the number that best 
represents your feelings.  
I feel confident that I can provide restorative care activities related to: 
                                                                                1=   No confidence                                 10= Total 
Confidence  
Having residents participate in bathing. 1 2 3 4 5 6 7 8 9 10 
Having residents participate in dressing. 1 2 3 4 5 6 7 8 9 10 
Having residents participate in eating. 1 2 3 4 5 6 7 8 9 10 
Having residents participate in a walking 
program.  
1 2 3 4 5 6 7 8 9 10 
Having residents participate in a specific 
exercise program.  
1 2 3 4 5 6 7 8 9 10 
Having residents participate in toileting 
activities.  
1 2 3 4 5 6 7 8 9 10 
 
  
Episodes when the resident refuses to 
participate in specific activities.   
1 2 3 4 5 6 7 8 9 10 
Days when I am assigned more residents 
than usual because of staffing issues.  
1 2 3 4 5 6 7 8 9 10 
When the residents are anxious to get ready 
for an appointment or a visit from someone.  
1 2 3 4 5 6 7 8 9 10 
When the family wants me to provide total 
care.  
1 2 3 4 5 6 7 8 9 10 
 
Part IV: Caregiving Appraisal  
These questions are about how you feel about the caregiving situation. Please indicate 




Not at all  
2 








Your health has suffered because of the 
care you must give to the nursing home 
residents with Alzheimer’s disease.  
1 2 3 4 5 
You are isolated and alone as a result of 
your caring for the nursing home 
residents with Alzheimer’s disease. 
1 2 3 4 5 
You will be unable to take care of the 
nursing home residents with Alzheimer’s 
disease much longer.   
1 2 3 4 5 
You are very tired as a result of your 
caring for the nursing home residents 
with Alzheimer’s disease. 
1 2 3 4 5 
Taking care of the the nursing home 
residents with Alzheimer’s disease gives 
you a trapped feeling.  





Not at all  
2 








Your social life has suffered because you 
care for nursing home residents with 
Alzheimer’s disease.    
1 2 3 4 5 
Because of the time you spend with the 
nursing home residents with Alzheimer’s 
disease, you don’t have enough time for 
yourself.  
1 2 3 4 5 
You really enjoy being with the nursing 
home residents with Alzheimer’s disease.   1 2 3 4 5 
The nursing home residents with 
Alzheimer’s disease pleasure over some 
little things gives you pleasure.  
1 2 3 4 5 
Helping the nursing home residents with 
Alzheimer’s disease has made you feel 
closer to them.  
1 2 3 4 5 
Taking responsibility for the nursing 
home residents with Alzheimer’s disease. 
Gives your self-esteem a boost.  
1 2 3 4 5 
You get a sense of satisfaction from 
caring for the nursing home residents 
with Alzheimer’s disease. 
1 2 3 4 5 
Caring for the nursing home residents 
with Alzheimer’s disease gives more 
meaning to your life.  
1 2 3 4 5 
You feel about to handle most problems 
in the care of the nursing home residents 
with Alzheimer’s disease. 
1 2 3 4 5 
You feel reassured about what to do 
about the nursing home residents with 
Alzheimer’s disease. 
1 2 3 4 5 
You feel uncertain about what to do 
about the nursing home residents with 
Alzheimer’s disease. 
1 2 3 4 5 
You feel that you should be doing more.  
1 2 3 4 5 
You feel that you could do a better job in 
caring for the nursing home residents 
with Alzheimer’s disease. 














Part V: Affiliate Stigma Scale  
These questions are about how you feel about the working with persons with Alzheimer’s 
disease. Please indicate your amount of agreement with each statement.    
 
 1 
Not at all  
2 






Other people would discriminate against me if I 
am with nursing home residents with 
Alzheimer’s disease.   
1 2 3 4 
My reputation is damaged because I work with 
nursing home residents with Alzheimer’s 
disease. 
1 2 3 4 
People’s attitude towards me sour when I am 
with nursing home residents with Alzheimer’s 
disease.  
            1 2 3 4 
Working with nursing home residents with 
Alzheimer’s disease negatively affects me.  1 2 3 4 
Working with nursing home residents with 
Alzheimer’s disease makes me think that I am 
incompetent compared to others.  




Not at all  
2 






Working with nursing home residents with 
Alzheimer’s disease makes me think that I am 
lesser than others.  
1 2 3 4 
Working with nursing home residents with 
Alzheimer’s disease makes me lose face.  1 2 3 4 
I feel inferior because I work with individuals 
with Alzheimer’s disease. 1 2 3 4 
I feel emotionally disturbed because I work with 
individuals with Alzheimer’s disease. 1 2 3 4 
The behavior of residents with Alzheimer’s 
disease makes me feel embarrassed.    1 2 3 4 
I feel helpless because I work with nursing 
home residents with Alzheimer’s disease. 1 2 3 4 
I feel sad because I work with nursing home 
residents with Alzheimer’s disease. 1 2 3 4 
I worry if other would know that I work with 
nursing home residents with Alzheimer’s 
disease.  
1 2 3 4 
I am under great stress as I work with nursing 
home residents with Alzheimer’s disease.  1 2 3 4 
I avoid communicating with nursing home 
residents with Alzheimer’s disease.  1 2 3 4 
I dare not tell others that I work with nursing 
home residents with Alzheimer’s disease.  1 2 3 4 
I have cut down on taking nursing home 
residents with Alzheimer’s disease on outings.  1 2 3 4 
Because of my work with nursing home 
residents with Alzheimer’s disease, I have 
reduced my contacts with friends and relatives.  
1 2 3 4 
When I am with the residents with Alzheimer’s 
disease, I keep an especially low profile.  1 2 3 4 
I have reduced my contacts with the nursing 




Not at all  
2 






I dare not participate in activities related to 
Alzheimer’s disease lest others suspect that I 
work with persons that have the disease.  
1 2 3 4 
Because of my work with nursing home 
residents with Alzheimer’s disease, I have 
reduced my contacts with my neighbors. 















APPENDIX B: INFORMED CONSENTS AND SURVEYS FOR CNAS CONTROL 
GROUP 
Subject Informed Consent Document and Research Authorization  
FOSTERING COMPASSIONATE CARE FOR INDIVIDUALS WITH 
ALZHEIMER’S DISEASE  
Investigator(s) name & address: Anna C. Faul, PhD & Samantha Cotton, MSSW, 300 E 
Market St, Suite 200, Louisville KY 40222.   
Site(s) where study is to be conducted: Institute for Sustainable Health & Optimal Aging 
Phone number for subjects to call for questions: 502-852-5629   
Introduction and Background Information  
You are invited to participate in a research study that focuses on compassionate care in 
nursing home settings, specifically focusing on residents with Alzheimer’s disease.  The 
purpose of this study is to evaluate a curriculum designed for nurse aides working with 
residents with Alzheimer’s disease. The study is being conducted by Dr. Anna C. Faul, 
PhD and Sam Cotton, MSSW, ABD. The study will take place at eight different nursing 
facilities in Kentucky. 
Approximately 300 subjects will be invited to participate.     
Purpose  
The purpose of this study is to evaluate a training curriculum delivered to state registered 
nurse aides (SNRA’s) in nursing homes.    
Procedures   
As part of this study, you will complete pre and post-test surveys about your experience 
with the curriculum, your knowledge of Alzheimer’s disease and related dementias, and 
your confidence in performing activities with residents with Alzheimer’s disease. 
Potential Risks  
There are no foreseeable risks other than possible discomfort in answering personal 
questions. There may be unforeseen risks.     
Benefits  
Nurse aides may increase their understanding of working with residents with Alzheimer’s 
disease, which could contribute to a transformation within the nursing home towards 
more compassionate care. The information collected may not benefit you directly. The 
information learned in this study may be helpful to others.   
 
Payment  
You will not be compensated for your time, inconvenience, or expenses while you are in 
this study.       
Revocation of Research Authorization 
You may cancel the permission you have given to use and share your protected health 
information at any time.  This means you can tell us to stop using and sharing your 
protected health information.  If you cancel your permission:  
 • We will stop collecting information about you. 
 • You may not withdraw information that we had before you told us to stop.  
o We may already have used it or shared it.  
o We may need it to complete the research.  
• Staff may ask your permission to follow-up with you if there is a medical reason 
to do so.   
To cancel your permission, you will be requested to complete a written “Revocation of 
Research Authorization” form located at the end of this document.  You may also obtain 
a copy from your study doctor, designated personnel or from the Human Subjects 
Protections Program Office website (http://louisville.edu/research/humansubjects/links-
to-forms).   
Confidentiality 
Total privacy cannot be guaranteed.  We will protect your privacy to the extent permitted 
by law.  If the results from this study are published, your name will not be made public. 
Once your information leaves our institution, we cannot promise that others will keep it 
private.     
Your information may be shared with the following: 
 • Organizations that provide funding at any time for the conduct of the research. 
 • The University of Louisville Institutional Review Board, Human Subjects 
Protection Program Office, Privacy Office, others involved in research 
administration and compliance at the University, and others contracted by the 
University for ensuring human subjects safety or research compliance  
• The local research team 
 • Researchers at other sites participating in the study (if applicable)  
• People who are responsible for research, compliance and HIPAA oversight at 
the institutions where the research is conducted  
• People responsible for billing, sending and receiving payments related to your 
participation in the study   
• Government agencies, such as:   
o Office for Human Research Protections   
o Office of Civil Rights    
Security 
Your information will be kept private. Any data collected will be stored at the Institute 
for Sustainable Health & Optimal Aging in secure area in a locked file cabinet.    
Voluntary Participation 
Taking part in this study is voluntary. You may choose not to take part at all. If you 
decide to be in this study, you may stop taking part at any time. If you decide not to be in 
this study or if you stop taking part at any time, you will not lose any benefits for which 
you may qualify.     
You will be told about any changes that may affect your decision to continue in the study.   
Contact Persons   
If you have any questions, concerns, or complaints about the research study, please 
contact Samantha Cotton at 502-852-5629.    
Research Subject’s Rights   
If you have any questions about your rights as a research subject, you may call the 
Human Subjects Protection Program Office at (502) 852-5188.  You may discuss any 
questions about your rights as a research subject, in private, with a member of the 
Institutional Review Board (IRB).  You may also call this number if you have other 
questions about the research, and you cannot reach the study doctor, or want to talk to 
someone else. The IRB is an independent committee made up of people from the 
University community, staff of the institutions, as well as people from the community not 
connected with these institutions.  The IRB has approved the participation of human 
subjects in this research study.      
Concerns and Complaints 
If you have concerns or complaints about the research or research staff and you do not 
wish to give your name, you may call the toll free number 1-877-852-1167.  This is a 24-




Acknowledgment and Signatures 
This informed consent document is not a contract.  This document tells you what will 
happen during the study if you choose to take part.  Your signature indicates that this 
study has been explained to you, that your questions have been answered, and that you 
agree to take part in the study.  You are not giving up any legal rights to which you are 
entitled by signing this informed consent document.  You will be given a copy of this 
consent form to keep for your records. 
________________________________________________________________________ 
Subject Name (Please Print)   Signature of Subject                   Date Signed 
 
Printed Name of Legally          Signature of Legally Authorized Rep     Date Signed     
Authorized Representative  
________________________________________________________________________  
Authority of Legally Authorized Representative to act on behalf of Subject 
 
Printed Name of Person  Explaining Consent Form Signature of Person Explaining                   Date Signed 
*Authority to act on behalf of another includes, but is not limited to parent, guardian, or 
durable power of attorney for health care. 
 
Printed Name of Person  Explaining Consent Form Signature of Person Explaining                   Date Signed 
 
Printed Name of Investigator Signed  Signature of Investigator Date Signed 
 
List of Investigators:     Phone Numbers: 
Anna Faul, PhD        502-852-1981   




REVOCATION OF AUTHORIZATION FOR USE AND DISCLOSURE OF YOUR 







To Whom It May Concern: 
 
I would like to discontinue my participation in the research study noted above. I 
understand that health information already collected will continue to be used as 
discussed in the Authorization I signed when joining the study. 
 
Your options are (choose one): 
 
□ Withdraw from Study & Discontinue Authorization: 
Discontinue my authorization for the future use and disclosure of protected health 
information. In some instances, the research team may need to use your information 
even after you discontinue your authorization, for example, to notify you or 
government agencies of any health or safety concerns that were identified as part of 
your study participation.  
 
□ Withdraw from Study, but Continue Authorization: 
Allow the research team to continue collecting information from me and my personal 
health information. This would be done only as needed to support the goals of the 
study and would not be used for purposes other than those already described in the 
research authorization. 
 
____________________    ___  _____    
Printed Name and Signature of Subject      Date 
Signed 
 
____________________    ___  _____            
 ________ 
Signature of Subject’s Legal Representative (if subject is unable to sign)  Date 
Signed 
 
___________________   _  _____                      
________ 
PI Address: 300 E Market St. Suite 200  
Louisville KY 40222          
PI Phone:   502-852-5629   
Institutional Review Board 
MedCenter One, Suite 200 
501 E. Broadway 
Louisville, KY 40202 
OR 
Do not sign this letter unless you are withdrawing from this research.   You will be 
sent confirmation that this notice was received. 
 
 




Relationship of Legal Representative to Subject 
 
____________________   _____   ____________ 























CNA Baseline and 12 Survey (Control Group)  
Participant ID: __________________ 
Part I: Demographics 
 
Please answer the following questions about yourself.  
 
1.) Date of Birth:  ____ /_____ /____  
 
2.) Gender:  
 
3.) Do you consider yourself Hispanic? Yes____ No_____ 
 










5.) Number of years working in nursing facilities: __________ 
 
6.) Number of years working in this specific facility: _______ 
 










Part II: Alzheimer’s Disease Knowledge Scale (ADKS)  
Please answer each question by indicating whether the statement is true or false.  
 
1. People with Alzheimer’s disease are particularly prone to depression.  
a. True  
b. False  
2. It has been scientifically proven that mental exercise can prevent a person from 
getting Alzheimer’s disease.  
a. True  
b. False  
3. After symptoms of Alzheimer’s disease appear, the average life expectancy is 6 to 
12 years.  
a. True 
b. False  
4. When a person with Alzheimer’s disease becomes agitated, a medical 
examination might reveal other health problems that caused the agitation.  
a. True  
b. False 
5. People with Alzheimer’s disease do best with simple instructions given one step 
at a time.  
a. True  
b. False  
6. When people with Alzheimer’s disease begin to have difficulty taking care of 
themselves, caregivers should take over right away.  
a. True  
b. False 
7. If a person with Alzheimer’s disease becomes alert and agitated at night, a good 
strategy is to try to make sure that the person gets plenty of physical activity 
during the day.  
a. True  
b. False  
8. In rare cases, people have recovered from Alzheimer’s disease.  
a. True  
b. False  
9. People whose Alzheimer’s disease is not yet severe can benefit from 
psychotherapy for depression and anxiety.  
a. True  
b. False  
10. If trouble with memory and confused thinking appears suddenly, it is likely due to 
Alzheimer’s disease.  
a. True  





11. Most people with Alzheimer’s disease live in nursing homes.  
a. True  
b. False  
12. Poor nutrition can make the symptoms of Alzheimer’s disease worse.  
a. True  
b. False  
13. People in their 30’s can have Alzheimer’s disease.  
a. True  
b. False  
14. A person with Alzheimer’s disease becomes increasingly likely to fall down as 
the disease gets worse.  
a. True  
b. False  
15. When people with Alzheimer’s disease repeat the same question or story several 
times, it is helpful to remind them that they are repeating themselves.  
a. True  
b. False  
16. Once people have Alzheimer’s disease, they are no longer capable of making 
informed decisions about their own care.  
a. True  
b. False  
17. Eventually, a person with Alzheimer’s disease will need 24-hours supervision.  
a. True  
b. False  
18. Having high cholesterol may increase a person’s risk of developing Alzheimer’s 
disease.  
a. True  
b. False  
19. Tremor or shaking of the hands or arms is a common symptom in people with 
Alzheimer’s disease.  
a. True  
b. False  
20. Symptoms of severe depression can be mistaken for symptoms of Alzheimer’s 
disease.  
a. True  
b. False  
21. Alzheimer’s disease is one type of dementia.  
a. True  
b. False  
22. Trouble handling money or paying bills is a common early symptom of 
Alzheimer’s disease.  
a. True  
b. False  
 
 
23. One symptom that can occur with Alzheimer’s disease is believing that other 
people are stealing one’s things.  
a. True  
b. False  
24. When a person has Alzheimer’s disease, using reminder notes is a crutch that can 
contribute to decline.  
a. True  
b. False  
25. Prescription drugs that prevent Alzheimer’s disease are available.  
a. True  
b. False  
26. Having high blood pressure may increase a person’s risk of developing 
Alzheimer’s disease.  
a. True 
b. False  
27. Genes can only partially account for the development of Alzheimer’s disease.  
a. True  
b. False  
28. It is safe for people with Alzheimer’s disease to drive, as long as they have a 
companion in the care at all times.  
a. True  
b. False  
29. Alzheimer’s disease cannot be cured.  
a. True  
b. False  
30. Most people with Alzheimer’s disease remember recent events better than things 
that happened in the past.  
a. True  














Part III: Self-Efficacy for Restorative Care Activities  
These questions are about your confidence in your ability to provide restorative care at 
this present time. For each question, there is a scale from 1 to 10, with 1 representing no 
confidence and 10 representing total confidence. Please circle the number that best 
represents your feelings.  
 
I feel confident that I can provide restorative care activities related to:  
                                                            1=   No confidence                                                  10= Total Confidence  
Having residents participate in bathing. 1 2 3 4 5 6 7 8 9 10 
Having residents participate in dressing. 1 2 3 4 5 6 7 8 9 10 
Having residents participate in eating. 1 2 3 4 5 6 7 8 9 10 
Having residents participate in a walking program.  1 2 3 4 5 6 7 8 9 10 
Having residents participate in a specific exercise 
program.  
1 2 3 4 5 6 7 8 9 10 
Having residents participate in toileting activities.  1 2 3 4 5 6 7 8 9 10 
Episodes when the resident refuses to participate in 
specific activities.   
1 2 3 4 5 6 7 8 9 10 
Days when I am assigned more residents than usual 
because of staffing issues.  
1 2 3 4 5 6 7 8 9 10 
When the residents are anxious to get ready for an 
appointment or a visit from someone.  
1 2 3 4 5 6 7 8 9 10 







Part IV: Caregiving Appraisal  
These questions are about how you feel about the caregiving situation. Please indicate 
your amount of agreement with each statement.    
 1 
Not at all  
2 








Your health has suffered because of the care 
you must give to the nursing home residents 
with Alzheimer’s disease.  
1 2 3 4 5 
You are isolated and alone as a result of your 
caring for the nursing home residents with 
Alzheimer’s disease. 
1 2 3 4 5 
You will be unable to take care of the nursing 
home residents with Alzheimer’s disease 
much longer.   
1 2 3 4 5 
You are very tired as a result of your caring 
for the nursing home residents with 
Alzheimer’s disease. 
1 2 3 4 5 
Taking care of the nursing home residents 
with Alzheimer’s disease gives you a trapped 
feeling.  
1 2 3 4 5 
Your social life has suffered because you care 
for nursing home residents with Alzheimer’s 
disease.    
1 2 3 4 5 
Because of the time you spend with the 
nursing home residents with Alzheimer’s 
disease, you don’t have enough time for 
yourself.  
1 2 3 4 5 
You really enjoy being with the nursing home 
residents with Alzheimer’s disease.   1 2 3 4 5 
The nursing home residents with Alzheimer’s 
disease pleasure over some little things gives 
you pleasure.  
1 2 3 4 5 
Helping the nursing home residents with 
Alzheimer’s disease has made you feel closer 
to them.  
1 2 3 4 5 
Taking responsibility for the nursing home 
residents with Alzheimer’s disease. Gives 
your self-esteem a boost.  
1 2 3 4 5 
You get a sense of satisfaction from caring for 
the nursing home residents with Alzheimer’s 
disease. 
1 2 3 4 5 
Caring for the nursing home residents with 
Alzheimer’s disease gives more meaning to 
your life.  
1 2 3 4 5 
You feel reassured about what to do about the 
nursing home residents with Alzheimer’s 
disease. 




Not at all  
2 








You feel uncertain about what to do about the 
nursing home residents with Alzheimer’s 
disease. 
1 2 3 4 5 
You feel that you should be doing more.  
1 2 3 4 5 
You feel that you could do a better job in 
caring for the nursing home residents with 
Alzheimer’s disease. 



















Part V: Affiliate Stigma Scale  
These questions are about how you feel about the working with persons with Alzheimer’s 
disease. Please indicate your amount of agreement with each statement.    
 1 
Not at all  
2 




Quite a bit  
Other people would discriminate against me if I 
am with nursing home residents with 
Alzheimer’s disease.   
1 2 3 4 
My reputation is damaged because I work with 
nursing home residents with Alzheimer’s 
disease. 
1 2 3 4 
People’s attitude towards me sour when I am 
with nursing home residents with Alzheimer’s 
disease.  
            1 2 3 4 
Working with nursing home residents with 
Alzheimer’s disease negatively affects me.  1 2 3 4 
Working with nursing home residents with 
Alzheimer’s disease makes me think that I am 
incompetent compared to others.  
1 2 3 4 
Working with nursing home residents with 
Alzheimer’s disease makes me think that I am 
lesser than others.  
1 2 3 4 
Working with nursing home residents with 
Alzheimer’s disease makes me lose face.  1 2 3 4 
I feel inferior because I work with individuals 
with Alzheimer’s disease. 1 2 3 4 
I feel emotionally disturbed because I work with 
individuals with Alzheimer’s disease. 1 2 3 4 
The behavior of residents with Alzheimer’s 
disease makes me feel embarrassed.    1 2 3 4 
I feel helpless because I work with nursing 
home residents with Alzheimer’s disease. 1 2 3 4 
I feel sad because I work with nursing home 
residents with Alzheimer’s disease. 1 2 3 4 
I worry if other would know that I work with 
nursing home residents with Alzheimer’s 
disease.  




Not at all  
2 




Quite a bit  
I am under great stress as I work with nursing 
home residents with Alzheimer’s disease.  1 2 3 4 
I avoid communicating with nursing home 
residents with Alzheimer’s disease.  1 2 3 4 
I dare not tell others that I work with nursing 
home residents with Alzheimer’s disease.  1 2 3 4 
I have cut down on taking nursing home 
residents with Alzheimer’s disease on outings.  1 2 3 4 
Because of my work with nursing home 
residents with Alzheimer’s disease, I have 
reduced my contacts with friends and relatives.  
1 2 3 4 
When I am with the residents with Alzheimer’s 
disease, I keep an especially low profile.  1 2 3 4 
I have reduced my contacts with the nursing 
home residents with Alzheimer’s disease.  1 2 3 4 
I dare not participate in activities related to 
Alzheimer’s disease lest others suspect that I 
work with persons that have the disease.  
1 2 3 4 
Because of my work with nursing home 
residents with Alzheimer’s disease, I have 
reduced my contacts with my neighbors. 


















I am invited to be in a research study being done Dr. Anna Faul, PhD, and Sam Cotton, 
MSSW, ABD. When a person is in a research study, they are called a “subject”.  I am 
invited because I have been diagnosed with Alzheimer’s disease and I live in a nursing 
home.  
 
This means that myself or my caregivers at the nursing home will be asked questions 
about me including questions about my demographics, my quality of life, and questions 
about when I get upset or agitated. As a subject in this study, I will have my salvia taken 
3 times during the study so that the research team can look at my stress levels. There may 
be some risks with this study. These risks are having your saliva taken and answering 
questions which may cause discomfort. This study will last 8 months. The benefit to me 
for participating in this study is that the data we collect will be used to help inform your 
care and the care of others at the nursing home where you live.  
 
My family, the researchers, and the workers at the nursing home I live at will know that 
I’m in the study.  If anyone else is given information about me, they will not know my 
name.  A number or initials will be used instead of my name. 
 
I have been told about this study and know why it is being done and what I have to do.  
My family has agreed to let me be in the study.  If I have any questions I can ask Dr. Faul 
or Sam Cotton.  They will answer my questions.  If I do not want to be in this study or I 
want to quit after I am already in this study, I can tell the researcher and they will discuss 
this with my family.  
             
Printed Name of Subject   Signature of Subject  Date Signed 
 
             
Printed Name of Legal Representative       
 
             





Resident Survey Baseline, 6 weeks and 12 weeks  
 
Participant ID: __________________ 
Part I: Basic Demographics 
 
Please answer the following questions about the resident.  
 
1.) Date of Birth:  ____ /_____ /____  
 
2.) Gender:  
 
3.) Do you consider yourself Hispanic? Yes____ No_____ 
 






















Part II: Rapid Cognitive Screen (For Demographic purposes only)  
 
1.) Please remember these five objects. I will ask you what they are later. [Read 
each object to patient using approximately 1 second intervals.]  
 
Apple           Pen         Tie       House        Car 
 
Please repeat the objects for me. [If patient does not repeat all 5 objects correctly, repeat 
until all objects are recalled correctly or up to a maximum of 2 times.]  
 
2.) [Give patient pencil and blank sheet with clock face.]  
This is a clock face. Please put in the hour markers and the time at ten 
minutes to eleven o’clock.  
 
____/ 2 (points) Hour markers are okay  
 ____/2 (points) Time correct  
 
3.) What were the five objects I asked you to remember?  
 
____/ 1 (point) Apple  
____/ 1 (point) Pen  
____/ 1 (point) Tie 
____/ 1 (point) House  
 
 
____/ 1 (point) Car   
 
4.) I’m going to tell you a story. Please listen carefully because afterwards, I’m going 
to ask you about it.  
 
Jill was a very successful stockbroker. She made a lot of money on the stock market. 
She then met Jack, a devastatingly handsome man. She married him and had three 
children. They lived in Chicago. She then stopped work and stayed at home to bring 
up her children. When they were teenagers, she went back to work. She and Jack 
lived happily ever after.  
 
What state did she live in?  
____/ 1 (point) Illinois  
 
[Do not repeat the story but do make sure that the patient is listening the first time 
you read it to them. Do not prompt or give hints. The answer of “Chicago” as the 
state that she lives in gets no credit but you may prompt them once by repeating the 
question when “Chicago” is given as the answer.]  
 


































Part III: The Cohen-Mansfield Agitation Inventory  
Please read each of the 29 agitated behaviors, and circle how often (from 1-7) each was 


























Pace, aimlessly wandering  1 2 3 4 5 6 7 
Inappropriate dress or 
disrobing  1 2 3 4 5 6 7 
Spitting (including at meals)   1 2 3 4 5 6 7 
Cursing or verbal aggression   1 2 3 4 5 6 7 
Constant unwarranted 
request for attention or help   1 2 3 4 5 6 7 
Repetitive sentences or 
questions    1 2 3 4 5 6 7 
Hitting (including self)   1 2 3 4 5 6 7 
Kicking   1 2 3 4 5 6 7 
Grabbing onto people  1 2 3 4 5 6 7 
Pushing  1 2 3 4 5 6 7 
Throwing things  1 2 3 4 5 6 7 
Strange noises (weird 
laughter or crying)  1 2 3 4 5 6 7 
Screaming  1 2 3 4 5 6 7 
Biting  1 2 3 4 5 6 7 
Scratching  1 2 3 4 5 6 7 
Trying to get to a different 
place (e.g., out of the room, 
building)  
1 2 3 4 5 6 7 
Intentional falling  
1 2 3 4 5 6 7 




























Negativism  1 2 3 4 5 6 7 
Eating/drinking 
inappropriate substances  1 2 3 4 5 6 7 
Hurt self or others (cigarette, 
hot water, etc.)  1 2 3 4 5 6 7 
Handling things 
inappropriately  1 2 3 4 5 6 7 
Hiding things  1 2 3 4 5 6 7 
Hoarding things  1 2 3 4 5 6 7 
Tearing things or destroying 
property  1 2 3 4 5 6 7 
Performing repetitious 
mannerisms 1 2 3 4 5 6 7 
Making verbal sexual 
advances  1 2 3 4 5 6 7 
Making physical sexual 
advances  1 2 3 4 5 6 7 
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